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Abstract iii
Abstract/Summary 
 
The socio-economic impact of HIV/AIDS on South Africa has resulted in lower gross 
domestic product, loss of skills in key sectors such as education, and increased health-care 
costs in providing access to treatment. Currently active pharmaceutical ingredients (API’s) 
such as stavudine (d4T) and azidothymidine (AZT) are imported from India and China, while 
formulation is conducted locally. A strategy was initiated between CSIR Biosciences and 
LIFElab under the auspices of Arvir Technologies to investigate the feasibility of local anti-
retroviral manufacture (d4T and AZT) or the manufacture of a key intermediate such as β-
thymidine (dT). Several advantages associated with successful implementation of this strategy 
include ensuring a local supply of API’s, thus reducing reliance on procurement from foreign 
sources and reducing the effect of foreign exchange rate fluctuations on providing cost 
effective access to treatment. A local supply source would also reduce the imports and thus 
aid the balance of payments deficit, and in addition to this, provide stimulus in the local 
pharmaceutical manufacturing industry (which has been in decline for several decades), 
resulting in increased skills and employment opportunities. 
 
This thesis describes the development of a superior chemo-enzymatic process for the 
production of β-thymidine (72% yield, prior to isolation), a key intermediate in the 
preparation of anti-retrovirals. Alternative processes based purely on chemical or bioprocess 
transformations to prepare either 5-methyluridine (5-MU) or dT suffer from several 
disadvantages: lengthy transformations due to protection/deprotection strategies, low 
selectivties and product yields (30% in the chemical process) and isolation of the product 
from dilute process streams requiring the use of large uneconomical reactors (bioprocess). 
This contributes significantly to the cost of d4T and AZT manufacture. Our novel chemo-
enzymatic process comprises of a biocatalytic reaction for the production of 5-MU, with 
subsequent chemical transformation into dT (3 steps) negating and circumventing the 
limitations of the chemical or bioprocess routes. During the course of this project 
development, the β-thymidine selling price declined from 175 $/kg (2005) to 100 $/kg (2008). 
However, the process described in this work is still competitive based on the current β-
thymidine selling price of 100 $/kg. The process economics show that with further 
optimization and increasing the isolated dT yield from 70% to 90%, the variable cost 
decreases from 136 $/kg to 110 $/kg. The increase in isolated yield is highly probable, based 
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on solubility data of β-thymidine. The decrease in β-thymidine selling price and technological 
improvement in dT manufacture should translate into lower API manufacture costs and more 
cost effective access to treatment. 
 
Our novel biocatalytic process producing 5-MU uses a coupled enzyme system employing 
PNP, Purine Nucleoside Phosphorylase and PyNP, Pyrimidine Nucleoside Phosphorylase. 
The overall transglycosylation reaction may be decoupled into the phosphorolysis reaction 
(PNP) and synthesis reaction (PyNP). During the phosphorolysis reaction, guanosine is 
converted into guanine and ribose-1-phosphate (R-1-P) in the presence of PNP enzyme. The 
reaction intermediate R-1-P is then coupled to thymine in the presence of PyNP enzyme 
during the synthesis reaction, producing 5-MU. The process was scaled up from lab-scale to 
bench-scale (10 - 20 L) and demonstrated to be robust and reproducible. This is evident from 
the average guanosine conversion (94.7% ± 2.03) and 5-MU yield (88.2% ± 6.21) and mole 
balance (104% ± 7.61) which were obtained at bench-scale (3 replicates, 10 L). The reaction 
was carried out at reactor productivities of between 7 – 11 g.L-1.h-1. The integration of the 
biocatalytic process and chemical processes was successfully carried out, showing that 5-MU 
produced using our novel biocatalytic process behaved similarly to commercially available 5-
MU (ex. Dayang Chemicals, China). 
 
A PCT patent application (Ref. No. P44422PC01) on this chemo-enzymatic process has been 
filed and currently public private partnerships are being explored through Arvir Technologies 
to evaluate and validate this technology at one ton scale. 
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CHAPTER ONE 
 
1 Introduction 
 
1.1 Acquired immune deficiency syndrome (AIDS) 
 
Human immunodeficiency virus (HIV) is a retrovirus that causes Acquired Immunodeficiency 
Syndrome (AIDS)1, a condition in which the immune system begins to fail, leading to life-
threatening opportunistic infections. Infection by the HIV occurs via the transfer of bodily 
fluids, such as blood, semen, vaginal fluid and breast milk. The major routes of transmission 
are sexual intercourse, contaminated needles, transmission from mother to child at birth, or 
through breast milk. Transmission through blood transfusions has largely been eliminated 
through screening of blood products. HIV has also been found in low concentrations in saliva, 
tears and urine, but the risk of transmission by these secretions is negligible. 
 
HIV infection has reached pandemic proportions, and as of January 2006 the joint United 
Nations Program on HIV/AIDS (UNAIDS) and the World Health Organization (WHO) 
estimate that AIDS has killed more than 25 million people since it was first recognized on 1 
December 1981. In 2005 AIDS claimed an estimated 2.4-3.3 million lives worldwide, of 
which 570,000 were children. A third of these deaths occurred in sub-Saharan Africa, 
resulting in retarded economic growth and increasing poverty2,3. 
 
Currently no cure exists for HIV and AIDS; however the use of antiretroviral treatment 
effectively reduces the mortality and morbidity of HIV infection4, as well as reducing 
transfection. The use of antiretroviral drugs (ARV’s) in the treatment of HIV and AIDS in 
developing countries has been met with limited success due to the high expense associated 
with this class of drugs; as a result infected individuals do not have access to medication. 
Hence, there is an opportunity for development of cheaper synthetic routes for ARV’s. 
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1.1.1 HIV life cycle 
 
HIV was classified as a member of the genus lentivirus, which is part of the family of 
retroviridiae. Lentiviruses are able to infect many different species and are characteristically 
responsible for long-duration illnesses, accompanied by long incubation periods. The 
structure of HIV is shown in Figure 1.11. 
 
 
Figure 1.1: Diagram of HIV1 
 
The HIV replication cycle, shown in Figure 1.21, takes place via the following mechanism. 
Lentiviruses are transmitted as single-stranded, positive-sense enveloped RNA viruses. On 
infecting the target cell, the viral RNA genome is converted into double stranded DNA, by the 
virally encoded reverse transcriptase enzyme that is present in the virus particle. The viral 
DNA is then integrated into the cellular DNA by virally encoded integrase enzyme, so that the 
genome can be transcribed. Once the virus has infected the cell, two pathways are possible; 
either the virus becomes latent and the infected cell continues to function, or the virus 
becomes active and replicates, releasing a large number of virus particles that can infect other 
cells5. 
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Figure 1.2: The HIV replication cycle1 
 
HIV differs from other viruses in that it has a very high genetic variability due to its fast 
replication cycle. Coupled with a high mutation rate, this leads to the generation of many 
variants of HIV in a single infected patient in the course of one day. This variability is 
compounded when a single cell is simultaneously infected with two or more different strains 
of HIV. 
 
1.2 Epidemiology 
 
Sub-Saharan Africa remains the worst affected region (see Figure 1.3), with an estimated 21.6 
- 27.4 million people currently living with HIV. Approximately 64% of all people living with 
HIV worldwide are found in this region, of which more than 75% are women. The impact of 
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the disease has resulted in 12 million orphans living in this region. It is estimated that 5.5 
million people or 11.9% of the South African population are infected with HIV. 
 
 
Figure 1.3: Prevalence of HIV among adults per country at the end of 20051 
 
The implementation and prevention of HIV programs in South Africa has resulted in 
significant inroads, against the epidemic and significant progress has also been made with 
respect to access to treatment. However based on findings from WHO/UNAIDS 2005, it was 
estimated that approximately 190 000 patients had access to anti-viral therapy, corresponding 
to less than 20% of the one million patients requiring treatment6 at that time. 
 
1.3 Treatment of HIV/AIDS 
 
Currently there is no preventative vaccine7 or cure for HIV or AIDS. The only known method 
of prevention is avoiding exposure to the virus. The current treatment for HIV infection 
consists of using highly active antiretroviral therapy (HAART). HAART treatment involves 
combinations or “cocktails” consisting of at least three drugs belonging to two types, or 
“classes” of anti-retroviral agents. Typically the drug cocktail includes two nucleoside 
analogue reverse transcriptase inhibitors (NARTI’s or NRTI’s) combined with either a non-
nucleoside reverse transcriptase inhibitor (NNRTI) or a protease inhibitor (PI)8. Examples of 
drugs from each class are shown in Figure 1.4. 
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Figure 1.4: Examples of NRTI’s, NNRTI and PI  
 
In general nucleoside analogues (the NRTI’s) are converted in the body into active 
nucleotides. Tenofovir (see Figure 1.5) is a nucleotide analogue active against HIV which 
does not require activation by the body and may be more effective in treating the infection. 
 
N N
NH2
N
N
OP
O
HO
HO
Tenofovir (TDF)
 
 
Figure 1.5: Tenofovir is an example of a Nucleotide Analog Reverse Transcriptase 
Inhibitor. 
 
The use of HAART in the treatment of a patient infected with HIV stabilizes the patient’s 
symptoms but does not cure the patient. On ceasing treatment, high levels of the HIV-1 
HAART resistant virus returns. Irrespective of this, many HIV-infected individuals have 
experienced remarkable improvements in their general health and quality of life, resulting in a 
large reduction of HIV associated morbidity and mortality in the developed world4. HAART 
treatment prevents or delays the progression of the disease from HIV to AIDS. 
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1.4 Synthesis of NRTI’s 
 
Stavudine (d4T), zidovudine (AZT), lamivudine (3TC), nevirapine (NVP) and efavirenz 
(EFV) are widely used during the first line regimen treatment of HIV/AIDS. The drugs may 
be used in single, or combination therapy, and represent 96% of the ARV’s used in sub-
Saharan Africa9 to treat HIV/AIDS. Currently both stavudine (d4T) and zidovudine (AZT) 
may be prepared from 5-methyluridine (5-MU) using a route commercialized by Bristol 
Meyers Squibb (BMS, see Scheme 1.110,11). The overall yield of d4T by this process is 75%, 
while that of AZT is 44%. 
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Scheme 1.1: Preparation of stavudine (d4T) and zidovudine (AZT) from 5-MU10,11 
 
An alternative procedure to prepare AZT from β-thymidine (see Scheme 1.2)12 was also 
reported in the literature. The overall AZT yield from this method was ca. 46%12.  
 
Chapter One 8 
O
OH
HO
HN
N
O
O
O
N3
HO
HN
N
O
O
i) diphenyl sulphite
dimethylacetamide
(65%)
O
HO
HN
N
O
O
ii) Lithium azide
dimethylacetamide
(71%)
AZT
 
 
Scheme 1.2: Preparation of AZT from thymidine12 
 
1.5 Synthesis of Nucleosides13 
 
5-Methyluridine is currently produced by chemical routes, but the methods suffer from 
several disadvantages such as lengthy process steps14, low yields15,16 and low selectivities 
(since a mixture of isomers is produced17). Although β-thymidine may also be produced by 
chemical routes, similar limitations to those discussed above limit the economical preparation 
of β-thymidine18,19,20,21. It is, therefore, preferentially synthesised by fermentation in low 
thymidine concentrations (7 g.L-1). The low concentration of β-thymidine in the cells may be 
attributed to β-thymidine being involved in DNA synthesis and is thus tightly controlled. 
Consequently few fermentation processes are available for β-thymidine production22. Due to 
the low concentration of β-thymidine produced by fermentation processes, additional costs in 
isolating the product from dilute process streams are incurred, thus limiting the economical 
production of β-thymidine. 
 
1.5.1 Nucleoside and oligionucleotide products for pharmaceuticals and 
pharmaceutical production 
 
In general, nucleosides such as inosine and guanosine have been produced commercially by 
fermentation processes23; however the economical production of β-thymidine has not been 
achieved using this methodology. β-Thymidine may be obtained from natural sources such as 
milt (by hydrolysis and separation from deoxyribonucleic acid). Companies such as Yamasa 
in Japan and Reliable Biopharmaceuticals Corp. in St. Louis have digested hundreds of tonnes 
of salmon milt each year to isolate tonne quantities of individual nucleosides such as 
deoxyadenosine, deoxycytidine, deoxyguanosine and β-thymidine. However, the use of 
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natural resources is unlikely to be sustainable to produce the amounts required for the 
manufacture of therapeutic oligionucleotides, as typically 100 tonnes of salmon yield 
approximately 55 kg of the above deoxynucleosides in roughly equal amounts. Therefore, 
alternative chemical, enzymatic and fermentation processes are being developed to meet the 
pharmaceutical industry requirements. Mitsui Chemicals produce the deoxynucleoside 
building blocks by chemical conversion of D-glucose to deoxyribose phosphate, followed by 
the enzyme-catalyzed addition of the required purine or pyrimidine base. Yamasa and 
Ajinomoto are also active in the production of nucleosides by biosynthetic methods, using 
enzymatic and fermentative methods as the main source of building blocks in the future. 
Currently di-sodium inosine-5'-monophosphate and di-sodium guanosine-5'-monophosphate, 
which are important components of the umami taste, are manufactured in Japan by 
fermentation of yeast. Subsequently, methods to produce β-thymidine using fermentation24 
have been developed as an alternative to the chemical processes and natural sources. β-
Thymidine (dT) is required in multi-tonne quantities as a precursor to the anti-AIDS drugs 
stavudine (d4T) and zidovudine (AZT). 
 
Considerable effort has also been expended on the chemical synthesis of nucleosides25 
(natural and synthetic). Classical chemical methods used to synthesise nucleosides may be 
classified according to the following three classes: 
 
- A preformed purine or pyrimidine derivative is treated with a suitably reactive form of 
sugar, commonly a glycosyl halide. 
- The purine or pyrimidine ring system may be constructed from a simple N-glycosyl 
precursor 
- A preformed nucleoside is modified in either the sugar moiety or in the purine or 
pyrimidine base. 
 
The application of the above chemical methodologies suffer from numerous disadvantages, 
such as the use of toxic metals reagents such as silver, mercury and tin which are used to 
activate substrates. The transformations are also carried out using multi-step synthesis, 
resulting in low overall process yields.  
 
Chapter One 10 
A typical method involves the treatment of a silver activated purine (silver 2,8-
dichloradenine) with a protected sugar substrate (2,3,4,5-tetra-O-acetyl-α-D-glucopyranosyl 
bromide), followed by subsequent dehalogenation of the 2,8-dichlor-9-glucosyladenine to 
yield the product (9-β-D-glucopyranosyladenine). Application of this method to the synthesis 
of pyrimidines has limited success, since pyrimidines contain a lactam-lactim tautomeric 
system. The use of protected pyrimidines such as 2,6-diethoxypyrimidine, however, restricts 
the prototropic shift and circumvents the above limitation. The method was also adapted to 
synthesize naturally occurring nucleosides such as cytidine and uridine (by deamination) 
starting from acetobromoribofuranose and 2,4-diethoxypyrimidine, which required the 
development of a procedure to prepare ribofuranosyl halides. For example, the first successful 
synthetic approach to the naturally occurring nucleoside guanosine gave the desired product 
in an overall yield of 3%.26 The method also suffers from the disadvantage that it cannot be 
applied to purines containing basic amino groups. Yields can be improved by using 
chloromercury purines rather than the silver derivatives, in which case the guanosine yield 
based on 2,6-diaminopurine is 21% (Scheme 1.3)13. The method requires extensive protection 
and de-protection, and concomitant with the use of toxic mercury27 is a rather uneconomical 
and environmentally hazardous process. 
 
The mercury procedure has also been applied to the synthesis of 2'-deoxynucleosides. Earlier 
attempts at synthesizing the naturally occurring 2'-deoxynucleosides were not successful 
using a protected 2'-deoxyhalogeno-furanose due to the halogenose instability. 
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Scheme 1.3: Preparation of guanosine from 2,6-diaminopurine13 
 
1.5.2 Chemical preparation of 5-MU from thymine 
 
The synthesis of 5-MU via the mercury method28 has also been demonstrated using 
thyminylmercury and tri-O-acetyl-D-ribofuranosyl chloride in toluene. The condensation 
product, 2',3',5'-tri-O-acetyl-D-ribofuranosylthymine, was de-acetylated using methanolic 
hydrogen chloride to yield the product. Product yields were low and variable (between 5 and 
25%) due to instability of the sugar halide. 
 
Alternative protocols using 2',3',5'-tri-O-benzoyl-D-ribosyl chloride or bromide (prepared 
from 2',3',5'-tri-O-benzoyl-D-ribosyl or 1-O-acetyl-tri-O-benzoyl-D-ribose) and 
dithyminylmercury produce the condensation product (tri-O-benzoyl-D-ribofuranosyl 
chloride and tri-O-benzoyl-D-ribofuranosyl bromide) as crystalline materials in 50% and 36% 
yields. While showing improved stability, the overall yields of 5-MU by this approach is still 
low (< 50%). 
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While 5-MU may also be prepared from β-thymidine, using toxic and expensive reagents such 
as osmium tetra-oxide to carry out the di-hydroxylation reaction, the high cost of the β-
thymidine starting material (170 - 177 $/kg) compared to the 5-MU product (55 $/kg) renders 
this approach impractical. 
 
Depending on the choice of substrate, this procedure can be used to prepare a number of 2'-
deoxynucleosides, generally as a mixture of the α- and β-anomers. As a result, separation of 
the α- and β-anomers, a tedious and complex process (chromatography), must be carried out. 
 
The above constraints, demonstrate the limitations of chemical processes used to prepare 
nucleosides. 
 
1.5.3 Preparation of 5-MU using biocatalytic processes 
 
Alternatively 5-MU may be prepared by a biocatalytic process; this has been conducted using 
a variety of nucleoside donors such as inosine or guanosine in combination with purine base 
such as thymine. Using this method, 5-MU preparation was carried out continuously in a 
column reactor23 over a period of 17 days to demonstrate the feasibility of 5-MU (3100 g) 
production, albeit at low substrate (1 to 2% m/m) and product concentrations (1% m/m). The 
reactions were carried out at low concentrations to prevent hypoxanthine from precipitating 
out of solution and blocking the column reactor. Several advantages of using the column 
reactor include increased enzyme stability, and thus enzyme lifetime at elevated temperatures, 
and ease of separation of the product from the enzyme system. However due to enzyme 
immobilization the reactor may be operating under mass transfer limiting conditions, leading 
to lower reactor productivities. The 5-MU yield, which was 40% using this system, was not 
considered to be economical. 
 
The transglycosylation reaction may be carried out using inosine and thymine as shown in 
Scheme 1.4. During the phosphorolysis reaction inosine, in the presence of PNP enzyme and 
phosphate buffer, was converted to ribose-1-phosphate and hypoxanthine. It was hypothesized 
that the hypoxanthine would have to be oxidized to uric acid using xanthine oxidase (XO) in 
order to drive the reaction to completion. This was based on the relatively high hypoxanthine 
solubility (0.34% m/m at 63oC) allowing for the reverse phosphorolysis reaction to compete 
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with 5-MU production. Unfortunately uric acid has limited economical value and thus further 
decreases the attractiveness of the process. This process also requires three enzymes, making 
for a complex route which is less attractive economically.  
 
It was subsequently proposed to produce 5-MU using thymine and guanosine, whilst 
producing guanine as a by-product. Guanine has significant economic value (22 – 27 $/kg) 
and has application in the cosmetic and pigment industry. The re-sale of guanine would also 
offset the cost of the guanosine and thymine raw materials, thus improving the process 
economics. In addition, guanine which is produced during the phosphorolysis reaction, has a 
very low solubility (< 50 ppm, 0 - 100oC), effectively shifting the equilibrium to force the 
reaction to go to completion. 
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Scheme 1.4: Preparation of 5-MU using inosine and thymine 
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The preparation of 5-MU using thymine and guanosine has been documented in the 
literature29. Excellent yields of 5-MU (74%) have been achieved at relatively high guanosine 
(9% m/m) and thymine (4% m/m) concentrations. The reactions were carried out at 60oC 
using thermostable enzymes over 24 - 48 hours. The chief disadvantage of this process is the 
long reaction times, which lead to low reactor productivities (1.19 g.L-1.h-1). During the scope 
of this investigation, methods to improve the 5-MU yield and reactor productivity will be 
conducted in order to improve the process economics of 5-MU production. 
 
 
1.6 Process for the preparation of β-thymidine  
 
1.6.1 Chemical Processes for the preparation of β-thymidine 
 
1.6.1.1 Preparation of β-thymidine from D-xylose 
As mentioned previously β-thymidine is an important intermediate in the commercial 
production of AZT30. β-thymidine may be prepared by coupling a protected 2-deoxy-D-ribose 
with protected thymine, however the process is not economical due to the high cost of the 
starting materials and the production of a mixture of α- and β-nucleosides. The α-nucleoside 
has no commercial use in the synthesis of pharmaceutical intermediates and separation of the 
mixtures of α and β-nucleosides by column chromatography or crystallization is a complex 
and labour intensive process. 
 
An alternative process starting from a protected D-xylose is shown in Scheme 1.534, a 
relatively cheaper starting material. The route shows that multiple protection and de-
protection of substrates is required, leading to a lengthy process and a low overall yield of β-
thymidine (32%). The low yield contributes to the increased commercial selling price of β-
thymidine with 100 kg batches costing 171 – 177 $/kg (Dayang Chemicals Co. Ltd and 
Junwee Chemical Co. Ltd). Therefore β-thymidine produced by chemical synthesis 
contributes significantly to the cost of d4T and AZT manufacture. 
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Scheme 1.5: Preparation of β-Thymidine from xylose34 
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1.6.2 Biochemical processes used to produce β-Thymidine 
 
An alternative process to produce β-thymidine using fermentation,31 has been carried out by 
GSK and Samchully Pharmaceuticals. The enzymes that degrade β-thymidine such as uridine 
and thymidine phosphorylase, have been removed from the organism by mutation to allow 
thymidine to accumulate. During the fermentation process, thymidine monophosphate is 
produced, which is then degraded to β-thymidine. The fermentation process may not be 
commercially viable due to the requirement that the activity and production of cells that 
express deoxythymidine mono phosphate phosphorylase be continuously increased, and 
thereby increase the levels of β-thymidine production20,32. The fermentation is carried out 
over 40 - 45 hours and the final β-thymidine concentration is 7 g.L-1. Typically, where 
biocatalytic processes such as fermentation are used, significant costs are associated with the 
isolation and purification of the product from complex mixtures and dilute feed streams, thus 
contributing to significant increases in the products’ selling price. 
 
1.7 Statement of the problem 
 
The detrimental impact of HIV/AIDS on the socio-economic development of South Africa 
and the associated Southern African region has far reaching consequences in terms of skills 
losses in active sectors of the economy and which consequently result in lower economic 
growth rates. In addition, the cost associated with providing access to treatment must also be 
taken into account. Although significant progress has been made with respect to negotiating 
patent concessions in terms of the manufacture of anti-retrovirals (ARV’s) from multi-
national pharmaceutical companies and obtaining price reductions, a strategy was initiated 
between CSIR Biosciences, LIFElab (Kwa-Zulu Natal, South Africa) under the auspices of 
Arvir Technologies to investigate the feasibility of locally manufacturing ARV’s. Currently 
active pharmaceutical ingredients (API’s) such as stavudine and AZT are imported from 
China and India, while formulation is conducted locally. The manufacture of key 
intermediates, such as 5-methyluridine and β-thymidine, was also considered. A key 
advantage of implementing such a strategy would be to increase economic activity in the 
sector of pharmaceutical production33, since this area has been in decline since the 1990s. In 
this context, setting up this type of industry may act as an incubator to grow this sector of the 
economy allowing for skills development and reducing imports from India and China. The 
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additional benefits include securing a local source of the active pharmaceutical ingredients 
(API’s) and reducing the impact on foreign exchange burden on the South African economy. 
This would also circumvent any variations in foreign exchange playing a role in providing 
cost effective treatment. In addition to this the development of novel processes generating 
intellectual property (IP) could possibly reduce the cost of ARV production. This would in 
turn result in broader access of the public to treatment. 
 
5-Methyluridine is a key intermediate in the preparation of stavudine, AZT and β-thymidine, 
since β-thymidine (dT) may also be prepared from 5-MU (see Scheme 1.6) 34,97. Therefore an 
efficient synthesis of 5-MU would provide access to a variety of routes used to manufacture 
both stavudine and AZT. 
 
O
OHOH
HO
HN
N
O
O
i) AcBr, CH3CN, AcBr
ref lux, 1 h
(98%)
O
BrOAc
AcO
HN
N
O
O
ii) MeOH, H2,
Ni catalyst
3-5 bar, 4-5h
O
OAc
AcO
HN
N
O
O
iii) MeOH, NaOMe, 40oC, 1h
iv) Amberlite IR-120-A
(80%)
O
OH
HO
HN
N
O
O
dT
5-MU
 
 
Scheme 1.6: Preparation of β-thymidine (dT) from 5-MU34,97 
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1.8 Process targets/Objectives 
 
This thesis describes the development of a bench-scale chemo-enzymatic process to produce 
β-thymidine, comprising of a biocatalytic route to synthesise 5-methyluridine, followed by 
chemical manipulation34 to produce β-thymidine, as an alternative to the processes currently 
available. The process targets shown in Table 1.1 and Table 1.2 were identified as having an 
impact on the process economics. 
 
The following bench marks were used to set up the techno-economic model. 
 
Table 1.1: Biocatalytic preparation of 5-methyluridine 
5-MU yield (reaction) 75% 
5-MU yield (isolated) 75% 
Guanine recovery 90% 
5-MU productivity 20 g.L-1.h-1 
 
Table 1.2: Chemical preparation of β-thymidine 
3',5'-di-O-acetyl-2'-bromothymidine 
(DABT) yield  
90% 
DABT productivity 20 g.L-1.h-1 
3',5'-di-O-acetylthymidine (DAT) yield  90% 
DAT productivity 20 g.L-1.h-1 
β-thymidine (dT) yield  90% 
dT productivity 20 g.L-1.h-1 
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CHAPTER TWO 
 
2 Biocatalysis 
 
2.1 Introduction 
 
The application of enzymes in organic chemistry is of increasing importance as enzymes have 
been found to catalyze a wide variety of organic reactions. The main drivers of utilizing 
biocatalytic processes are a need to improve process economics and to reduce the 
environmental impact of the process. Biotechnology and biocatalysis offer the possibility of 
unique technology options and solutions, thus acting as enabling technologies. 
 
The application of biocatalysis in the preparation of fine chemicals and pharmaceuticals35,36,37 
is well documented38,39. Biocatalytic processes are increasingly being used to penetrate the 
chemical industry. A recent study, comprising of 134 industrial scale bio-transformations 
carried out at scales >100 kg, using whole cells or enzymes, showed that hydrolases and 
oxido-reductases dominate industrial applications. An analysis40 of the average reaction 
performance based on fine chemicals (not pharmaceuticals) showed product yields of 78%, 
final product concentrations of 11% m/m and volumetric productivities of 15.5 g.L-1.h-1 were 
reported. 
 
Increased demand for enantiomerically pure compounds in the life science industries (e.g., 
pharmaceutical, food and agriculture) is based on the requirement to develop structurally 
optimized inhibitors, which invariably contain chiral centers. In such cases the most important 
performance criterion for a catalyst is not the catalyst activity, but rather the selectivity. A 
comparison of conventional chemical catalysts shows that enzymes exhibit superior 
selectivity, especially regio- and enantioselectivity. Enzymes are capable of carrying out the 
desired transformation in the presence of several similar functional groups and stereogenic 
centres.  
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2.2 Advantages and disadvantages of biocatalysts  
 
A summary of the advantages and disadvantages of biocatalytic processes are reported in 
Table 2.1 and discussed in more detail below. 
 
Table 2.1: Advantages and disadvantages of biocatalysts  
Advantages Disadvantages 
Very high selectivity (enantio- chemo- and 
regioselectivity), which provides better 
reaction selectivities and yields. 
Extended and lengthy development times 
for new enzymes41 
Are not harmful to the environment (unlike 
heavy metal catalysts). 
May be unstable in the presence of high 
concentrations of reactants, and hence low 
volumetric productivities are obtained. 
Instability at extremes of pH and 
Temperature42,43 
Transformation under mild conditions 
(safer, and yields less by-products). 
Availability for selected reactions only 
Solvent often water (environmentally 
friendly, cheap and safe) 
Solvent often water (poor solvent for many 
chemical intermediates44). 
 
2.2.1 Advantages of biocatalysts45 
 
2.2.1.1 Efficient catalysts 
The rates of enzyme-mediated processes are increased, compared to the corresponding 
process being carried out in the absence of enzymatic catalyst, by a factor of 108 - 1010. The 
rate enhancement may even exceed 1012, which is a far more efficient rate enhancement than 
that achieved using chemical catalysts. Furthermore, enzymatic catalysts may be used at 
concentrations between 10-3 – 10-4 mole % with respect to substrate compared to chemical 
catalysts which are employed at concentrations between 0.1 – 1 mole % with respect to 
substrate loading. They are frequently highly selective in the reactions they perform, and 
hence tend not to generate wasteful by-products. 
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2.2.1.2 Enzymes are environmentally acceptable 
The use of biocatalysts to carry out a specific biotransformation can circumvent the use of 
toxic heavy metals, and they are also biodegradable. Reactions are also generally carried out 
in aqueous medium, which reduces the impact on the environment by minimizing the use of 
hazardous or toxic solvents. 
 
2.2.1.3 Enzymes operate under mild conditions 
Generally enzymes operate in a pH range of 5 to 8 and in a temperature range of 20 to 40oC. 
The use of mild conditions may minimize problems associated with undesired side-reactions 
such as decomposition, isomerisation, racemisation and rearrangement which may take place 
using traditional methodologies. As a result, operating the enzymatic process under mild 
conditions (such as at low temperatures) also reduces the energy requirements to operate the 
process and thus has an additional beneficial impact on the environment. 
 
2.2.1.4 Broad substrate specificity 
The use of a specific enzyme is not limited to their natural role, as enzymes exhibit broad 
substrate specificity towards un-natural synthetic substrates. Although enzymatic reactions are 
typically carried out in water, the aqueous medium may be replaced in certain cases with an 
organic solvent if advantageous to the overall process. 
 
2.2.1.5 Enzyme selectivity 
- Chemoselectivity 
The use of an enzyme to carry out a specific transformation based on a particular functional 
group in the presence of other sensitive functional groups is far superior to the use of 
chemical catalysis. For example, selective enzymatic ester hydrolysis does not show any 
susceptibility to acetyl cleavage. 
- Regioselectivity and Diastereoselectivity 
Enzymes exist as complex three-dimensional structures and may therefore distinguish 
between identical functional groups which are situated in different regions of the same 
substrate molecule. 
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- Enantioselectivity  
Enzymes are comprised mainly of L-amino acids and are thus chiral catalysts. Therefore any 
type of chirality present in the substrate molecule is “recognized” during the formation of the 
enzyme-substrate complex. Thus a prochiral substrate may be transformed into an optically 
active product. Since the rates of reaction of both enantiomers present in the racemate differ, 
kinetic resolution of the product may be achieved. 
 
2.2.2 Disadvantages of biocatalysts 
 
The use of biocatalysts to carry out transformations suffers from the following limitations: 
 
2.2.2.1 Enzymes are provided by nature in only one enantiomeric form 
It is impossible to convert the chiral induction of a given enzymatic reaction, by choosing the 
“other enantiomer” of the biocatalyst, a methodology which is possible if chiral chemical 
catalysts are used. To gain access to the other enantiomeric product an enzyme has to be 
found or engineered that has the exactly the opposite stereochemical selectivity. 
 
2.2.2.2 Enzymes require narrow operation parameters 
The numerous advantages of biocatalysts operating under mild conditions, such as low 
temperatures and narrow pH ranges, may also be disadvantageous, for example if the rate of 
reaction proceeds slowly, since the scope of alteration is limited. The use of extreme elevated 
temperatures, extreme pH ranges (acidic and basic) and a high salt concentration can lead to 
denaturation of the proteins and a decrease in enzyme activity. These limitations may be 
overcome by using directed evolution46,47, producing an enzyme having the desirable thermal, 
pH and high salt concentration characteristics required during the bio-catalytic process. 
Alternatively, thermostable enzymes from thermophilic micro organisms may be used which 
have a greater thermal stability. 
 
2.2.2.3 Enzymes display their highest catalytic activity in water 
Water is considered to be an environmentally friendly “green solvent”, however due to its 
high boiling point and high heat of evaporation, the ease of recovery and isolation of 
substrates and/or products to the required specification from water may prove difficult. In 
addition to this, the majority of organic compounds exhibit low solubility in water and the 
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possibility of increasing substrate solubility by heating is limited owing to the possibility of 
thermal deactivation of the enzyme. The possibility of conducting the reaction in an organic 
medium does exist, however generally with a concomitant loss of enzymatic activity. 
 
2.2.2.4 Enzymes are prone to inhibition phenomena 
Typically, enzymatic reactions are limited due to substrate and/or product inhibition at 
increased substrate and/or product concentrations and this has an impact on the 
efficiency/productivity of the process. Substrate inhibition may be circumvented by 
maintaining a low concentration of substrate through continuous addition or operating in a 
semi fed batch mode. The continuous removal of product via in-situ product removal (ISPR)48 
may circumvent product inhibition, but is technically challenging. The use of this 
methodology also adds production costs49 and before being implemented, the advantages and 
disadvantages must be carefully evaluated. 
 
2.2.2.5 Source and cost of enzyme 
Although catalytic quantities of enzymes are used in a biotransformation, access to limited 
quantities of enzyme may result in non-development of a commercial bio-catalytic process. In 
addition to this, should the enzyme be readily available, exorbitant enzyme costs may also 
limit commercial exploitation of the process42. 
 
2.3 Applications of biocatalysis in industry 
 
The main areas of application of biotechnology and biocatalysis include: 
 
- Production and transformation of compounds, mainly in the chemical and 
pharmaceutical industry 
- Analytics and diagnostics, (medical applications) 
- Environmental protection and bioremediation 
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The chemical industry of the future will look considerably different from the current 
landscape due to the following driving forces: 
 
- The effect of cost and margin pressures, resulting from competition in an increasingly 
open market-orientated economy; and 
- Operation of the industry in a societal framework which puts emphasis on a clean and 
less polluted environment. 
 
Processing with a view towards this new set of goals and objectives requires the development 
of production routes with fewer processing steps, and increased yields on each step in order to 
conserve material and energy. As a result, less waste is produced, consequently leading to 
lower waste treatment and disposal costs. The impact of environmental compliance costs are 
directly affected by the above market requirements. 
 
2.4 The application of a biocatalytic process used in the synthesis of 5-MU. 
 
We envisaged the biocatalytic reaction50 (see Scheme 2.1) to be carried out using a coupled 
enzyme system, using purine nucleoside phosphorylase (PNP) and pyrimidine nucleoside 
phosphorylase (PyNP) to produce 5-MU. 5-Methyluridine is a key intermediate in the 
preparation of stavudine, AZT and β-thymidine, since β-thymidine may also be prepared from 
5-MU. Therefore an efficient synthesis of 5-MU would provide access to a variety of routes 
used to manufacture both stavudine and AZT. 
 
The reaction carried out in the presence of the PNP, the phosphorolysis reaction, and produces 
guanine (GN) and ribose-1-phosphate (R-1-P). The reaction carried out in the presence of the 
PyNP enzyme, the synthesis reaction, produces 5-MU and inorganic phosphate ion (Pi). The 
reaction intermediate R-1-P may decompose under acidic conditions to give ribose and Pi thus 
limiting 5-MU production. The stability of the R-1-P will therefore have to be carefully 
monitored during the course of the reaction, based on the amount of ribose detected in the 
reaction mixture by ion chromatography. 
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Scheme 2.1: Preparation of 5-MU using guanosine and thymine 
 
2.5 PNP and PyNP 
 
2.5.1 PNP 
 
We planned to carry out the biocatalytic reaction using a coupled enzyme system namely PNP 
and PyNP to produce 5-MU. The PNP enzyme may be isolated from many sources and may 
be classified according to molecular weight, sub-unit composition and substrate specificity as 
shown in Figure 2.151,52 
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Low-molecular-mass (low-MM) homotrimers, with Mr ~ 80-100 kDa, specific for the 
catalysis of 6-oxopurines and their nucleosides, are often referred to as “Ino-Guo 
Phosphorylases” (Inosine-Guanosine). Enzymes of this type have been isolated from many 
mammalian tissues and from some micro organisms, for example PNPI from Bacillus 
stearothermophilus TH6-2. The enzymes are listed in the SWISS-PROT data bank as 
“PNP/5'-deoxy-5'-methylthioadenosine phosphorylase53 (MTAP) family 2 phosphorylases”. 
 
High-molecular-mass (high-MM) homohexamers, with Mr ~ 110 - 160 kDa, have a broader 
substrate specificity in that they accept the 6-oxo- and/or 6-aminopurines and nucleosides and 
are found in micro organisms. In some cases, Bacillus subtilis is known as “Ado-PNP” and 
adenosine is a much better substrate than inosine and guanosine. The enzymes are listed in the 
SWISS-PROT data bank as “PNP/UDP family 1 phosphorylases”. 
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PNP
Low MM High MM Others
Homotrimers
Mr ~ 80 -100KDa
Homohexamers
Mr ~ 110 -160KDa
Homo-, dimers, trimers
tertramers, pentamers or
hexamers
Mr ~ 60 -180KDa
Specificty:
Specific for 6-oxo-purinesand their
nucleosides, and some of their
analogues
Natural substartes:
Inosine, Guanosine
Specificty:
Very broad, accepting as substrates
both 6-oxo- and 6-amino purines and
their nucleosides and many
analogues
Natural substartes:
Inosine, Guanosine, Adenosine
Specificty:
- First group:
 specificty as for low-MM PNPs,
 but not homotrimers
- Second group:
specificty as for high-MM PNPs,
 but not homohexamers
Sources:
- Mainly mammals
e.g. human, calf
- Some bacteria
e.g. Bacillus subtilis PNP I
       Cellulomonas
Sources:
- Mainly bacteria
e.g. E. coli, Salmonella, typhimurium,
Sulfolobus solfataricus
- Mycoplasma
classified by sequence similarity to
E. coli PNP
e.g. Mycoplasma pnuemoniae,
Mycoplasam genatilium
Sources:
- Some bacteria
e.g. Proteus vulgaris
- Mammals
e.g. bovine liver mitochondria
- Parasites
e.g. Plasmodium falciparum
 
Figure 2.1: Tentative classification of PNPs from various sources, based on Mr, subunit 
composition and substrate specificity51 
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2.5.2 Subunit composition 
 
The crystal structure of E. coli PNP (high-MM) has been established as a trimer of 
dimers5455,56(see Figure 2.2A) while the low-MM PNP located mainly in mammalian sources 
may be described as a dimer of trimers (see Figure 2.2B).  
 
 
 
Figure 2.2: Comparison of tertiary PNP structures from a bacterial source and a 
mammalian source 
A shows a ribbon representation of the E. coli PNP tertiary structure (PDB code – 1K9S). B shows a ribbon 
representation of the bovine PNP tertiary structure (PDB code – 1LVU). Figures were viewed using Accelrys 
Discovery Studio 2.1. 
 
2.5.3 Amino acid sequences 
 
Limited sequence similarity is observed between the two classes (low and high-MM PNP), 
although they virtually catalyze the same chemical reactions. The similar catalytic ability may 
be explained by the fact that the amino acids present in the active site are almost all conserved 
for PNPs from each class, as shown in three dimensional structures of calf spleen, human 
erythrocyte and E. coli PNPs. 
 
 
A B 
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2.5.4 PyNP 
 
Thymidine phosphorylase (TP) and uridine phosphorylase (UP) both belong to the class of 
PyNPs and may also be used to carry out a phosphorolysis reaction. Similarly to PNP, the 
PyNP enzymes may be isolated from a wide variety of bacterial and mammalian sources. 
However, phosphorolysis reactions are typically not carried out using TP due to the high 
expense associated with the substrate β-thymidine. It was also reported in the literature that 
UP is a hexamer comprising of six sub-units and thus shares major structural features with 
E. coli. PNP. Amino acid sequence similarities of 49% and sequence identity of 25% between 
E. coli PNP and UP have been reported in the literature57. 
 
2.6 Mechanistic considerations51 
 
2.6.1 Non-Michaelis-Menten kinetics 
 
A frequent feature of reactions catalyzed by PNP are that non Michaelis-Menten kinetics are 
observed for some substrates. This may be attributed to “substrate activation at high 
concentrations” and is known “negative co-operativity58”. It was also reported that numerous 
attempts to elucidate a mechanistic model have resulted in ambiguous results with a mixture 
of positive and negative co-operativity, and incorrect binding leading to substrate inhibition at 
high substrate concentrations. Attempts to fit experimental data to models at low substrate 
concentrations resulted in poor fitting models. 
 
Thus, the interpretation of the mechanism responsible for the complex kinetic behaviour of 
PNPs over a broad substrate concentration range has yet to be adequately formulated. In 
addition to this, the assumption of rapid equilibrium in the assessment of kinetic data may be 
questionable, as release of the purine base may be the rate limiting step in the phosphorolysis 
of guanosine59 by calf spleen PNP. 
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2.6.2 Stoichiometry of binding and possible co-operativity between subunits 
 
Several reports indicated that non-identity of the binding sites and co-operativity between 
sub-units should be taken into account in analyzing both kinetic and binding data for PNPs. It 
was subsequently reported that Pi59 binds to a single site of calf spleen monomer, once as a 
substrate in the phosphorolytic direction and again after the release of pentose-1-phosphate as 
an effector to enhance the rate-limiting release of the purine base. It was also reported that the 
presence of phosphate ion improved the stiochiometry of ligands to enzyme from one to six 
per enzyme hexamer. 
 
2.6.3 Order of substrate binding and product release 
 
A comprehensive review of the active sites of low and high molecular mass PNP’s was 
reported in the literature60. The active site comprises of binding pockets for the phosphate, 
pentose and base moieties. A sequential mechanism, where all substrates bind to the enzyme 
before any product is released, has been proposed for high-MM E. coli and Salmonella 
typhimurium PNP’s and low-MM PNP’s from several sources.  
 
In the case of the E. coli enzyme, a ternary complex of enzyme / nucleoside / phosphate 
(sulphate) and enzyme / base / R-1-P have been revealed by X-ray studies. Therefore, it seems 
that a sequential mechanism with a central ternary complex of the enzyme with both of its 
substrates is well documented for PNPs in both low and high-MM classes. Whether the 
reaction proceeds via an ordered binding of substrates or a random mechanism (substrates 
bind to, and/or products are released from the enzyme in parallel reactions) is not clear at this 
stage.  
 
In the case of high-MM E. coli enzymes, a postulated mechanism where pentose-1-phosphate 
binds prior to the purine base seems to be consistent with the architecture of the active site in 
which the phosphate and pentose pockets are buried deep within the active site, while the base 
binding site is exposed to the solvent and no specific interaction between base and enzyme are 
observed. The formation of a binary complex of the enzyme and some purine bases may exist 
which protect the enzyme against thermal inactivation.  
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The role of R-1-P is reported in the phosphorolytic direction to cause a rapid structural 
relaxation and this facilitates hypoxanthine release61 from the active site. 
 
In the case of low-MM PNPs almost all possible types of sequential mechanisms have been 
proposed from various tissues of the same organism. A detailed study into the mechanism 
proposed that phosphate binds to the enzyme prior to the nucleoside, during the 
phosphorolysis reaction. Subsequently, additional studies were conducted and formation of 
binary complexes with calf spleen PNP/ inosine and PNP/ guanosine have been detected 
confirming this proposed mechanism.  
 
The discrepancies in reported substrate binding and product release may be attributed to the 
complex and ambiguous kinetic behaviour of PNPs. The observation of non Michaelis-
Menten kinetics is observed for Pi and other substrates. In summary, the most feasible kinetic 
mechanism for PNPs from various sources appears to be one with random binding in both the 
phosphorolytic direction and synthetic directions, with an alternative ternary complex of 
enzyme/base/phosphate resulting in deactivation. 
 
 
2.6.4 Catalytic mechanism: active site mutants 
 
PNP cleaves the glycosidic bond of natural purine nucleosides in the β-configuration, with 
inversion of configuration to produce R-1-P62,63. Enzyme kinetics indicates that the catalysis 
takes place via a ternary complex of enzyme with both of its substrates. The reaction takes 
place without the involvement of phosphorylated or ribosylated enzyme intermediates. 
However, as discussed, attempts to analyze the kinetic data have revealed discrepancies in the 
order of substrate binding and product release. The study was largely based on trimeric PNPs. 
 
Initial attempts to elucidate the mechanism involved the comparison of PNP catalyzed 
phosphorolysis and non-enzymatic hydrolysis of the glycosidic bond of purine nucleosides. 
Under acidic conditions, the N(7) of the purine base is protonated, resulting in a positive 
charge on the imidazole ring, in turn leading to delocalization of electron density at the 
glycosidic bond, thus facilitating bond cleavage64. Subsequent studies using data obtained 
during kinetic α-deuterium isotope experiments during the phosphorolysis and arsenolysis 
 Chapter Two 32 
studies catalysed by PNP, were found to be consistent with the hypothesis of protonation of 
purine ring at N (7)65. Using the kinetic α-deuterium isotope, data indicates that bond cleavage 
precedes bond formation, and therefore proceeds via a SN1 mechanism. Concomitant with 
this, the ribose ring in the transition state (TS) has oxocarbenium character (see Scheme 
2.2)66. Attack by phosphate (arsenate) was proposed to lag far behind glycosidic bond 
breakage 
 
In the absence of phosphate, the rate of hydrolysis of inosine to hypoxanthine and ribose was 
very slow, concomitant with the release of the pentose and subsequent formation of a stable 
enzyme-hypoxanthine complex. In the presence of phosphate under phosphorolytic reaction, 
release of the pentose moiety results in the rapid structural relaxation and release of the base 
hypoxanthine. 
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Scheme 2.2: Attack by phosphate (arsenate) was proposed to lag far behind glycosidic 
bond breakage66 
 
Stabilization of the oxocarbenium ion of the pentose ring by the enzyme was confirmed by 
using transition state analogue inhibitors (immucillin H and G)67 which feature an iminoribitol 
moiety. The oxocarbenium ion character of the transition state was found to be a characteristic 
feature of N-ribose scission enzymes (purine N-ribohydrolyases, phosphorylases and 
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transferases). N-ribose scission enzymes also activate the purine-leaving group by protonation 
or hydrogen bonding to effect electron withdrawal. 
 
An alternative catalytic mechanism (see Scheme 2.3)68 was proposed based on a negatively 
charged purine ring for trimeric PNPs from calf spleen. Based on fluorescence studies, it was 
proposed that the enzyme binds to the anion of guanine, the negative charge on the purine ring 
being stabilized by the enzyme. This is consistent with the oxocarbenium character of the 
pentose moiety, as electrons would shift from the ribose moiety to the negatively charged 
purine ring setting up the transition state. The set-up of this transition state is based on the 
presumption that the base was not pre-protonated by the enzyme. X-ray studies of calf spleen 
and human erythrocyte PNP complexes with various ligands failed to identify any acidic 
residues which may be in contact with N(7). The Asn243 of mammalian PNP and Asn246 in 
Cellulomonas PNP appear to be flexible and adopt different conformations and are located in 
the vicinity of N(7) depending on the ligand in the active site. A hydrogen bond between 
Asn243δ and N(7) is hypothesized to stabilize the transition state due to charge de-localization 
between N(7) and N(9). Once the transition state has been set up, the oxocarbenium ion may 
be stabilized by the phosphate dianion, which is part of a catalytic triad (Glu89-His86-
phosphate).The phosphate mono-ion is deprotonated by the His86 residue which accepts the 
proton from the phosphate, thereby producing the di-anion. The highly negative charged di-
anion then attacks the ribose ring, leading to a shift of electrons into the purine ring. In 
parallel, Asn243-N(7) hydrogen bond removes electrons from the glycosidic bond to the 
purine ring. Attack of the phosphate di-anion results in bond cleavage of the glycosidic bond 
and stabilization of the intermediate oxocarbenuim ion. The residue Glu201 is not directly 
involved, however participation due to ligand binding results in a high-energy unusual 
conformation (χ =145o for mammalian PNP and χ =100-130o for E. coli PNP) facilitating 
glycosidic bond cleavage. 
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Scheme 2.3: Alternative catalytic mechanism proposed based on a negatively charged 
purine ring68 
 
It was also proposed that a protonated residue Asp243 may hydrogen bond to the 6-amino 
group, donating hydrogen to the N(7) of the base as required for stabilization of the transition 
state (TS). The residue Asp243 in the mutant is in the equivalent position to Asp204, relative 
to the purine base, based on the three dimensional structure of the hexameric E. coli PNP. The 
E. coli enzyme accepts both 6-oxo and 6-aminopurines as substrates; however the active site 
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does not contain the Glu201 residue found in mammalian PNPs. In addition to this, the N(1) 
of the base is linked to a chain of water molecules. Mutant studies were conducted and 
indicate that Glu201 plays a crucial role in the catalysis of 6-oxopurines by trimeric PNPs. 
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Figure 2.3: 8-iodo-guanine in a ternary complex with phosphate and Cellulomonas 
PNP69 
 
The kinetic properties and three-dimensional structure of Cellulomonas PNP, a trimer of the 
low-MM class showed that the residue Asn246 (Asn243 in mammalian PNPs) does not 
interact directly with the base substrate, but is bridged to the exocyclic substituent at C(6) via 
a water molecule (see Figure 2.3)69. Direct contact with the base was via Glu201 
(corresponding to Glu204). As a result, an alternative mechanism was proposed indicating 
that the role of Glu201 (Glu204) is in the stabilization of the negatively charged purine base 
intermediate (see Scheme 2.4), while Asn243 plays a role in the recognition of substrates 
rather than a catalytic role. The phosphate ion attack at the C(1') of the pentose weakens the 
glycosidic bond, causing a shift of electrons into the purine ring (negatively charged). The 
negative charge is localized at the purine O6, thus forming an anion of the purine base 
analogous to “rare” tautomeric enolic forms of guanosine and inosine. The role of Glu201 
(Glu204) is to prevent formation of the keto tautomer via a hydrogen bond interaction with 
N(1)-H. 
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Scheme 2.4: Catalytic mechanism proposed for trimeric PNP Cellulomonas 
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PNP catalyzed glycosidic cleavage is far more complex than anticipated, therefore definitive 
conclusions with respect to purine ring activation are still outstanding and require further 
investigation. In summary, the catalytic mechanism for low-MM PNP has not yet been 
adequately elucidated, due to variation/speculation of the following roles: 
 
-
 The catalytic role of Pi 
-
 The amino acid residues that stabilize the TS 
 
-
 The electronic state of the purine ring in the TS
 
 
In the case of high-MM, studies based on E. coli indicate an oxocarbenuim TS. The low and 
high-MM PNPs differ in the residues stabilizing the TS. In the case of low-MM, the residues 
Glu201 and Asn243 appear to be highly conserved and may account for the specificity 
towards 6-oxopurines, since replacement of each by Ala results in a significant reduction in 
catalytic activity. The replacement of Asn by Asp changes the specificity of trimeric PNPs to 
include both 6-oxo- and 6-aminopurines. 
 
2.7 Commercial enzymes70 and in-house enzymes 
 
2.7.1 Commercial enzymes 
 
The preliminary investigation into the biocatalytic reaction evaluated the feasibility of using 
commercially available enzymes such as PNP (ex. Sigma Aldrich) and TP (ex. Sigma 
Aldrich). The results obtained (see Table 2.2) show that no 5-MU product was produced 
under the reaction conditions investigated. This may be attributed to the TP exhibiting 
stricter/narrower substrate specificity for the 2'-deoxyribose-1-phosphate compared to the R-
1-P substrate produced during the transglycosylation reaction using thymine and guanosine as 
the substrates.  
 
During the enzyme screening exercise, a crude extract of PyNPs isolated from E. coli was also 
considered. The isolated enzyme mixture comprised of a crude extract which exhibited both 
PNP and PyNP activity. The results obtained (see Table 2.2) using this crude mixture 
demonstrated the potential feasibility of carrying out the biocatalytic reaction, albeit at low 
substrate concentrations (< 0.1% m/m). 
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Table 2.2: Biocatalytic preparation of 5-MU using commercially available enzymes 
GS/TM conc. 
(mM) 
GS conc. 
(% m/m) 
TM conc. 
(% m/m) 
Enzymes source 5-MU 
(Area %) 
50a 1.42 0.63 Commercial PNPc, TPd 0 
100a 2.83 1.26 Commercial PNPc, TPd 0 
150a 4.25 1.89 Commercial PNPc, TPd 0 
250a 7.08 3.15 Commercial PNPc, TPd 0 
2.5a 0.071 0.032 Crude PNP, PyNP 30 
Note a: Experimental conditions commercial enzyme: Reactions carried out at 3ml scale, TM: GS mole ratio 1:1, 
Reaction Temperature 25oC, pH 7.4, sodium phosphate buffer (50 mM), Reaction Time: 3 hours, PNP 0.1U, 
PyNP 0.1U Ratio PNP:PyNP 1:1, GS – Guanosine; TM - Thymine 
Note b: Experimental conditions using crude PNP/PyNP extract: As above, except that the reaction temperature 
was increased to 40oC and reaction time 24 hours. 
Note c: PNP (ex. Sigma Aldrich, 10U/mg protein ~ 60% protein)  
Note d: TP from E. coli belonging to the class of PyNP (pyrimidine nucleoside phosphorylase) recombinantly 
expressed in E. coli (ex. Sigma Aldrich). 
 
2.7.2 PNP and PyNP produced in-house 
 
The PNP, BH1531, used to conduct the phosphorolysis reaction was obtained from bacterial 
sources (Bacillus halodurans), but exhibited properties similar to enzymes isolated from 
mammalian sources. On the other hand, the uridine phosphorylase (UP), a type of PyNP 
obtained from E. coli., that was used to conduct the synthesis reaction, exhibited properties 
characteristic of PNP from bacterial sources. UP PyNP is a hexamer which shares major 
structural features with E. coli PNP, although the amino acid sequence of both enzymes show 
only 20% identity. 
 
2.7.2.1 Influence of increased substrate concentration and reaction temperature. 
The preliminary results obtained demonstrated that the biocatalytic reaction could be carried 
out using the crude enzyme mixture (E. coli. and B. halodurans), albeit at low substrate 
concentrations (< 0.1% m/m). Subsequently a series of experiments were conducted to 
determine the effect of increasing the individual substrate concentrations (see Table 2.3) and 
reaction temperature from 25 - 40oC. The reaction mixtures were analyzed semi-quantitatively 
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by HPLC so as to improve the confidence in the reaction performance with respect to 
guanosine conversion and 5-MU yield. The results obtained showed that the guanosine 
conversion decreased from 93.9 to 28.6% as the substrate concentration increased from 1 to 
3% m/m. Similar 5-MU yields (30 - 40%) were obtained irrespective of the substrate 
concentration used. The mole balances obtained (75 - 141%) were inconsistent. This was 
attributed to using a non-validated HPLC method and errors associated with sampling. 
However, the results obtained demonstrated that the production of 5-MU was feasible. 
 
Table 2.3: Effect of increased substrate concentration and reaction temperaturea 
GS conc. 
(%m/m) 
TM conc. 
(%m/m) 
GS conv. 
(%) 
5-MU sel. 
(%) 
5-MU yield 
(%) 
Mole bal. 
(%) 
5-MU prod. 
(g.L-1.h-1) 
0.85 0.38 93.9 29.9 28.1 79.2 0.09 
1.42 0.63 74.4 54.0 40.2 75.0 0.21 
1.98 0.88 72.8 42.6 31.0 81.1 0.23 
2.83 1.26 28.6 119 34.1 141 0.35 
Note a: Reactions carried out at 5.2 g scale, Temperature 40oC, pH 7.4, TM:GS mole ratio 1:1, sodium 
phosphate buffer conc. (50 mM, pH 7.5-8.0), Reaction Time: 24 hours, PNP 0.1 U, PyNP 0.1 U, Ratio 
PNP:PyNP 1:1 
 
The actual cause of the lower 5-MU yield was not ascertained during this study and may have 
been attributed to a host of process parameters associated with the biocatalytic process, 
including enzyme quality (encompassing enzyme stability and activity), reaction equilibrium 
and possible instability of the reaction intermediate R-1-P and possible substrate and or 
product inhibition phenomena. These issues were addressed in subsequent studies (Chapters 4 
and 5). 
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CHAPTER THREE 
 
3 Biocatalytic process parameters 
 
3.1 Introduction 
 
The development of a commercial biocatalytic process is a complex task owing to the 
numerous process variables involved and the interaction between process variables. 
Biocatalytic processes typically operate under mild conditions with respect to temperature and 
pH due to the enzyme’s instability at extremes of temperature and pH. The enzyme may also 
be prone to substrate and/or product inhibition limiting the use of high substrate 
concentrations to increase reactor productivity. The physical characteristics of the substrates 
also play a role in determining the stability of the enzyme. Substrates having a low solubility 
in the reaction medium may have an adverse effect on enzyme stability by causing 
mechanical degradation, and thus high enzyme loadings or the use of an enzyme fed batch 
protocol would be necessary. The effect of reactor configuration also has an impact on the 
enzyme stability and activity, for example the type of impeller used may have a high shear 
rate and thus lead to mechanical degradation of the enzyme. The effect of reactor 
configuration also has an impact on the reaction performance with respect to conversion and 
product yield based on the hydrodynamics of the system. Therefore, the operating conditions 
required to maintain enzyme stability and activity may differ significantly from the operating 
conditions required to develop a commercial biocatalytic process. A discussion follows 
indicating the process variables and parameters used to develop a successful commercially 
viable biocatalytic process. 
 
3.2 Characterisation of a Biocatalyst71 
 
3.2.1 Enzyme stability 
 
Enzymes are a class of macromolecules capable of binding to relatively smaller molecules 
and carry out the desired transformation. Enzymes are inherently unstable as the effects of 
hydrophobic forces dominate in stabilizing the protein structure, while Coulombic forces of 
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equal polarity destabilize. As a result, the Gibbs free enthalpy of formation of proteins 
(∆Gformation), is only weakly negative. 
 
3.2.2 Enzyme kinetics 
 
The initially free enzyme (E) and substrate (S) in their respective ground states combine 
reversibly to form an enzyme-substrate complex (ES, see Equation 1), which then passes 
through a transition state [ES]* during the formation of the enzyme-product (EP) complex. 
The enzyme (E) and product (P) then return to their respective ground states. The rate law 
according to Michaelis-Menten (Km) is based on saturation kinetics with respect to substrate 
(zero order at high substrate concentrations, and first order at low substrate concentrations) 
and is first order with respect to enzyme concentration. 
 
Equation 1 
PEESSE +→↔+ *][  
 
The kinetic schemes for enzymes are similar to those used for homogeneous and 
heterogeneous catalysis. In the case of heterogeneous catalysis, a mechanism postulating the 
reaction rate of a mobile molecule onto a solid surface support is used for modelling purposes. 
Kinetics based on this principle assumes a limited number of active sites which may be 
saturated with reacting molecules from the continuous phase. 
 
The maximum reaction rate for an enzyme-catalysed reaction at saturation is denoted by vmax 
where vmax = kcat[E]. The KM value corresponds to the substrate concentration at half 
saturation (vmax/2) and is a measure of the binding affinity of the substrate to the enzyme: A 
high Km corresponds to a loose binding and a low Km value to a tight binding between 
enzyme and substrate. Consequently at low substrate concentrations where [S] << Km, then v 
= vmax[S]/KM and is therefore first order with respect to substrate concentration [S]. However 
at high substrate concentrations, where [S] >> Km then v = vmax. Irrespective of the conditions, 
v is directly proportional to, or first order to the enzyme concentration [E]. 
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Based on the formation of the enzyme-substrate complex (ES), which binds reversibly, the 
following situations may arise: 
 
- If [S] > Km, the free enthalpy of the ES complex is lower than the enzymes ground 
state. 
- If [S] < Km, the free enthalpy of the complex is higher than the enzyme’s ground state. 
- If [S] = Km, both free enthalpies are the same. 
 
In the case of immobilized enzymes, the observed overall reaction rate is limited by external 
mass transfer (through a laminar film around a solid macroscopic carrier) or internal mass 
transfer (diffusion of substrate or product through the pores of a solid carrier or gel network to 
an enzyme molecule in the interior of the carrier). 
 
3.3 Performance criteria for catalysts, processes and process routes 
 
3.3.1 Basic performance criteria for a catalyst: 
 
Every catalyst, including biocatalysts, can be characterized by activity, selectivity, and 
stability. 
 
- Biocatalysts often feature an improved selectivity compared with non-biological 
catalysts and are therefore developed for their selectivity (enantio-, chemo-, or regio-
selectivity). 
- Enzyme activity is measured and studied in order to establish experimental protocols. 
In contrast to other catalysts, most enzymes are only active and stable within a limited 
temperature (15 - 50oC) and pH range (5 - 10). 
- Stability of enzymes is often related to thermal stability only, (i.e. a temperature 
beyond which the enzyme loses its stability). It should be noted that the enzyme 
stability is dependent on the exposure time at a specific temperature. Process or 
operational stability, which is the long term stability under specified reaction 
conditions, must also be taken into account. 
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Enzyme characteristics may be measured by (a) turnover frequency (tof = 1/kcat); (b) 
enantiomeric ratio (E value) or purity (e.e.), and (c) melting point (Tm) or deactivation rate 
constant. In terms of evaluating or optimizing a process, the following dimensions of merit 
are important: 
 
- Product yield; 
- Biocatalyst productivity (turnover number, TON, = [S]/[E]); 
- Biocatalyst stability (total turnover number (TTN, = mole product/mole catalyst); and 
- Reactor productivity, space-time yield (s.t.y.) [kg.L-1.d-1 or g.L-1.h-1]. 
 
Threshold values based on the above for a good biocatalyst and biocatalytic process are listed 
below: 
 
Turnover frequency: (tof, =1/kcat) kcat > 1 s-1. 
Enantiomeric ratio (E value) or purity (e.e.): An E > 100 and e.e. > 99% 
Total turnover number (TTN): a TTN > 104-105. 
Space-time yield (s.t.y.): 0.1 kg.L-1.d-1 ~ 4 g.L-1.h-1. 
 
3.3.1.1 Activity  
 
The activity may be measured and quantified using the following units, (1 Unit = 1 µmol. 
min-1. To evaluate the quality of an enzyme specific activity (U. mg pure protein-1) is used as 
a bench mark. A typical threshold for a useful biocatalyst is 1 U.mg pure protein-1, however 
the threshold value for a biocatalyst being developed at pilot-plant scale lies much higher at 
100 U.mg pure protein-1. Specific activity may be improved by optimization of the reaction 
conditions, or through variation of the enzyme carrier or even enzyme.  
 
The use of turnover frequency (tof) is mass-independent and superior to specific activity and 
may be defined as Equation. 2: 
 
Equation 2 
sitesactivenumberxtime
eventscatalyticofnumberfrequencyturnover =  
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The use of turnover frequency allows a performance comparison between different catalyst 
systems (biological or non-biological). A threshold value for tof of one event per second per 
active site is required. However, the number of active sites must be ascertained, or in the case 
of an enzyme obeying Michaelis-Menten kinetics, the following equation (Equation 3) may be 
used. 
 
Equation 3 
catk
frequencyturnover 1=  
 
3.3.1.2 Selectivity 
 
The enantiomeric ratio or E value (Equation 4 and Equation 5) serves as a measure of 
enantioselectivity at a certain degree of conversion, producing enantiomers A and B. 
 
Equation 4 
BMcatAMcat KkKkE )/()(=  
 
Equation 5 
)]/([]/([)]/[]([ 00 BBAAE =  
 
The enantiomeric excess (e.e., see Equation 6) reflects the overall selectivity up to the point of 
isolation of the product. The enantiomeric excess (e.e.) may be calculated as follows: 
 
Equation 6 
%100])[]/([])[]([.. xBABAee +−=  
 
The threshold values for an enantioselective biocatalyst is either at E = 100 or at a 99% e.e. 
depending on whether the reaction performance or reaction product is being evaluated. The 
above criteria are based on the requirement of the Food and Drug Administration (FDA) of 
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the United States that separate toxicological studies be conducted on an impurity (including 
the enantiomer of the active drug) where the concentration exceeds 0.5%. 
 
3.3.1.3 Stability 
Typically, stability is related to thermal stability, although other factors such as inhibitors, 
oxygen, and unsuitable pH, mechanical stress and shear also play a role in enzyme stability. 
Thermal stability may be characterized by using the melting temperature (Tm, Equation 7), the 
temperature at which the protein is half unfolded i.e. in equilibrium between the native (N) 
and unfolded species (U). The melting temperature may be influenced by intrinsic inherent 
characteristics such as amino acid sequence, number of disulphide bridges and salt pairs and 
external factors such as solvent, added salt type and salt concentration. 
 
Equation 7 
][0 SKTTM +=  
 
where T0 is the melting temperature in the absence of salt, [S] is the salt concentration and K 
the corresponding coefficient. 
 
Storage stability over time, under specific conditions such as temperature, pH and 
concentration of additives may be expressed (Equation 8) by a first-order decay law. 
 
Equation 8 
).exp(][][ 0 tkEE d−=  
 
where [E] and [E]0 are the active enzyme concentration at time t, or 0 and kd is the 
deactivation rate constant. 
 
3.3.2 Performance criteria for the process 
 
In evaluating a biocatalytic process there are performance criteria relating to the biocatalyst, 
and also for the process. The following criteria are important when determining, evaluating or 
optimizing a route for a process; product yield, biocatalyst productivity, biocatalyst stability 
and reactor productivity. 
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3.3.2.1 Yield 
The chemical yield of the product may be calculated as follows (Equation 9) and is the most 
important parameter for determining the economics of the process. The product yield is 
inversely proportional to the amount of reactants required per unit of product output. 
Typically key substrates and other raw materials make up more than 50% of the variable cost; 
therefore a high product yield is required in order to obtain an economically viable process.  
 
Equation 9 
ySelectivitxConversionYield =  
 
A product yield much lower than 100% is no longer economically and environmentally 
tolerable in the current market conditions. However, in the case of separation of a racemate, 
where the maximum possible yield is 50% per pass, the co-product material may either be 
sold or discarded if the starting material is inexpensive. Furthermore, the yield may be 
increased by carrying out internal or external racemisation in order to improve the overall 
yield. 
 
To define a threshold yield value is difficult, as the threshold value seems to correlate 
inversely with the unit product value of the product. In the case of commodity chemicals, 
chemical yields of 98 - 99% are essential, while in the case of fine chemicals, yields of 90 - 
95% are acceptable. In the case of extreme performance pharmaceuticals, yields >80% may 
still appear to be highly attractive, however yields as low as 50% have also been encountered. 
An acceptable yield also depends on the number of process steps, including isolation, as 
defined by Equation 10. 
 
Equation 10 
n
stepsoverall YieldYield )(=  
 
where n is the number of steps. For example a ten step process where the yield per step is 
90%, translates into an overall yield of 35%. Based on the process economics, this would 
need to be evaluated to assess if this is the most economically viable route. 
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3.3.2.2 Biocatalyst productivity  
Typically improved results may be obtained by adding a large amount of biocatalyst to a 
substrate solution, or by adding just a small amount of highly productive active catalyst. 
However, the basis of a catalyst is that it should not be stoichiometric and therefore the lower 
the amount of material added to achieve similar results, the better its performance. Turnover 
number (TON, Equation 11) is a dimensionless criterion used, but is not commonly used in 
biocatalysis compared to homogeneous catalysis, as the molecular mass of the enzyme has to 
be known or determined. 
 
Equation 11 
]/[][ CS
ratiocatalyst
substrate
catalystofamount
productofamountTON ===  
 
Furthermore TON is not used in biocatalytic processes as an important criteria, as the focus is 
in reusability and recycling of the enzyme, with emphasis on enzyme performance over the 
lifetime instead of focusing on batch reactions, as for homogeneous catalysis. The turnover 
number also does not take into account the time-scale, therefore an alternative assessment 
parameter called the productivity number72 (Equation 12) should be used.  
 
Equation 12 
timexcatalystunit
productofmassPN =  
 
3.3.2.3 Biocatalyst stability 
The thermal stability or storage stability of a bio-catalyst is independent of its process or 
operating stability. It may be ascertained by comparing the amount of product generated with 
the amount of catalyst consumed. This may be defined as the total turnover number (TTN, 
Equation 13) 
 
Equation 13 
spentcatalystofmole
productofmolesTTN =  
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Typically where the purity of the biocatalyst is not known, as in applied biocatalysis, the 
enzyme consumption number (e.c.n., Equation 14) is used as an expression of biocatalyst 
stability. 
 
Equation 14 
productofkg
enzymeofg
generatedproductofamount
spentnpreparatioenzymeofamount
nce ==...  
 
The e.c.n. value is dependant on process parameters such as temperature, pH, and 
concentrations of substrate(s) and product(s) and the TTN (Equation 15) may then be 
calculated as follows: 
 
Equation 15 
)/(.)../1000( productenzyme MWMWxnceTTN =  
 
The use of TTN in assessing the operational stability of an enzyme, suffers from the following 
limitation: The number of moles of biocatalyst is not a suitable reference for the complexity 
and cost associated with its manufacture. However, based on the enzyme and product cost, the 
contribution of biocatalyst to the overall cost may be readily assessed. The threshold values 
for sufficient biocatalyst stability depend on the application, as does the value for product 
yield. However for any application, the TTN should exceed 10 000 and for large-scale 
processes, values > 1 000 000 are preferable. 
 
3.3.2.4 Reactor productivity 
The assessment of reactor productivity that is independent of catalyst is based on the space-
time-yield (s.t.y., see Equation 16). 
 
Equation 16 
]..[]..[)/(... 1111 −−−−= hLgordLkgtimexvolumereactorgeneratedproductofmassyts  
 
An increase in s.t.y. in the same reactor is equivalent to an increase in reaction rate. In the 
case of Michaelis-Menten kinetics as defined below (Equation 17), there are three possible 
methods of achieving a maximum reaction rate: 
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- Increasing substrate concentration; 
- Increasing enzyme concentration; and 
- An increase in the time constant kcat. 
 
Equation 17 
])[/(]][[])[/(][max SKSEkSKSvv McatM +=+=  
 
3.3.3 Increasing substrate concentration. 
 
The rate of an enzyme-catalysed reaction may be increased by increasing the enzyme 
concentration and substrate concentration up to the limit of saturation (≈ 10 KM). If [S] » KM, 
the enzyme is saturated (Equation 18). 
 
Equation 18 
][max Ekvv cat==  
 
Under substrate saturation conditions, the reaction is zeroth-order with respect to substrate 
(assuming high KM values which implies loosely binding substrate). Enzymes are often 
saturated only above the solubility limit of the substrate.  
 
3.3.4 Increasing enzyme concentration.  
 
The reaction rate and s.t.y. may be enhanced by increasing the enzyme concentration [E]; in 
practice, however, a maximum concentration limit may be reached due to either excessive 
viscosity increases or excess of deactivated protein in the reactor. 
 
3.3.5 Rate acceleration 
 
Kcat signifies the time constant of the enzyme reaction [time-1] which is performed over the 
time scale 1/ kcat [time]. An increase may be effected through increasing reaction temperature 
(Arrhenius behaviour), but also through changing a protecting group in peptide synthesis. A 
minimum threshold value for reactor productivity may be set up at a space-time-yield of 
 Chapter Three 50 
100 g.L-1.d-1 (4 g.L-1.h-1). This value tends to be limited more by a lack of substrate solubility 
than by the biocatalyst. Well-developed biocatalytic processes operate at space-time yields 
between 500 - 1000 g.L-1.d-1 (20 - 40 g.L-1.h-1). 
 
3.3.6 Ratio between catalytic constant (kcat) and the deactivation rate constant (kd) 
 
The effect of deactivation depends linearly on the dimensionless ratio kcat/kd, which may be 
used to assess the potential of a deactivating enzyme for synthesis (Equation 19). 
 
Equation 19 
)}*exp(1{*)/(][)1ln(][* 00 tkkkxExKSx ddcatM −−=−−  
 
Where x is the degree of conversion. 
 
3.3.7 Relationship between Deactivation Constant Kd and total turnover number 
(TTN) 
 
The specific enzyme consumption [U per kg of product] may be used to assess an enzyme’s 
potential as follows (Equation 20). 
 
Equation 20 
.)../()(.)..( 0, ytskxacespnconsumptioenzymespecific dvol=  
 
Where avol,0 is the initial volumetric activity. A high value for s.t.y. and low values of [E]’ (g 
enzyme L-1), avol,0 or kd all lead to a favourable low specific enzyme activity. 
 
TTN may also be derived from specific enzyme consumption as follows (Equation 23): 
 
Equation 21 
])([/)][...(.)..( 10,' −= productkgenzymegaExcespncenumbernconsumptioenzyme vol  
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Equation 22 
)]/([.)..1000()/(])([ '1 dproductenzyme kxEytsxMWMWcatalystmolproductmolTTN =−  
 
Equation 23 
)][/(.)..1000(])([ 01 dproduct kxExMWytsxcatalystmolproductmolTTN =−  
 
A high TTN is achieved by increasing the s.t.y, while maintaining a low [E]0 and kd. The 
factor (1000) must be removed if the s.t.y. was calculated in g.L-1.h-1. 
 
3.3.8 Effect of temperature on process time 
 
The following mathematical relationships may be used for estimating the overall process time 
by determining the time constraints for the each of the following sub-processes involved: 
substrate dissolution (Equation 24), enzymatic conversion (Equation 25), and enzyme 
deactivation (Equation 26). 
 
Equation 24 
0)/(1: akndissolutioSubstrate Ldis =τ  
 
Equation 25 
)][/(: 0ExkKconversionEnzymatic catMenz =τ  
 
Equation 26 
)][/(1: 0ExkondeactivatiEnzyme ddeact =τ  
 
The above mathematical relationships may be used to predict process time and may be used to 
evaluate the effect of increasing the reaction temperature on reaction productivity. An 
increase in the reaction temperature; results in an increase in the rate of substrate dissolution 
and minimizes solid-liquid mass transfer limitations, an increase in the rate of substrate 
conversion (Arrhenius kinetic rate) and increase in the rate of thermal enzyme deactivation. 
Therefore a compromise in operating temperature is required to maximize reactor productivity 
without denaturation of the enzyme system. 
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3.3.9 Effect of co-solvents73 
 
Contrary to expectations that enzymes are only active in aqueous solutions, activity has been 
demonstrated in almost every type of anhydrous solvent. Subsequent studies have shown a 
more accurate description of the environment that enzymes operate in as follows: 
 
- In nature, enzymes are not active in water but in the proximity of a cell membrane; 
therefore a double layer of lipid micelle would be the preferred environment to 
emulate than an aqueous bulk phase. 
- Enzymes do not necessarily deactivate in organic solvents – other process parameters 
such as low enzyme solubility or denaturation during lyophilisation may account for 
loss of activity. 
 
Typically water-miscible hydrophilic solvents such as methanol and acetone have an adverse 
effect on the enzyme reaction performance compared to water-immiscible hydrophobic 
solvents such as toluene or cyclohexane. This may be attributed to the hydrophilic solvents 
ability to remove water molecules from the enzyme surface, thus rendering the enzyme 
inactive. The advantages of organic media for conducting enzymatic reactions are:  
 
- Increasing the solubility of hydrophobic reagents which are moderately or sparingly 
soluble in water. In the case of moderately soluble reagents in water, the solubility 
may limit the maximum attainable reaction rate.  
- Effect a shift in reaction equilibrium: Reactions in organic media are possible where 
equilibrium constants favour reagents; as a result the reagents are only present in 
water. The effect of conducting a reaction in predominantly anhydrous media shows 
that the equilibrium for hydrolytic reactions will be shifted towards condensation. 
- Facile separation of organic solvents compared to water: Organic solvents can be 
recycled more readily than water, due to the high enthalpy of vaporization of water. 
- Enzymes are not dissolved in organic solvents: The recovery of enzymes from organic 
media may be conducted simply, since the enzymes are not dissolved, but merely 
suspended. Therefore the limitations associated with enzyme immobilization, such as 
low yields, activities and mass transfer limitations may be circumvented. 
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- In certain cases improved stability of enzymes in organic solvents has been observed. 
- Altered selectivity, including substrate specificity, enantioselectivity, regio- and 
chemoselectivity. 
 
While enzymes may display activities orders of magnitude lower in organic solvents 
compared to aqueous media, the following treatment procedures may result in improved 
enzyme activity: 
 
- Sufficient hydration in the organic solvent (1% v/v – saturation); 
- Lyophilisation at the pH of maximum activity in water; 
- Addition of lyoprotectants, such as polyols;  
- Addition of hydrophobic binding pocket protectants such as phenols or anilines; and 
- Lyophilisation in the presence of strong salts such as potassium chloride (KCl > 90% 
m/m). 
 
Increasing the rate of an enzymatic conversion of substrates in aqueous suspensions may be 
carried out by increasing the temperature as previously discussed or by addition of a co-
solvent in order to increase the dissolution of the substrate. However, cases have been 
reported whereby on addition of the co-solvent, longer process times were observed, although 
significant increases in substrate solubility had been achieved due to the addition of co-
solvent. On raising the temperature, substrate solubility, substrate dissolution rate and 
enzymatic reaction rate all increased, resulting in shorter process times provided enzyme 
deactivation does not take place. 
 
3.3.10 Process criteria for process schemes: Atom economy and environmental quotient 
 
A list of desirable criteria for chemical and biochemical process technologies has been 
proposed by Roger Sheldon74,75 
- Catalytic reactions instead of stoichiometric ones; 
- Reactions with 100% selectivity at 100% conversion; 
- High substrate concentrations; 
- No detrimental solvents and no change of solvent during the process; and 
- Enhanced use of solid or volatile acids and bases, as well as pH stat techniques. 
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The importance of high conversions, selectivities and yields has been recognized, as have 
processes that use high substrate concentrations, which leads to increases in s.t.y. and TTN. 
However, during the optimization of a process, the following criteria have to be investigated: 
 
- Atom economy, which is defined as the fraction of carbon (or other elements) in the 
substrate that is utilized or recovered in the product. An example of a process with low 
atom economy is any synthesis requiring protection and deprotection steps such as 
peptide synthesis (while possibly still featuring high product yields). 
- The specific consumption of solvents, salts and other auxiliaries such as work up 
materials (active carbon, filter aids) per kg of product. This may be quantified in terms 
of an “environmental quotient” (EQ) as defined by Sheldon 74,75. The EQ shows the 
amount of by-product produced versus the target product [kg.kg-1] multiplied by a 
measure of environmental unfriendliness. Water or sodium chloride may carry a factor 
of 1, while mercury, halogenated solvents or other toxic by-products may carry a 
factor between 10 and 100. 
- The degree of recovery of all materials, ranging from main process components to 
solvents, salts and traces impurities. This encompasses losses present in dilute streams, 
often termed ancillary losses. Eco-balances have become increasingly popular with 
regulators to gauge the impact of discharges. Increasingly such instruments have 
replaced the simple levying of costs on discharges or setting inflexible upper limits for 
the concentrations of a range of ecologically unfriendly agents. 
 
3.4 Discussion 
 
The quantitative parameters used to determine the feasibility of the biocatalytic process may 
be used to assess the feasibility of commercializing the process. The 5-MU process may be 
complicated by the interdependence of process variables, e.g. temperature where an increase 
in temperature increases substrate solubility and rate of reaction, but also decreases enzyme 
stability and activity, thus possibly leading to an uneconomical process due to the high cost 
associated with the enzyme catalyst. The feasibility of the biocatalytic 5-MU process has been 
demonstrated, albeit at low 5-MU yields of 30%. The main objectives during the next phase 
of the investigation were to assess operational parameters under which the biocatalytic 
reaction could be carried out, while improving the guanosine conversion and 5-MU yield. 
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CHAPTER FOUR 
 
4 Biocatalytic preparation of 5-Methyluridine (5-MU): Selection of 
process operating conditions 
 
4.1 Introduction 
 
The successful development of a biocatalytic process is a complex task, due to the activity 
and stability constraints under which enzymes operate. The advantages and disadvantages of 
using biocatalysts have been discussed in detail (see Section 2.2). Typically the disadvantages 
include substrate and/or product inhibition phenomena, thermal and pH instability, and 
mechanical instability. Numerous methods such as enzyme immobilization, in-situ product 
removal (ISPR) and recombinant DNA technology are methods used to circumvent the 
limitations of biocatalytic processes. 
 
During the investigation into the biocatalytic preparation of 5-methyluridine (5-MU), a series 
of small scale screening experiments were conducted to establish the feasibility of carrying 
out the biocatalytic transformation and to establish the range of operating conditions. The 
degree of complexity in development of the biocatalytic process was increased significantly 
due to the use of a coupled enzyme system (PNP and PyNP), as the enzymes may have 
different thermal and pH characteristics. During the development of a successful biocatalytic 
process, the enzyme’s activity and stability profiles under ideal conditions with respect to pH 
and temperature (see Section 4.2.14 and 4.2.15) must be determined, as well as the enzyme’s 
activity and stability under operational process conditions. 
 
The effect of the following variables on the biocatalytic reaction performance and operational 
parameters were investigated: 
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- Reaction medium buffer system (Trizma base/phosphate buffer versus phosphate 
buffer only);  
- Effect of buffer concentration (0 – 100 mM) and counter ion (K+ versus Na+); 
- Effect of substrate concentration (0.1 – 9% m/m) and mode of operation (fed-batch 
versus one-pot); 
- Effect of temperature (40oC, 50oC and 60oC); 
- Effect of pH (6 - 11); 
- Effect of thymine to guanosine mole ratio (2.3:1 versus 1:1); 
- Effect of enzyme batch variability; 
- Effect of co-solvents (methanol, ethanol and DMSO); and 
- Effect of surfactants (Tween 80, Triton-X-100). 
 
The effect of the above variables on guanosine conversion and 5-MU yield were evaluated 
and the results described in the sections that follows. The reactions were carried out in 
triplicate in order to establish the reaction reproducibility and experimental error. 
 
The overall transglycosylation reaction (see Scheme 4.1) may be de-coupled into the 
phosphorolysis (see Scheme 4.2) and synthesis reactions (see Scheme 4.3). Although the 
transglycosylation reaction was carried out in one pot, the reactions were “de-coupled” to 
study where process improvements may be made with respect to improving guanosine 
conversion and/or 5-MU yield. 
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Scheme 4.1: Overall transglycosylation reaction used to prepare 5-MU  
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Scheme 4.2: Phosphorolysis reaction 
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Scheme 4.3: Synthesis reaction 
 
4.2 Results and discussion 
 
4.2.1 Influence of phosphate ion  
 
4.2.1.1 Effect of phosphate ion and increasing thymine:guanosine mole ratio 
 
It was postulated that the low 5-MU yields of 30% previously observed by us in the initial 
screening experiments were due to the decomposition of R-1-P to ribose and phosphate. 
Owing to the relatively low solubility of thymine in the reaction medium, the R-1-P could 
decompose before reacting with thymine, thus leading to lower 5-MU yields. Due to the low 
solubility of substrates in the reaction medium and possible solid liquid mass transfer 
limitations, the effect of increasing the thymine to guanosine mole ratio from 1:1 to 2.3:1 was 
then evaluated. 
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The effect of phosphate ion on the biocatalytic reaction was also evaluated, since phosphate 
ion is a substrate used during the phosphorolysis reaction and a by-product of the synthesis 
reaction. Therefore high concentrations of phosphate ion may have an adverse effect on the 
synthesis reaction equilibrium. The PNP and PyNP enzyme loading was also increased from 
0.1 U.mL-1 to 0.6 U.mL-1 to limit the possible effects of thermal enzyme degradation at 
extended reaction times leading to lower guanosine conversions and 5-MU yields. The 
biocatalytic reaction was carried out using the experimental conditions reported in Table 4.1. 
 
Table 4.1: Experimental conditions used to investigate the effect of phosphate and 
increasing thymine (TM) and guanosine (GS) mole ratio 
GS conc. 
(% m/m) 
TM conc. 
(% m/m) 
TM:GS 
mole 
ratio 
PNP 
(U) 
PyNP 
(U) 
pH Temp. 
(oC) 
Na2HPO4 
conc.a 
(mM) 
1.5 1.6 2.3:1 60 60 5.7-7.5 40 50 
Note a: di-sodium hydrogen phosphate salt (50 mM) was only added after 2.5 days reaction time. Total Reaction 
time 4.5 days.  
 
It has been reported76 that the transglycosylation reaction may be carried out in the absence of 
phosphate ions; the reaction, therefore, was initiated in the absence of phosphate ions. The 
results obtained (Figure 4.2 and Table 4.2) showed that a low guanosine conversion of 30% 
and 5-MU yield of 10% was observed after 2.5 days reaction time had elapsed. The pH of the 
reaction medium was measured and found to be 5.7. It is known that R-1-P decomposes under 
acidic conditions to ribose and phosphate thus leading to the low 5-MU yield observed. The 
pH was then adjusted to 7.5 by the addition of di-sodium hydrogen phosphate salt (50 mM) 
and the reaction continued for another 2 days. Remarkably, the results obtained showed that 
guanosine conversion had increased to > 90%, however no significant improvement in 5-MU 
yield was observed. 
 
The results demonstrated, as expected, that phosphate ion was required as a co–substrate 
during the phosphorolysis reaction, with the low solubility of guanine driving phosphorolysis 
reaction to completion. The results obtained also indicated that the PNP enzyme was 
relatively stable under the reaction conditions used with respect to temperature and pH. The 
low 5-MU yield of 30% may be attributed to decomposition of the R-1-P intermediate under 
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acidic conditions and / or possible enzyme degradation. The impact of increased thymine to 
guanosine mole ratio was thus not adequately assessed under the conditions used and 
therefore the reaction was repeated. 
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Figure 4.1: Effect of phosphate and increased thymine to guanosine mole ratio 
 
Table 4.2: Effect of phosphate and increased thymine to guanosine mole ratio 
Time 
(days) 
GS conv. 
(%) 
5-MU sel. 
(%) 
5-MU yield 
(%) 
Mole bal. 
(%) 
0 0 0 0 - 
2.5 21.1a 38.6 8.1 83.2 
3.5 38.1 27.7 10.6 91.0 
4.5 96.7 30.9 29.9 91.6 
Note a: di-sodium hydrogen phosphate salt (50 mM, Na2HPO4) added after sample was taken 
 
The possibility of phosphate contamination during enzyme preparation could not be excluded 
and thus further studies of the biocatalytic reaction medium, such as mixtures of Trizma base 
and phosphate buffer versus phosphate buffer only, sodium phosphate versus potassium 
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phosphate, and phosphate buffer concentration were conducted (see Section 4.2.3, 4.2.4 and 
4.2.5). 
 
The above reaction was repeated at a larger scale (650 mL) with the following variations; the 
reaction medium was buffered from the beginning using Trizma Base (50 mM) and sodium 
phosphate buffer (50 mM) at pH 7.8, while the PNP and PyNP enzyme loading was 
maintained at approximately the same levels previously used during the small scale studies 
(0.1 U.mL-1 - see Table 4.3). The main objectives were to assess the effect of increasing the 
thymine:guanosine mole ratio from 1:1 to 2.3:1 and produce isolated material for DSP 
studies. 
 
Table 4.3: Effect of increased thymine:guanosine mole ratio (2.3:1) 
GS conc. 
(%m/m) 
TM conc. 
(% m/m) 
TM:GS 
mole ratio 
PNP 
(U) 
PyNP 
(U) 
PNP:PyNP 
enzyme ratio 
Temp. 
(oC) 
1.5 1.6 2.3:1 105 75 1.4:1 40 
Note a: The buffer system used comprised of a mixture of Trizma base (50 mM) and sodium phosphate buffer 
(50 mM, 0.71% m/m, pH 7.8). 
 
The results obtained (Figure 4.2 and Table 4.4) show that a guanosine conversion of 86% and 
a significant improvement in the 5-MU yield to 73% were achieved. The 5-MU yield obtained 
was similar to the 5-MU yields reported in the literature77. The overall improvement in 
reaction performance may be attributed to using a buffered system at pH 7.8, thus minimizing 
R-1-P decomposition under acidic conditions. Concomitant with this, the increased thymine 
to guanosine mole ratio may also have contributed to the improved 5-MU yield, although the 
exact mechanism is not known. The mechanism may be influenced by the hydrodynamics of 
the system and the effect of solid liquid mass-transfer effects. 
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Figure 4.2: Effect of increased thymine to guanosine mole ratio (2.3:1) 
 
Table 4.4 : Effect of increased thymine to guanosine mole ratio (2.3:1) 
Time 
(h) 
GS conv. 
(%) 
5-MU sel. 
(%) 
5-MU yield 
(%) 
5-MU prod. 
(g.L-1.h-1) 
Mole bal. 
(%) 
1 0.00 0.0 6.35 0.84 103 
2 11.3 173 19.5 1.30 99.4 
3 35.8 98.1 35.1 1.56 94.2 
4 52.7 91.3 48.2 1.60 104 
5 64.2 86.6 55.6 1.48 83.6 
6 77.8 80.0 62.2 1.37 99.8 
7 86.0 84.6 72.8 1.38 86.3 
23 94.7 83.5 79.1 0.46 91.9 
 
The results obtained demonstrated that the biocatalytic reaction can be carried out 
successfully at reasonable guanosine conversions and 5-MU yields. However relatively low 5-
MU productivities were observed, compared to the target required productivity of 20 g.L-1.h-1. 
The effect of process variables such as increasing reaction temperature (increased substrate 
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solubility) and varying pH to form salts and increase substrate solubility were investigated to 
improve the reactor productivity. 
 
4.2.2 Biocatalytic screening experiments 
 
A series of small scale screening experiments (2 mL) were conducted using crude enzyme 
extract PNP (BH 1531) and PyNP (E. coli) enzyme available in order to establish the 
operating conditions/range of the biocatalytic reaction and identify the most important 
variables. The results obtained during this preliminary investigation provided an insight into 
trends observed within a particular set of experiments as the reaction mixture was only 
sampled at the end of the required time period. In order to compare results obtained during 
different experimental batches, a control experiment was conducted within each batch. The 
experimental set-up used a Radley’s starfish to effect heating and stirring. The experiments 
were also carried out in triplicate so as to ascertain the experimental error and reaction 
variability/reproducibility. As the reactions were carried out at 2 mL scale, the actual 
operating conditions may not have been optimum with respect to solid-liquid mass transfer 
phenomena and scaling up the reaction. The results obtained during this experimental study 
do not give any insight into the effect of the variables on the rate of the biocatalytic reaction, 
as the individual experiments were not sampled with time. The complete reaction mixture was 
worked-up using sodium hydroxide solution (NaOH, 10 M) after the required time had 
elapsed (24 - 260 hours). 
 
The selection and screening experiments were conducted at 2 mL scale in triplicate using the 
equipment shown in Figure 4.3. 
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Figure 4.3: Radleys Starfish used for small scale biocatalysis experiments (ex. Discovery 
Technologies) 
 
4.2.3 Reaction medium buffer composition 
 
During the preliminary biocatalytic experiments it was established that inorganic phosphate 
ion was required as a co-substrate and as a reaction medium pH modifier (pH 7.5, 50 mM). 
Subsequently, an experiment was conducted using a mixture of Trizma base (50 mM) and 
phosphate buffer (50 mM) and a guanosine conversion of > 90% and 5-MU yield of 80% was 
achieved. However it was unclear as to whether phosphate buffer on its own would provide 
sufficient buffering capacity for the reaction. Concomitant with this, an increase in the 
thymine to guanosine mole ratio from 1:1 to 2.3:1 was also used in the experiment. Therefore 
a series of bench-mark reactions were conducted using the conditions reported in Table 4.5, 
investigating the influence of reaction medium (Trizma base/phosphate buffer system versus 
phosphate buffer (PB) on the overall reaction. 
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Table 4.5: Effect of reaction medium Trizma base/phosphate buffer (Trizma/PB) 
mixture versus phosphate buffer (PB)c 
Trizma base 
buffer 
(%m/m) 
Phosphate 
buffer 
(% m/m) 
GS 
conv. 
(%) 
5-MU 
sel. 
(%) 
5-MU 
yield 
(%) 
Mole bal. 
(%) 
0.60a 0.59 91.6 + 2.40 72.5 + 1.51 66.5 + 1.93 91.1 + 2.14 
- 0.59b 92.3 + 1.10 73.4 + 0.59 67.7 + 0.36 93 + 2.09 
Note a Reaction carried in phosphate buffer (PB, 50 mM, and 0.71% m/m) and Trizma base buffer (50 mM, 
0.60% m/m)  
Note b: Reaction carried out in phosphate buffer (PB, 50 mM, and 0.59% m/m)   
Reaction conditions: TM: GS 2.3: 1, GS conc. 1.7% m/m, TM 1.5% m/m, PNP 0.14 U, PyNP 0.16 U, 
PNP:PyNP 0.88:1, Time 24 hours, Temp 40oC, pH 7.8 
Note c: Enzyme batch: PNP 1.87 U.mg-1, PyNP 0.659 U.mg-1 
 
The results obtained (Table 4.5 and Figure 4.4) indicate that irrespective of the reaction 
medium buffer composition, no adverse effect on reaction performance with respect to 
guanosine conversion and 5-MU yield was observed. 
 
Although low concentrations of Trizma base (50 mM, 0.60% m/m) and phosphate buffer 
(50 mM, 0.59% m/m) were used during the biocatalytic reaction, the significant cost of 
Trizma base (60 $/kg) compared to phosphate buffer (2 $/kg) prompted the use of the 
phosphate buffer system only (with the view to improve the techno-economics of the 
process). 
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Figure 4.4: Effect of reaction medium (Trizma base/phosphate buffer system versus 
phosphate buffer (PB) 
Triplicate reactions per set.  
 
4.2.4 Effect of phosphate buffer concentration (0 - 100 mM) 
 
The effect of increasing potassium phosphate buffer concentration from 25 - 100 mM was 
then investigated to determine the effect on the transglycosylation reaction equilibrium, 
guanosine conversion and 5-MU yield. Since phosphate ion is a substrate used in the 
phosphorolysis reaction and a product of the synthesis reaction, phosphate ion was expected 
to play a role in the transglycosylation reaction equilibrium. The results obtained previously 
demonstrated that the phosphorolysis reaction goes to completion due to the low solubility of 
guanine. Thus, the effect of phosphate ion on the phosphorolysis reaction was expected to be 
negligible, while using increased concentrations of phosphate ion would have an adverse 
effect on the synthesis reaction equilibrium. The results obtained (Table 4.6 and Figure 4.5) 
show, as expected, that the potassium phosphate buffer concentration had no adverse effect on 
the guanosine conversion (> 95%). However, as the potassium phosphate buffer concentration 
was increased from 25 – 100 mM, a decrease in the 5-MU yield from 85.0 - 71.7% was 
observed. 
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Table 4.6: Effect of potassium phosphate buffer concentration (25 - 100 mM)a 
Buffer conc. 
(mM)/%m/m 
PO43- : GS 
Mole ratiob 
GS conv. 
(%) 
5-MU sel. 
(%) 
5-MU yield 
(%) 
Mole bal. 
(%) 
25/0.35 0.47 : 1 97.9 + 0.35 86.8 + 5.35 85.0 + 5.44 95.3 + 2.74 
50/0.71 0.94 : 1 98.1 + 0.01 78.6 + 1.49 77.1 + 1.46 90.1 + 1.18 
75/1.06 1.41 : 1 98.1 + 0.06 75.1 + 3.77 73.7 + 3.66 90.9 + 0.66 
100/1.42 1.89 : 1 98.1 + 0.10 73.0 + 1.89 71.7 + 1.78 94.5 + 1.58 
Note a: Reaction conditions: TM 1.5%m/m, GS 1.5%m/m, TM: GS mole ratio 2.3:1, Temp. 40oC, Phosphate 
buffer, pH 8.2, Time 24 hours, PNP 0.27 U, PyNP 0.27 U, PNP:PyNP 0.98:1, Enzyme batch: PNP 1.87 U.mg-1, 
PyNP 0.659 U.mg-1 
Note b: The effective phosphate ion to guanosine mole ratio may be limited by the solubility of guanosine (0.4 - 
0.6% m/m at 40oC). 
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Figure 4.5: Effect of potassium phosphate buffer concentration (25 - 100 mM) 
Triplicate reactions per set. 
 
In principle, phosphate ion may be used catalytically in the transglyscosylation reaction since 
it is used as a substrate during the phosphorolysis reaction and produced during the synthesis 
reaction, thus effectively recycling the phosphate ion. It has been reported that phosphate 
buffer concentrations between 25 and 50 mM can be used to carry out the transglycosylation 
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reactions78. It has also been reported that phosphate ion plays a role in the ligand binding 
stoichiometry. In the absence of phosphate ion, a lower ligand binding stoichiometry was 
reported at increased product concentrations79. 
 
4.2.5 Effect of type of phosphate buffer (potassium versus sodium) used 
 
A series of bench-mark reactions were then conducted comparing the effect of potassium 
phosphate versus sodium phosphate buffer to determine if the phosphate buffer counter-ion 
(potassium (K+) versus sodium (Na+)) had any effect on the biocatalytic reaction. The results 
obtained (Figure 4.6 and Table 4.7) show that the nature of the counter ion of the buffer 
medium used does not affect the reaction performance with respect to guanosine conversion 
and 5-MU formation. There is no significant difference in price between sodium phosphate 
(Na2HPO4, 1.80 $/kg) and potassium phosphate (K2HPO4, 1.67 $/kg), so no significant impact 
on the techno-economic model is expected. 
 
Table 4.7: Effect of type phosphate buffer (potassium versus sodium)a 
Buffer conc. 
(mM)/%m/m 
PO43- : GS 
Mole ratio 
GS conv. 
(%) 
5-MU sel. 
(%) 
5-MU yield 
(%) 
Mole bal. 
(%) 
Buffer 
system 
50/~0.87 0.84 : 1 98.1 + 0.01 78.6 + 1.49 77.1 + 1.46 90.1 + 1.18 Potassiumb 
50/~0.71 0.85 : 1 97.9 + 0.1 75.5 + 3.15 73.9 + 3.04 90.2 + 1.89 Sodiumc 
Note a: Reaction conditions: TM 1.5% m/m, GS 1.5% m/m, TM: GS mole ratio 2.3:1, Temp. 40oC, Time 24 
hours, PNP 0.27U, PyNP 0.27U, PNP: PyNP 0.98:1, Enzyme batch: PNP 1.87 U.mg-1, PyNP 0.659 U.mg-1 
Note b: Effect of K2HPO4/KH2PO4 buffer, pH 8.23 
Note c: Base case reaction Na2HPO4/NaH2PO4 buffer, pH 7.5-8.0 
 
However, based on differences in molecular weight between sodium phosphate 
(141.96 g.mol-1) and potassium phosphate (174.18 g.mol-1), sodium phosphate would be 
preferred, as less material would have to be added to afford the same phosphate buffer 
concentration. 
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Figure 4.6: Effect of potassium versus sodium phosphate buffera 
Triplicate reactions per set. 
 
4.2.6 Influence of thymine on reaction equilibrium  
 
4.2.6.1 Effect of thymine to guanosine mole ratio on equilibrium 
The effect of thymine to guanosine mole ratio on the biocatalytic reaction was investigated 
with the view to gain insight into the potential improvement in 5-MU yield at increased 
thymine:guanosine mole ratio’s. Due to the low solubility of substrate in the reaction medium, 
a complex interaction between the physical and chemical properties of the substrate and the 
hydrodynamics of the system probably exists, and which warrants further investigation. An 
excess of thymine does not appear to influence the reaction performance owing to its low 
solubility in the reaction medium. The biocatalytic reaction may, therefore, be operating under 
various solid-liquid mass transfer regimes. A series of experiments were conducted to 
investigate the effect of various thymine:guanosine mole ratio’s on the reaction equilibrium.  
 
The results obtained (Figure 4.7 and Table 4.8) show that irrespective of the 
thymine:guanosine mole ratio, no adverse effects with respect to guanosine conversion (> 
90%) were observed. However, as the thymine to guanosine mole ratio was increased from 
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1:1 to 2.3:1, an increase in the 5-MU yield from 61.9 - 85.3% was observed. It is possible that 
the excess thymine reduces the extent of the reverse synthesis reaction equilibrium (see 
Scheme 4.3) thus leading to increased 5-MU yields. 
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Figure 4.7: Effect of increasing the thymine to guanosine mole ratio 
Triplicate reactions per set.  
 
Table 4.8: Effect of increasing the thymine to guanosine mole ratio (1:1 - ~2.3:1)a,b 
TM:GS 
Mole ratio 
GS conv. 
(%) 
5-MU sel. 
(%) 
5-MU yield 
(%) 
Mole bal. 
(%) 
1.0:1 91.4 + 0.87 67.8 + 4.23 61.9 + 3.28 86.4 + 1.90 
1.5:1 95.3 + 0.21 76.4 + 3.43 72.8 + 3.11 91.3 + 3.29 
2.0:1 96.1 + 0.16 75.9 + 1.02 72.9 + 9.15 97.3 + 6.52 
2.3:1 98.0 + 0.06 85.3 + 1.02 83.5 + 0.95 95.0 + 1.76 
Note a: Experimental conditions: Temp 40oC, Time 24 hours, TM 1.5% m/m, GS 1.5% m/m, PNP 0.27 U, PyNP 
0.27 U, PNP:PyNP: 1:1  
Note b: Enzyme batch: PNP 1.87 U.mg-1, PyNP 0.659 U.mg-1 
The highest 5-MU yield was obtained using a thymine:guanosine mole ratio of 2.3:1. 
Subsequently all further biocatalytic reactions were conducted using this ratio. 
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4.2.7 Effect of enzyme type (PNP versus PyNP) on the synthesis reaction equilibrium  
 
It was postulated that the lower 5-MU yields observed during the screening experiments could 
be attributed to a reaction equilibrium being set up during the synthesis reaction (see Scheme 
4.3). A series of experiments were then conducted investigating the effect of PNP or PyNP on 
the synthesis reaction equilibrium. 
 
Due to the limited quantities of R-1-P (bis-cyclohexylamine salt ex. Sigma Aldrich) substrate 
available, and the cost associated with obtaining this material ($ 500/10 mg), the effects of 
PNP or PyNP enzyme on the synthesis reaction was not studied (see Scheme 4.3). However, 
as 5-MU and phosphate ion are both readily available, the effect of PNP or PyNP on the 
reverse synthesis reaction equilibrium was investigated. The results reported in Table 4.9 
show that the PyNP enzyme exhibited the expected substrate specificity for 5-MU compared 
to the PNP enzyme with 5-methyluridine conversions of 29% and 16% obtained respectively. 
Similarly, an increased thymine yield of 21.0% was obtained using the PyNP enzyme 
compared to a thymine yield of 3% using the PNP enzyme. The results obtained suggest that 
lower 5-MU yields may be observed in cases where extended reaction times are used and an 
equilibrium is set up. 
 
Table 4.9: Effect of enzyme type (PNP versus PyNP) on the synthesis reaction 
equilibriuma 
PNPb 
U 
PyNPb 
U 
5-MU Conv. 
(%) 
Thymine Sel. 
(%) 
Thymine Yield 
(%) 
Mole bal. 
(%) 
0.27 - 15.5 + 0.95 19.9 + 1.99 3.10 + 0.47 87.6 + 0.50 
- 0.27 28.7 + 0.89 73.1 + 1.97 21.0 + 0.14 92.3 + 0.81 
Note a: Experimental conditions: 5-MU 1.5% m/m, Phosphate buffer 50 mM, Time 24 hours, Temp. 40oC 
Note b: Enzyme batch: PNP 1.87 U.mg-1, PyNP 0.659 U.mg-1. Triplicate reactions per set.  
 
4.2.8 Effect of enzyme type (PNP versus PyNP) on the biocatalytic reaction 
 
The thermal stability of the PNP enzyme compared to the PyNP enzyme would make the use 
of PNP as a single enzyme system (as opposed to the coupled PNP and PyNP system) an 
attractive alternative. The results obtained for experiments conducted using PNP and PyNP as 
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single enzyme systems are reported in Table 4.10 and show that the use of the individual 
enzymes produced inferior results compared to using the coupled enzyme system reported 
previously in Table 4.7. This was to be expected, as PNP and PyNP exhibit different substrate 
specificities. However, the results obtained indicated some residual activity as a guanosine 
conversion of 32% was observed using the PyNP enzyme. This may possibly be attributed to 
the presence of other unknown enzymes capable of N-ribose scission reactions which were 
not assayed for. 
 
Table 4.10: Effect of enzyme type (PNP versus PyNP) on the phosphorolysis reaction 
equilibrium and the biocatalytic reactiona  
PNPb 
U 
PyNPb 
U 
GS conv. 
(%) 
5-MU sel. 
(%) 
5-MU yield 
(%) 
Mole bal. 
(%) 
0.27 - 77.2 + 1.60 45.4 + 3.40 35.0 + 2.38 96.0 + 8.69 
- 0.27 31.6 + 6.05 21.6 + 4.99 7.01 + 2.72 97.2 + 2.81 
Note a: Experimental conditions: TM 1.5% m/m, GS 1.5% m/m, TM: GS 2.3:1, Temp 40oC, Time 24 hours. 
Phosphate buffer 50 mM. Triplicate reactions per set. 
Note b: Enzyme batch: PNP 1.87 U.mg-1, PyNP 0.659 U.mg-1 
 
4.2.9 Effect of increasing substrate concentration 
 
During the optimization and screening of the biocatalytic reaction, a series of experiments 
were conducted in which the substrate concentration was increased from 1.5% m/m to 9% 
m/m. The main objectives of this study were to establish if any substrate or product inhibition 
was taking place and possibly to increase the 5-MU reactor productivity. In order to improve 
the reactor productivity (s.t.y) with respect to 5-MU production, an increase in guanosine and 
thymine substrate concentration was investigated. Due to the possibility of substrate and 
product inhibition during the course of the reaction, a series of tests were conducted whereby 
the substrate concentration was increased using either a fed-batch or one-pot procedures. 
 
4.2.10 Fed-batch mode of operation (1.5 - 4.5% m/m) 
 
The experimental conditions used are reported in Table 4.11. During the fed batch 
experiments, fresh aliquots of solid substrate guanosine and thymine were added at 24 or 48 
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hour intervals and the substrate concentration was increased from 1.5% m/m to 4.5% m/m 
with respect to guanosine. The guanosine:thymine mole ratio was maintained at 2.3:1 and 
subsequently the thymine concentration was also increased from 1.5% m/m to 4.5% m/m. The 
results obtained (Table 4.11 and Figure 4.8) show that no significant adverse effect on 
reaction performance (guanosine conversion and 5-MU yield) was observed as the substrate 
concentration was increased from 1.5 - 3.0% m/m. However, a lower guanosine conversion of 
85.9% and 5-MU yield of 70.4% were observed as the substrate concentration was increased 
above 3.0% m/m to 4.5% m/m. The exact cause of the lower guanosine conversion and 5-MU 
yield was not determined at this scale, but may possibly be attributed to one of the following: 
 
- Thermal deactivation of the PyNP enzyme at extended reaction times (72 hours); 
- Substrate and / or product inhibition phenomena; and/or 
- The substrate dosing time (24 or 48 hours) used was not optimal and had an effect on 
reaction equilibrium. 
 
Table 4.11: Effect of increasing substrate concentration (fed batch)a,b 
GS conc. 
(% m/m) 
TM conc. 
(% m/m) 
Time 
(h) 
GS conv. 
(%) 
5-MU sel. 
(%) 
5-MU yield 
(%) 
Mole bal. 
(%) 
1.50 1.56 23 97.9 + 0.06 85.2 + 1.02 83.5 + 0.95 94.9 + 1.76 
3.0 3.1 48 94.6 + 2.43 88.3 + 1.40 83.6 + 1.75 97.7 + 1.03 
4.5 4.6 72 85.9 + 2.99 81.9 + 3.32 70.4 + 1.43 93.6 + 2.62 
Note a: Experimental conditions: TM :GS mole ratio ~2.3:1, Temperature 40ºC, sodium phosphate buffer (50 
mM, pH 8.26). PNP 0.27/PyNP 0.27U PNP: PyNP 0.99: 1 
Note b: Enzyme batch: PNP 1.87 U.mg-1, PyNP 0.659 U.mg-1 
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Figure 4.8: Effect of increasing substrate concentration (fed-batch) 
Triplicate reactions per set. 
 
 
4.2.11 One-pot mode of operation (1.5 - 4.5% m/m) 
 
In order to establish the most efficient mode of operation (fed batch versus one pot), the above 
series of reactions were repeated under similar conditions (Table 4.12) using a one-pot mode 
of operation. The reactions were carried in triplicate out under identical conditions except that 
all the required reagents (guanosine and thymine) were added at the beginning of the reaction. 
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Table 4.12: Effect of increasing substrate concentration (one pot)a,b 
GS conc. 
(% m/m) 
TM conc. 
(% m/m) 
GS Conv. 
(%) 
5-MU Sel. 
(%) 
5-MU Yield 
(%) 
Mole bal. 
(%) 
1.5 1.5 98.3 + 0.07 76.7 + 2.87 75.3 + 2.82 90.1 + 0.87 
3.0 3.1 98.7 + 0.17 77.2 + 4.44 76.2 + 4.5 87.6 + 2.79 
4.4 4.8 98.9 + 0.07 77.3 + 4.86 76.4 + 4.75 86.5 + 5.77 
Note a: Experimental conditions: TM: GS 2.3: 1, Temperature 40oC, Time 96 hours, sodium phosphate buffer 
(50 mM, pH 8.3), PNP 0.27 U, PyNP 0.27 U, PNP:PyNP ratio 1:1. 
Note b: Enzyme batch: PNP 1.87 U.mg-1, PyNP 0.659 U.mg-1 
 
Surprisingly, the results obtained (Table 4.12 and Figure 4.9) showed no significant effect on 
reaction performance with respect to guanosine conversion and 5-MU yield. In addition, there 
does not appear to be any significant difference in reaction performance with respect to 
guanosine conversion and 5-MU yield between the fed batch and the one pot procedures when 
the substrate concentrations are increased. Subsequently, a series of reactions were conducted 
to investigate further substrate increases to 9% m/m using the fed batch and one pot 
procedures. 
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Figure 4.9: Effect of increasing substrate concentration (one-pot) 
Triplicate reactions per set. 
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4.2.12 Fed-batch mode of operation (4.5 - 9% m/m) 
 
During previous studies, we have shown that the biocatalytic reaction may be carried out 
using either a fed-batch or one-pot mode of operation. The effect of further increases in the 
guanosine and thymine substrate concentrations was initially investigated using the fed batch 
protocol only. 
 
The results obtained (Figure 4.10 and Table 4.13) show that as the substrate concentration 
increases from 4.5 - 9.0% m/m, a decrease in the guanosine conversion from 96% to 76% was 
observed. Similarly, a corresponding decrease in the 5-MU yield from 85% to 61% was also 
observed. This was contrary to what was expected, as the fed-batch mode of operation limits 
the extreme physical concentrations the PNP and PyNP enzyme may be exposed to, thus 
circumventing possible substrate and product inhibition. In addition to this, the fed-batch 
procedure operates in much less demanding solid-liquid reaction conditions, thus improving 
the mixing and hydrodynamics of the system. 
 
Table 4.13: Effect of increasing substrate concentration (4.5 - 9.0%m/m, fed-batch)a,b 
GS 
(% m/m) 
TM 
(% m/m) 
Time 
(hrs)d 
GS conv. 
(%) 
5-MU sel. 
(%) 
5-MU yield 
(%) 
Mole bal. 
(%) 
4.40 4.88 84 95.5 88.8 84.9 96.4c 
6.04 6.16 192 96.9 84.2 81.6 93.4 
7.44 7.75 216 85.9 78.7 67.7 90.5 
9.08 9.52 240 75.5 80.4 60.7 91.3c 
Note a: Experimental conditions: TM: GS mole ratio 2.3: 1, Temperature. 40oC, sodium phosphate buffer (50 
mM, pH 8.26), PNP 0.27 U, PyNP 0.27 U, PNP:PyNP: 1:1 
Note b: Enzyme batch: PNP 1.87 U.mg-1, PyNP 0.659 U.mg-1 
Note c: Due to low mole balances obtained only one sample of each triplicate was used. The reactions were not 
repeated due to the extended times required (84 – 240 hours). The low mole balances obtained may be attributed 
to errors associated with the accurate and precise substrate dosing of guanosine (30 mg) and thymine (31 mg) 
during the fed batch reactions. 
Note d: Total reaction time 
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However the lower 5-MU yields may possibly be attributed to the reasons discussed in 
Section 4.2.10 relating to non optimal substrate dosing (24 - 48 hour intervals) and effect of 
reaction equilibrium being set up. 
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Figure 4.10: Effect of increasing substrate concentration. (Fed-batch) 
 
4.2.13 One-pot mode of operation (6.0 - 9.0% m/m) 
 
The effect of increased substrate concentration when using the one pot procedure was then 
investigated using the experimental conditions reported in Table 4.14. The results obtained 
(Figure 4.11 and Table 4.14) were once again somewhat contrary to what was expected, as 
substrate and / or product inhibition phenomena were not observed. The unexpected results 
were despite the high solids loading of 18% in terms of guanosine and thymine levels. Due to 
the high solids loading, the reaction mixture did not appear to be stirred efficiently, and it was 
expected that the reaction may not have been operating under optimal solid liquid mass 
transfer conditions. However this did not appear to have an adverse effect on the overall 
reaction performance. 
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Table 4.14: Effect of increasing substrate concentration (6 - 9.0% m/m, one pot)a,b 
GS 
(% m/m) 
TM 
(% m/m) 
Time 
(hrs)c 
GS conv. 
(%) 
5-MU sel. 
(%) 
5-MU yield 
(%) 
Mole bal. 
(%) 
5.95 6.22 192 97.8 + 0.15 84.8 + 0.56 83.0 + 0.51 92.5 + 1.11 
7.45 7.79 216 98.0 + 0.17 84.9 + 2.87 83.2 + 2.68 92.8 + 1.77 
8.94 9.45 60 87.1 79.9 69.7 91.8 
8.94 9.31 156 97.1 85.6 83.1 92.2 
8.95 9.32 252 98.2 80.2 78.8 84.9 
Note a: Experimental conditions: TM: GS mole ratio 2.3: 1, Temperature. 40oC, sodium phosphate buffer (50 
mM, pH 8.26), PNP 0.27U, PyNP 0.27U, PNP: PyNP: 1:1 
Note b: Enzyme batch: PNP 1.87 U.mg-1, PyNP 0.659 U.mg-1 
Note c: Total reaction time 
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Figure 4.11: Effect of increasing substrate concentration (6.0 - 9.0%m/m, one pot)a 
Note a: The average guanosine conversion and 5-MU yield at different reaction times were used during the 
experiment using the maximum guanosine concentration (9% m/m) (triplicate) 
 
The rate of the biocatalytic reaction was also investigated using the increased guanosine 
concentration of 9% m/m and using the one pot procedure. The experiments were terminated 
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and quenched with 10 M sodium hydroxide solution after the required time. The results 
obtained (see Figure 4.12) show that after 60 hours a relatively high guanosine conversion of 
87% and 5-MU yield of 70% was obtained, with similar 5-MU productivities of 1 g.L-1.h-1 
achieved. Previously, using a lower guanosine concentration of 1.5% m/m, the reaction was 
complete within 7 – 10 hours. However, with the current experimental conditions using an 
increased guanosine concentration of 9% m/m, the reaction appeared to be complete after 150 
hours (6 days). The results, however, do indicate the feasibility of carrying the biocatalytic 
reaction out at increased substrate concentrations using a slurry system which offers the 
potential of improving the reactor productivity. 
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Figure 4.12: Effect of increasing substrate concentration (one-pot, GS 9% m/m) 
 
4.2.14 Effect of reaction temperature (40oC, 50oC and 60oC) 
 
The effect of temperature (40 - 60oC) on the biocatalytic reaction was investigated using the 
lower bench-mark substrate concentrations of guanosine 1.5% m/m and thymine 1.5% m/m. 
Temperature influences the rate of the biocatalytic reaction, as well as the enzyme stability 
and activity. The complexity of the current biocatalytic process using the coupled enzyme 
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system with the PNP and PyNP enzymes, which exhibit different thermal characteristics, is 
illustrated by the results of stability studies in Table 4.15. 
 
Table 4.15: PNP and PyNP enzyme thermal stability and activity characteristics80. 
Temperature stability Enzyme Temperature range 
(oC) a Half-life (t1/2) 60 (oC) Half-life (t1/2) 40 (oC) 
PNP 32 - 74 ~20 hours >190 hours 
PyNP 30 - 52 9.89 37 
Note a: 60% activity retained 
 
The half-life (t1/2) of the PNP enzyme at 60oC was determined to be ~20 hours, while at 40oC 
no significant loss in activity was observed. In contrast, the PyNP enzyme appeared to be less 
thermo-stable as the half-life (t1/2) at 60oC was ~10 hours. Based on the above enzyme 
characteristics PNP (ex. B. halodurans) is slightly thermophilic while PyNP (ex. E. coli) is 
mesophilic. 
 
The results (Table 4.16 and Figure 4.13) obtained for reactions using increasing reaction 
temperatures (40 - 60oC); show that the reaction temperature has virtually no significant effect 
on reaction performance with respect to guanosine conversion and 5-MU yield. This implies 
that higher reaction temperatures may be used since an increase in reaction temperature 
increases the solubility of guanosine and thymine, thereby increasing the rate of the 
biocatalytic reaction. However, increasing the temperature may have a significant 
disadvantage in decreasing enzyme stability and activity over long periods of time, especially 
if the enzyme is to be recycled. The thermal limitations of enzymes may be circumvented by 
carrying out enzyme immobilization or using a fed batch protocol (adding the enzyme to the 
reaction mixture with time). The benefits of increased enzyme stability by carrying out 
enzyme immobilization should be weighed up against the increased cost and possible mass 
transfer limitations associated with the enzyme immobilization. Therefore, a compromise has 
to be reached between increasing the reactor productivity and the amount of enzyme required 
to carry out the biocatalytic reaction. 
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Figure 4.13: Effect of reaction temperature (40oC, 50oC and 60oC) 
 
Table 4.16: Effect of reaction temperature (40oC, 50oC and 60oC)a,b 
Temp. 
(oC) 
GS conv. 
(%) 
5-MU sel. 
(%) 
5-MU yield 
(%) 
Mole bal. 
(%) 
40 97.3 + 0.11 82.7 + 2.17 80.5 + 2.12 91.7 + 3.36 
50 97.4 + 0.15 79.6 + 3.06 77.6 + 2.90 91.6 + 2.13 
60 96.9 + 0.58 75.6 + 7.00 73.2 + 6.33 86.4 + 2.90 
Note a: Experimental conditions:  GS conc. 1.5% m/m, TM conc. 1.5% m/m, TM: GS mole ratio ~2.3: 1, 
Temperature. 40oC, sodium phosphate buffer (50 mM, pH 8.26), PNP 0.27U, PyNP 0.27U, PNP:PyNP: 1:1 
Note b: Enzyme batch: PNP 1.87 U.mg-1, PyNP 0.659 U.mg-1 
 
4.2.15 Effect of reaction medium pH (6 - 11) 
 
Due to the low solubility of the substrates in the reaction medium, which limits the ultimate 
reactor productivity that may be achieved; alternative process variables such as pH, co-
solvents and surfactants were investigated in an attempt to improve substrate solubility and 
thus the rate of the biocatalytic reaction. The pKa’s of the components present in the reaction 
mixture are as follows: Guanosine (9.42), Guanine (9.92), Thymine (9.94), and 5-MU (9.68). 
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The effect of varying the reaction medium pH on component solubility was investigated and 
the results obtained (see Section 4.3) show that the component solubility increased 
significantly as the pH of the reaction medium is increased from acidic to basic conditions. It 
has been reported previously that PNP exhibited a pH optimum of 7.0, retaining 60% activity 
between pH 5.7 and 7.4, while PyNP also showed an optimum of 7.0, retaining 60% activity 
between pH 6.0 and 8.280. 
 
4.2.15.1 Effect of pH and temperature on guanosine, thymine, guanine and 5-MU solubility 
 
The effect of pH on component solubility was then investigated, under basic and acidic 
conditions. The experiments were carried out initially at ~ 80oC and pH varied by the addition 
of sodium hydroxide or hydrochloric acid, once the maximum solubility at this temperature 
(acidic or basic pH) had been determined, the reaction mixture temperature was then 
incrementally decreased, and the reaction medium pH measured. Typically component 
solubility increased in the basic pH region (salt formation, component pKa’s) compared to the 
component solubility in the acidic pH region. 
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Figure 4.14: Effect of pH on guanosine solubility  
 
Table 4.17: Effect of pH range on guanosine solubility  
GS conc. (%m/m) Temp. (oC) pH 
1.43 70 7.67 
3.12 69.1 8.52 
10.2 70.2 9.6 
37.8 58 10.4 
25.7 43.8 10.6 
22.2 32.5 10.9 
9.31 14.3 11.3 
7.66 6.9 11.6 
9.5 6.9 12.5 
1.99 73.3 7.63 
1.41 74.7 5.92 
2.28 73.8 2.52 
6.36 65.3 1.52 
14.6 68.5 1 
11 59.5 0.83 
5.44 47.8 1.12 
1.83 32.8 1.11 
1.27 23.8 1.05 
0.91 5 0.97 
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Figure 4.15: Effect of pH on thymine solubility  
 
Table 4.18: Effect of pH range on thymine solubility  
TM conc. (%m/m) Temp. (oC) pH 
2.12 80.1 7.5 
3.56 81.5 8.55 
6.44 76.8 9.35 
7.42 70.5 9.47 
8.77 53.5 10 
7.00 43.5 10.29 
6.92 30.5 10.68 
2.56 5.2 11 
2.44 74.7 7.65 
2.55 88.8 5.78 
2.67 90 5.35 
2.66 90.5 2.65 
2.19 83.5 1.13 
1.68 74.8 0.97 
0.95 55.8 1.29 
0.62 40.2 1.65 
0.31 18 2.18 
0.12 4 1.34 
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Figure 4.16: Effect of pH on guanine solubility  
 
Table 4.19: Effect of pH range on guanine solubility 
GN conc. (%m/m) Temp. (ºC) pH 
0.02 65.7 8.26 
0.07 61.3 10.0 
1.04 60.2 11.0 
10.9 67 11.5 
11.8 55.7 11.9 
5.99 43 12.1 
5.68 37 12.5 
5.19 22.3 12.8 
4.93 6.9 13.3 
0.03 72.7 8.17 
0.03 71.3 6.87 
0.11 66.0 2.32 
0.21 68.1 1.26 
0.18 63.1 1.29 
0.14 43.2 1.34 
0.03 33.5 2.48 
0.08 22.1 1.03 
0.06 12.7 0.97 
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Figure 4.17: Effect of pH on 5-MU solubility  
 
Table 4.20: Effect of pH range on 5-MU solubility  
5-MU conc. (%m/m) Temp. (oC) pH 
46.4 63.1 7.13 
49.3 65 8.39 
62.7 66.3 9.15 
56.3 54.8 9.48 
46.9 40.1 9.72 
37.5 29.1 9.98 
35.0 4.9 10.7 
39.1 61.3 7.04 
32.9 59.9 5.93 
38.9 61.3 4.62 
36.6 60.3 2.43 
28.1 55.1 0.47 
20.4 44.9 0.67 
14.3 37 1.39 
7.37 24.3 2.32 
4.39 5.9 2.28 
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The results obtained during this investigation (Figure 4.18 and Table 4.21) suggest that the 
biocatalytic reaction may be carried out between pH 7 and 9.5 without any adverse effect on 
the guanosine conversion and 5-MU yield. Although the enzymes PNP and PyNP do show 
activity below pH 7, lower 5-MU yields are observed and this may be possibly be attributed 
to the decomposition of R-1-P under acidic conditions. The results also suggest that the 
biocatalytic reaction may be carried out at a pH as high as 9.5 without adversely affecting the 
guanosine conversion and 5-MU yield. The lower 5-MU yields obtained above pH 9.5 may be 
attributed to enzyme degradation and adverse effect on the phosphorolysis reaction 
equilibrium due to the increased solubility of guanine. The use of pH to increase the substrate 
solubility and increase the biocatalytic reaction productivity was thus a viable option. It has 
been reported that with changes in pH, the substrate may become charged and the mode of 
binding in the active site of the PNP enzyme may differ from the neutral substrate81. 
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Figure 4.18: Effect of reaction medium pH (6 – 11) 
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Table 4.21: Effect of reaction medium pH 
pH GS conv. 
(%) 
5-MU sel. 
(%) 
5-MU yield 
(%) 
Mole bal. 
(%) 
6a 80.0 + 5.80 86.1 + 6.31 68.7 + 2.89 92.7 + 0.51 
7a 97.8 + 0.07 81.8 + 0.99 80.0 + 1.02 89.6 + 1.40 
8.26a 97.9 + 0.06 85.2 + 1.02 83.5 +  0.95 94.9 + 1.76 
9.26b 97.7 + 0.13 86.1 + 6.03 84.2 + 5.89 96.6 + 2.14 
10c 96.1 + 0.38 80.5 + 5.44 77.3 + 4.92 93.2 + 3.96 
11c 85.7 + 0.43 79.4 + 2.89 68.0 + 2.68 92.1 + 1.34 
Note a: Experimental conditions: GS conc. 1.5% m/m, TM conc. 1.5% m/m, TM: GS mole ratio 2.3: 1, 
Temperature 40oC, PNP 0.27 U, PyNP 0.27 U, PNP: PyNP: 1:1, PNP 1.87 U.mg-1, PyNP 0.659 U.mg-1, 
Note b: di-sodium hydrogen phosphate salt (50 mM) 
Note c: Sodium carbonate buffer (50 mM) was prepared at the required pH, di-sodium hydrogen phosphate (50 
mM). 
 
To summarize, the results obtained show that no adverse effect on the biocatalytic reaction 
performance was observed between pH’s 7 – 9.5; the use of pH to increase substrate solubility 
should be used circumspectly, based on the following criteria: 
 
- Effect on reaction equilibrium 
During the phosphorolysis reaction (see Scheme 4.2) the reaction equilibrium is expected to 
move in the forward direction owing to the low solubility of the guanine product 
(< 0.1% m/m). Therefore by increasing the pH, the guanine solubility was increased (> 11% 
m/m). The impact on reaction equilibrium would have to be assessed. 
 
- Effect on downstream processing (DSP) 
Carrying out the biocatalytic reaction under alkaline conditions would require the addition of 
a mineral acid in order to neutralize the reaction mixtures and isolate the neutral components. 
This would add additional cost to the process. In addition, the removal of inorganic salts from 
the final 5-MU product will further complicate DSP, as would the possibility of forming acid 
salts of the organic components. 
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- Effect on enzyme stability and activity  
Based on the PNP and PyNP pH optima, decreased enzyme life times would be encountered, 
in the event the reactions were to be carried out at pH extremes from the pH optima, thus 
requiring increased levels of enzyme to be added to the reaction mixture; or alternatively, 
requiring the enzyme to be dosed over time to circumvent/reduce enzyme degradation.  
 
Therefore a compromise between enhanced substrate solubility, enzyme stability and activity 
must be reached. Based on the above results, it was recommended that the reaction medium 
be maintained between pH 7.0 and 8.5. 
 
4.2.16 Effect of enzyme batch variability 
 
The challenge typically facing the commercial development of a biocatalytic process is the 
lack of a commercially available enzyme at a reasonable price. Therefore, during the scale-up 
of a biocatalytic process, the preparation of sufficient and consistent quantities of PNP and 
PyNP enzyme is required. Most of the work carried out during this stage of development was 
conducted using, two batches of PNP and PyNP enzyme which were prepared in-house for 
evaluation and development work. Each batch of enzymes was carefully analyzed in terms of 
specific activity (see Section 4.3.1 and 5.5.1) as shown in Table 4.22. 
 
Table 4.22: Specific activity, enzyme quality 
Enzyme  Batch #1 Specific activity (ex. lab-
scale) U.mg-1 
Batch #2 Specific activity (ex. 
bench-scale) U.mg-1 
PNP 1.87 5.14 
PyNP 0.659 0.2 
 
The above results clearly showed that these initial enzyme batches differ substantially. The 
cause of the varying specific activities was not ascertained, but may be attributed to a variety 
of process variables associated with the fermentation process and isolation procedure of the 
enzymes. Subsequently, process optimization of the PNP and PyNP process has been carried 
out by Mr D.F. Visser82, which has enabled the production of sufficient quantities of PyNP 
enzyme having the desired quality with respect to specific activity (4.27 U.mg-1PyNP 
enzyme,). 
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Both enzyme batches # 1 and # 2 were evaluated in small-scale reactions for the synthesis of 
5-MU and the results obtained are summarised in Table 4.23. 
 
Table 4.23: Effect of enzyme batch variability 
GS conv. 
(%) 
5-MU sel. 
(%) 
5-MU yield 
(%) 
Mole bal. 
(%) 
Comments 
97.9 + 0.06a 85.2 + 1.02 83.5 + 0.95 94.9 + 1.76 Enzyme Bx#1 
95.1 + 1.3a 59.3 + 1.9 56.4 + 1.7 92.3 + 7.4 Enzyme Bx#2 
Note a: Experimental conditions: GS 1.5% m/m, TM 1.5% m/m, TM:GS mole ratio 2.3:1, Temp. 40oC, Time 24 
hours, pH 7.75. PNP 0.27 U, PyNP 0.27 U PNP:PyNP ratio 1:1, 2 mL scale 
 
The results obtained showed similar levels of guanosine conversion, but significantly different 
5-MU yields and selectivities. Whether the observed decrease in 5-MU yield from 83.5% to 
56.4% when using Enzyme Batch #2 was due to the lower specific activity of PyNP or to the 
presence of unknown enzymes were not investigated. The results obtained, however, highlight 
the importance of obtaining sufficient consistent quantities of enzyme having the required 
purity and specific activity in order to develop a biocatalytic process. 
 
4.2.17 Effect of co-solvents 
 
Increasing the rate of an enzymatic conversion of substrates in aqueous suspensions may be 
achieved by increasing the solubility of the substrate, e.g. by increasing the temperature of the 
reaction mixture, or by the addition of co-solvents. In the latter case, however, examples have 
been reported where the addition of the co-solvent resulted in longer process times despite 
achieving significant increases in substrate solubility. Raising the temperature may, apart 
from increasing substrate solubility, also increase the substrate dissolution rate and the 
enzymatic reaction rate, resulting in shorter process times (provided that enzyme deactivation 
does not take place (see Section 3.3.8). 
 
During this study the effect of co-solvents methanol, ethanol and dimethyl sulphoxide 
(DMSO) on substrate solubility and rate of biocatalytic reaction were investigated. Guanosine 
is easily “wetted” due to the hydroxyl groups on the ribose moiety. In the case of thymine, the 
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solid powder exhibits hydrophobic properties and is not easily “wetted”. A series of 
qualitative tests were conducted in which thymine was mixed with methanol (or ethanol) to 
form a paste. This shows that thymine is easily “wetted” using a polar organic solvent such as 
methanol or ethanol. In subsequent experiments, a mixture of solvent (methanol or ethanol) 
and water (50% / 50% (v/v)) was prepared to which guanosine and thymine were added at the 
required levels. The reaction mixture was stirred at room temperature for 1 hour. During these 
experiments, the reaction mixture consistency changed from a free flowing slurry to a cement-
like paste material, possibly due to solvent evaporation, resulting in very poor mixing 
efficiency. While it has been reported that enzymes perform better in hydrophobic solvents 
compared to hydrophilic solvents, the use of hydrophilic solvents such as methanol and 
ethanol were still of interest due to their ease of removal (boiling points: Methanol = 64.7oC; 
Ethanol = 78oC). The use of non-miscible hydrophobic solvents such as toluene was not 
considered, since this would further increase the complexity of the biocatalytic reaction (bi-
phasic liquids (water/toluene) and bi-phasic solids (guanosine/thymine)). The use of DMSO 
was also evaluated as a co-solvent (20% v/v), because of the significant enhancement in 
substrate solubility with this solvent. 
 
The results obtained for synthetic experiments (see Table 4.24:) in which co-solvents were 
added to a level of 20% v/v with respect to the water, show that the co-solvents (Methanol, 
Ethanol or DMSO) have no significant effect on improving the reaction performance with 
respect to relative guanosine conversions and 5-MU yields under standard conditions using 
batch #2 of the in-house produced enzyme.  
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Table 4.24: Effect of co-solvents (MeOH, EtOH and DMSO)a,b 
GS conv. 
(%) 
5-MU sel. 
(%) 
5-MU yield 
(%) 
Mole bal. 
(%) 
Comments 
95.1 + 1.3 59.3 + 1.9 56.4 + 1.7 92.3 + 7.4 Enzyme Bx #2 
90.7 + 2.5 67.7 + 5.4 61.4 + 4.4 92.2 + 7.5 20% MeOH 
87.7 + 2.3 67.4 + 12.6 59 + 9.8 87.2 + 14.9 20% EtOH 
94.3 + 1.1 67.2 + 15.4 63.3 + 14.0 84.4 + 18.4 20% DMSO 
Note a: Experimental conditions: GS conc. ~1.5% m/m, TM conc. ~1.5% m/m, TM: GS mole ratio ~2.3: 1, 
sodium phosphate buffer (50 mM, pH ~7.5-8.0)Temperature 40oC, PNP 0.27U, PyNP 0.27U, PNP: PyNP: 1:1 
Note b: Enzyme batch: PNP 0.659U/mg, PyNP 0.2U/mg 
 
Although no adverse effect on reaction performance in the presence of co-solvents (methanol, 
ethanol and DMSO) was observed, the impact of using a co-solvent with respect to cost and 
additional processing required should be evaluated against the possible benefits derived. For 
example when using DMSO as a co-solvent, high distillation temperatures are required 
(DMSO boiling point 189oC) and the solvent is generally difficult to remove. Therefore the 
additional costs associated with solvent recovery and isolation and separation of 5-MU from a 
more complex product stream, would result in increased processing costs. With this in mind, 
the use of co-solvents to improve substrate solubility and thus the rate of the biocatalytic 
reaction was not pursued further. 
 
4.2.18 Effect of surfactants  
 
The effect of adding surfactants (Tween-80 and Triton-X-100) to the biocatalytic reaction 
mixture on the performance of the reaction system was evaluated under the experimental 
conditions reported in Table 4.25. The results obtained (Table 4.25) shows that the addition of 
surfactant has no apparent effect on reaction performance with respect to guanosine 
conversion and 5-MU yield. However, some degree of foam formation was observed in the 
presence of the surfactants and generally the presence of surfactants lead to more complex 
down stream processing (DSP) such as long separation times. Since no direct benefit was 
observed using the above surfactants, and since their use would incur additional processing 
costs, no further investigations into the use of surfactants was conducted. 
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Table 4.25: Effect of surfactantsa,b 
GS conv. 
(%) 
5-MU sel. 
(%) 
5-MU yield 
(%) 
Mole bal. 
(%) 
Comments 
95.1 + 1.3 59.3 + 1.9 56.4 + 1.7 92.3 + 7.4 Enzyme Bx #2 
97.2 + 0.3 47.7 + 1.1 46.4 + 1.1 78.5 + 6.9 Triton-X-100 
96.7 + 0.8 52.5 + 10.7 50.8 + 10.0 80.8 + 16.5 Tween 80 
Note a: Experimental conditions: GS ~ 1.5% m/m, TM ~ 1.5% m/m, TM: GS mole ratio ~2.3:1, Temperature 
40oC, Time 24 hours, pH 7.75. PNP 0.27 U, PyNP 0.2 7U PNP:PyNP ratio 1:1. 
Note b: Enzyme batch: PNP 0.659 U/mg, PyNP 0.2 U/mg.  
 
4.3 Conclusions 
 
The small scale screening experiments conducted demonstrated the feasibility of carrying out 
the biocatalytic reaction under a variety of process conditions. The results obtained showed 
that the reaction can be successfully carried out using a phosphate buffer at 50 mM 
concentration. The most important findings obtained are summarized below: 
 
4.3.1 Increasing the thymine to guanosine mole ratio 
 
Increasing the thymine to guanosine mole ratio from 1:1 to 2.3:1 significantly improved the 5-
MU yield to 30% from 75%. , while maintaining the reaction medium pH between 7 and 8. 
The observation may possibly be attributed to the effect on reaction equilibrium and solid-
liquid mass transfer phenomena. 
 
4.3.2 Effect of increasing substrate concentration 
 
It was demonstrated that the guanosine and thymine substrate concentration may be increased 
to 9% m/m without adversely affecting the reaction performance due to substrate and / or 
product inhibition. The reactions were carried out using either a fed batch or one pot protocol. 
Superior 5-MU yields of 85% were obtained using the one pot protocol. This was attributed to 
the effect of reaction equilibrium and the possible use of non-optimal dosing times of 
substrates using the fed batch protocol. 
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4.3.3 Effect of temperature 
 
The results obtained demonstrated that the biocatalytic reaction may be carried out between 
40 – 60oC without adversely affecting the guanosine conversion and 5-MU yield. The results 
obtained further demonstrated that the biocatalytic reaction may be carried out at temperatures 
differing from the enzyme’s thermal optima. 
 
4.3.4 Effect of enzyme quality and batch variability 
 
The effect of enzyme batch variability on the development of the biocatalytic process was 
highlighted as lower 5-MU yields were obtained using the PyNP having a specific activity of 
0.2 U.mg-1. 
 
The effect of the above operational parameters on reactor productivity and improving the 5-
MU yield using the material from enzyme batch 2 were the main objectives during the 
optimization of the biocatalytic reaction discussed in Chapter 5. 
 
 Chapter Five 94 
CHAPTER FIVE 
 
5 Optimisation and scale-up of the biocatalytic process 
 
5.1 Introduction 
 
The results obtained during the small scale screening experiments demonstrated the feasibility 
of carrying out the biocatalytic reaction at guanosine conversions of 90% and 5-MU yields of 
at least 75%. The scale-up to bench-scale (10 - 20 L) and further optimization of the 
biocatalytic reaction with respect to increasing 5-MU reactor productivity to 20 g.L-1.h-1 were 
the main objectives of this study. Furthermore, insight into the effect of process variables such 
as temperature and enzyme loading on the rate of the biocatalytic reaction were also 
investigated. The complexity of optimizing and scaling up the biocatalytic process has already 
been highlighted, in particular the narrow operating window with respect to increasing 
temperature in order to increase substrate solubility but without decreasing enzyme activity 
and stability. Therefore, in order to develop a biocatalytic process successfully, a compromise 
in the operational parameters was required, ensuring that the reaction performance was 
achieved without reducing/compromising enzyme stability and activity. The reliable sampling 
of solid liquid slurries also added to the complexity of the research, as the operating 
conditions required for maintaining and sampling homogeneous solid liquid slurries were 
different to the operating conditions required to maintain enzyme activity and stability. The 
effect of variables such as solids loading, impeller type and reactor configuration all have an 
impact on the sampling and mechanical stability of the enzyme. The biocatalytic process 
improvement and intensification was further complicated as a batch of PyNP (the production 
of which was also under development) having a lower specific activity of 0.2 U.mg-1 was used 
during the development process. 
 
Typically, significant production costs, which are common in biotransformations, are 
associated with the isolation and purification of the product from dilute feed streams. Various 
DSP procedures were evaluated during the current study to recover and isolate the by-product 
guanine, which could be sold to offset raw material costs of guanosine and thymine. The 
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isolation and purification of 5-MU was also investigated from different feed streams to the 
specification required for the preparation of β-thymidine. 
 
The biocatalytic reaction was carried out at bench-scale (10 – 20 L) to produce 5-MU material 
for a β-thymidine market sample (250 – 500 g). During this experimental program, the 
reaction reproducibility and robustness were investigated. 
 
5.2 Scaling up a process 
 
During the preparation for scale-up, one should ensure that all process variables outside 
conventional boundaries have been tested (for example, temperature, pH and substrate 
concentration). Listed below (Table 5.1) is a general comparison of conditions used during 
laboratory scale and industrial scale processes. 
 
Table 5.1: Development of a biocatalytic process for industrial scale 
Variable Laboratory-scale process Industrial-scale process 
Medium Dilute solutions Highly concentrated media 
Substrate Often natural Often unnatural 
pH control Buffer Titration with acid/base; 
solid acids/bases 
Time Sufficient for reaction Rapid reactions desired 
Temperature, pH gradients None Heat and mass transfer 
influence reaction 
 
This chapter deals with the optimization and scale-up of a lab-scale process into an industrial 
scale process. 
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5.3 Effect of Solid-Liquid Mixing83 
 
The main objective of solid-liquid mixing is to create and maintain a slurry of the reaction 
mixture and to increase the rate of mass-transfer between the solid and liquid phases. The 
requirements of an efficient mixing operation are listed below: 
 
5.3.1 Suspension of solids 
 
The dispersion of solids is a physical process whereby solid particles or aggregates are 
suspended and dispersed by the action of an agitator in a fluid to achieve a uniform 
suspension or slurry. This is achieved by ensuring: 
 
- Re-suspension of settled solids. 
- Incorporation of floating solids. 
- Dispersion of solid aggregates or control of particle size from the action of fluid shear 
as well as abrasion due to particle-particle and impeller-particle impacts. 
- Mass transfer across the solid-liquid interface. 
 
The degree of solids suspension may be classified as follows84: 
- On-bottom suspension/Partial suspension;  
- Complete off bottom suspension; and  
- Uniform suspension. 
 
5.3.1.1 On-bottom suspension/Partial suspension 
This state is characterized by the qualitative visual observation of the complete motion of all 
particles around the bottom of the vessel. It excludes the formation of fillets, a loose 
aggregation of particles in the corners or other parts of the tank bottom. Since all particles are 
in contact with the base of the reactor, not all the surface area of the particles is available for 
chemical reaction or mass or heat-transfer. Partial suspension conditions are used for the 
dissolution of highly soluble solids. 
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5.3.1.2 Off bottom suspension/Complete suspension 
This state of suspension is characterized by the complete motion of all particles, with no 
particle remaining on the base of the vessel for more than 1 to 2 s. This is known as a 
Zweitering criterion, where the maximum surface area of particles is exposed to the fluid for 
chemical reaction, mass or heat transfer. During the current investigation, the effect of 
agitation rate and solids loading on sampling accuracy and precision, and biocatalytic reaction 
performance was determined. It was possible to determine the just suspended condition which 
relates to the minimum agitation conditions at which all particles attain complete suspension. 
 
5.3.1.3 Uniform suspension 
The conditions under which a uniform suspension is achieved are related to the point where 
the particle concentration and particle size distribution are practically uniform; any further 
increases in agitation speed or power does not appreciably enhance the solids distribution in 
the fluid. A coefficient of variation of the solid concentration of 0.05, or a uniformity of 95% 
is considered adequate for most process applications. Obtaining a uniformity of 100% is 
impractical, as there is always a fluid layer a few inches thick at the surface where the fluid 
concentration is lower because the axial lift velocity is lower near the fluid surface. Uniform 
suspensions are required for process operations where representative samples of the slurry are 
required or a uniform concentration of solids must be obtained. 
 
5.3.2 Rate of dissolution 
 
The rate of dissolution is a mass-transfer process during which the solid particles decrease in 
size and ultimately disappear as they are incorporated into the solution; the main objective of 
the dissolution process is to achieve the desired rate of dissolution by agitation so as not to 
limit the rate of reaction. 
 
In this process, although the saturated thymine concentration is relatively low (see Figure 
5.1), an excess of thymine solids present in the reaction mixture would act as a “reservoir” for 
ensuring that the thymine concentration in the supernatant is maintained at saturated levels. 
This would ensure optimum reaction conditions between R-1-P and thymine. However the 
rate of reaction may be limited by the rate of dissolution of guanosine and thymine, in setting 
up equilibrium concentrations of the substrates. 
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[Thymine] (Solid)    [Thymine] (Liquid)  
 
The rate of dissolution of a solid is also governed by solid-liquid mass transfer effects and 
therefore a study was conducted to determine the rate of dissolution of guanosine and thymine 
in the reaction medium under saturated conditions. The results obtained are shown in Figure 
5.1, and they demonstrate that equilibrium concentrations of thymine and guanosine (within 
experimental error) are attained relatively rapidly. Thus the rate of substrate dissolution is not 
expected to have a significant limiting effect on the reaction performance. 
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Figure 5.1: Rate of dissolution of thymine and guanosine 
 
5.3.3 Process considerations for solid-liquid mixing operations 
 
The desired process results for solid-liquid mixing operations vary from process to process. 
During the development stages, the process researcher and/or engineer are required to identify 
the pertinent and specific process requirements. Therefore it is essential to consider all 
physical and chemical phenomena necessary to achieve the desired process results. 
 Chapter Five 99 
Specifically, how these phenomena are influenced by the process chemistry, the properties of 
the solids and liquids, and the operational variables of mixing must be investigated. 
 
5.3.4 Process requirements for solid-liquid mixing 
 
The following variables were identified as important parameters influencing the process 
requirements for solid-liquid mixing: 
- Mode of process operation: batch, semi-batch, continuous addition to batch/fed batch, 
or continuous. 
- Phases: solid, liquid and or gas phases that are present at the beginning or at the end of 
the process. These parameters will have an impact on the total slurry loading during 
the course of the reaction. 
- Properties of the solids (such as density, solubility, hydrophobicity/hydrophilicity, 
melting point, crystal morphology and particle size) and liquids (such as boiling point, 
viscosity, density). 
- The operating temperature, which will have an impact on the physical properties of 
solids and liquids in the reaction mixture (listed above). 
- Unit operations involved during the course of the process. 
- Vessel geometry, materials of construction and internals. 
- Mixing parameters: local or average fluid velocity or flow, local or average shear 
rates, blend time, power input/agitation rate, impeller type. 
 
Where pertinent the above process variables will be discussed in detail. 
 
5.3.4.1 What is the process mode of operation: Batch, semi-batch/fed-batch or continuous? 
Whether the process is conducted as a batch, semi-batch / fed batch or continuous operation 
depends on the unit operation, upstream and/or downstream operations within the overall 
process and the volume of materials to be processed. During the optimization of the 
biocatalytic process, the use of a fed batch or batch process was investigated in order to 
improve the reactor productivity. The use of a continuous process was not considered, due to 
the low solubility of substrates and added complexity of pumping solid liquid slurries. 
However, the feasibility of carrying out a continuous process should be evaluated in the 
future, using an immobilized enzyme system. 
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In the case of batch operations, the mixing requirements changed during the course of the 
reaction due to changes in chemical and physical properties of the reaction mixture. An 
increase in substrate concentration was also investigated, to reduce the amounts of material to 
be processed to isolate a given quantity of product. At increased substrate and product 
concentrations the possibility of substrate and or product inhibition may limit further 
increases. In contrast to the batch reactions, the fed-batch methodology may be used to 
circumvent possible substrate and / or product inhibition and minimize the high initial solids 
loading. 
 
5.3.4.2 Is there a chemical reaction between the solid and the liquid?  
Solid-liquid mixing operations involving chemical reactions often require a high relative 
velocity between the solid particle and the liquid - a high local shear rate or agitation intensity 
so as to minimize the boundary layer for mass transfer. The above requirements are also used 
during the dissolution of sparingly soluble solids83. Thymine and guanosine have a relatively 
low solubility in water; increasing the agitation rate will therefore increase the rate of 
dissolution and thus increase the rate of the biocatalytic reaction. It was not established 
conclusively whether the biocatalytic reaction under investigation in this thesis takes place in 
the bulk medium or at the interfacial boundary layer, however, increasing the agitation rate 
minimizes the boundary layer and thus minimizes solid-liquid mass transfer effects. 
 
5.3.4.3 What are the physical and chemical properties of the solid and liquid phase? 
The degree of difficulty of forming a solid-liquid suspension depends on several properties of 
the fluid and solid particles. The specific properties of interest are the relative densities of the 
solid and liquid phases, the viscosity of the liquid, wetting characteristics of the solids, the 
shape of the solid particles, and the mass or volume ratio of the solids to liquid. Large and 
dense solids are more difficult to suspend than small light ones; spherical particles are more 
difficult to suspend than thin flat discs. Guanosine has hydrophilic properties as it is relatively 
easily wetted. By comparison, thymine shows hydrophobic properties. The difference may be 
attributed to polar hydroxyl groups present in the ribose moiety of guanosine compared to the 
relatively non-polar properties of thymine. Based on these physical properties guanosine 
tended to settle to the bottom of the reactor, while thymine floated on the reaction medium 
surface. The above effects may also be due to differential densities of the solids relative to the 
 Chapter Five 101 
water medium and possible air entrainment and entrapment into the thymine exacerbating the 
differential density observed. Detailed studies with respect to the physical shape and size of 
the substrates were not conducted.  
 
5.3.4.4 Mixing parameters: What degree of suspension and agitation speed is required? 
The required degree or level of suspension depends on the desired process result and unit 
operations involved. Typically solid-liquid mixing operations operate above the minimum 
speed for suspension. An increased agitation rate improves the degree of suspension and 
enhances mass transfer rates. The increased agitation rate also results in increased turbulence 
concomitant with local and average shear rates, which for some processes may cause 
undesirable particle attrition. Furthermore, a practical economic limit also exists relating to 
the maximum speed of agitation. Therefore, a compromise between the above opposing 
process requirements must be reached. 
 
For example, a higher degree of suspension was required in order to obtain reliable analytical 
data with respect to the sampling of slurries. It was found that the level of suspension required 
was dependent on the reactor configuration and solids loading. Generally, as the solids 
loading increased, an increase in agitation rate was required in order to obtain a uniform 
suspension. 
 
5.3.4.5 What effect does vessel geometry have on the process? 
The geometry of the vessel, specifically the shape of the reactor base, affects the location of 
dead zones or regions where solids tend to congregate. The reactor base geometry also 
influences the minimum agitation speed required to suspend all solids. In the case of flat 
bottomed vessels, dead zones, and thus “fillet formation” tend to occur in the corner between 
the tank base and the tank wall, whereas in the case of dished heads, solids tend to settle 
beneath the impeller or midway between the centre and the periphery of the base. The 
minimum agitation speed is typically 10 - 20% higher in a flat-bottomed vessel than in one 
with a dished head. 
 
5.3.4.6 What are the appropriate materials of construction for the process vessel? 
This may be dependent on the process being conducted and the corrosive nature of reagents. 
In the case of steel or alloy vessels, the standard four wall-mounted baffles provide an 
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improved environment for solid-liquid mixing. The standard glass-lined vessels are usually 
under-baffled, due to a deficiency in suitable positions/nodes from which to attach baffles. 
The biocatalytic process was carried out using a non-corrosive basic medium (pH 7.0 – 8.0), 
and relatively low temperatures (60oC) and ambient pressures compared to conventional 
chemical synthesis, thus minimizing the requirements for specialised materials of 
construction. 
 
5.3.5 Mass transfer in mechanically agitated solid liquid systems 
 
Listed below are examples of unit operations where solid liquid mass transfer has an impact: 
- Leaching. 
- Dissolution of solids with or without a chemical/enzymatic reaction. 
- Precipitation. 
- Crystallization. (Nucleation and crystal growth) 
- Adsorption/ De-sorption. 
- Ion exchange. 
- Solid catalyzed reactions. 
- Suspension polymerization. 
 
 
In the case of solid-liquid mass transfer processes, the following rate-controlling steps are 
involved: 
 
- Diffusion in the liquid film surrounding the solid particles (film diffusion) 
- Diffusion within particles – in pores or through the solid phase itself (particle 
diffusion), as in ion exchange 
- Chemical reaction at the surface of the particle (surface reaction) 
 
Agitation only affects the film diffusion controlled process. 
 
The rate of diffusional mass transfer M (see Equation 27), is defined as the product of the 
diffusional mass transfer coefficient (KSL), the interfacial area for mass transfer (ap) and the 
concentration driving force, [A*] – [A]. 
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Equation 27 
])[]([ * AAakM pSL −=  
 
The variables [A*] and [A] are the concentrations of the solid material at the solid surface and 
in the bulk of the liquid respectively. The constants KSL, (reaction rate constant) Kr, and 
concentration of substrate A raised to some power (n) are determined experimentally or from 
available correlations. In order to establish the solid-liquid mass-transfer conditions of the 
process (at either chemical reaction in the bulk liquid phase or mass transfer in the liquid film 
surrounding the solid particle), the effect of agitator speed on the observed process rate was 
determine. 
 
In reactive diffusion systems the rate of reaction may be calculated as shown in Equation 28. 
 
Equation 28 
n
r AkM ][=  
 
The controlling regime depends on the relative values of KSL and Kr, in the case of first order 
reactions: 
 
- Chemical reaction controls when Kr/ KSL ≤ 0.001. 
- Diffusional mass transfer controls when Kr/ KSL ≥ 100. 
 
In the reaction system where the chemical reaction controls the rate of the reaction, the rate of 
reaction is not limited by solid-liquid mass transfer phenomena. The rate of reaction may 
increased by increasing the substrate concentration, reaction temperature and catalyst loading. 
In the case of the latter system, where the reaction is operating under diffusional mass transfer 
controls, and not limited by the rate of reaction, the process rate may be increased by 
changing the physical characteristics of the system. Improvement in the mixing efficiency, by 
changing the reactor configuration and impeller type, reducing the particle size and possibly 
adding a surfactant. 
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During the phosphorolysis reaction, guanosine (GS) is a solid substrate and the inorganic 
phosphate (Pi) is a liquid phase substrate. During the synthesis reaction, thymine (TM) is 
present as a solid substrate, while R-1-P is the liquid phase substrate. The phosphorolysis and 
synthesis reactions may operate under one of the following regimes: 
 
In the case where A is the solid and B is the liquid phase substrate the reaction may operate 
under four different concentration gradient regimes: 
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Figure 5.2: Solid-liquid mass transfer regimes 
 
- Bulk reaction (regime 1) 
- Film diffusion (regime 2) 
- Film kinetics (regime 3) 
- Instantaneous reaction (regime 4) 
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5.3.5.1 Bulk reaction (Regime 1) 
The reaction is so slow or the solubility of the solid is so high that the concentration of the 
solid species is essentially equal to the equilibrium conditions at the solid liquid interface. 
Bulk liquid phase equilibrium reaction governs the overall process (see Figure 5.2). 
 
5.3.5.2 Film diffusion (Regime 2) 
The reaction is rapid enough to keep the bulk liquid phase concentration of the solid 
essentially zero, but not rapid enough to occur substantially in the liquid film. There is no 
enhancement of mass transfer due to the reaction taking place, since diffusion and reaction 
take place in series (see Figure 5.2). 
 
5.3.5.3 Film kinetics (Regime 3) 
The reaction is sufficiently fast to consume the dissolved solid reagent completely in the 
liquid film (see Figure 5.2). Diffusion and reaction take place in parallel in the liquid film. 
The mass transfer coefficient (KLA) has no effect on the overall process rate. 
 
5.3.5.4 Instantaneous reaction (Regime 4) 
The reaction is virtually instantaneous, the reactant (A) and liquid-phase reactant (B) cannot 
coexist. Diffusion of A from the solid-liquid interface and diffusion of B from the bulk liquid 
toward the reaction plane control the overall process (see Figure 5.2). 
 
In cases where the process is operating under mass-transfer controlled conditions, there are 
three possible regimes (2, 3, 4) depending on the kinetics of the reaction. Conditions between 
regimes may also be possible, for example when the concentration in the liquid films remains 
finite instead of reducing down to zero. In the case of a reactive diffusion system, the 
dissolved solid undergoes a reaction in the bulk of the solution or at the liquid-interface. 
 
It is important to know the operating regime of a particular reaction system, since the 
equipment choice and the effect of design on operating variables depends on the regime. A 
lack of this fundamental understanding leads to many apparent discrepancies between 
different scales of operations and sometimes to failure in scale-up. For example, during lab-
scale studies the process may be operating under regime 1, while in production-scale it could 
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be in regime 2. Alternatively, one may design equipment for mass transfer requirements based 
on lab scale results, only to find much lower rate of process at production scale. 
 
The effect of temperature is minimal if the system operates in regimes 2 and 4. However, the 
effect of temperature may be substantial if operating in regime 3 (apparent activation energy 
is half of the true activation energy) and maximum in regime 1 (apparent activation energy is 
equal to the true activation energy). 
 
5.3.6 Effect of impeller speed on solid-liquid mass transfer 
 
Reliable scale-up or design of the biocatalytic process requires investigation at various scales 
using different reactor configurations to investigate the effect of mass transfer on the process. 
It has been reported that solid-liquid mass transfer increases relatively rapidly with increasing 
impeller speeds, up to the just suspended state, Njs. This is attributable to an increase in both 
the interfacial area per unit volume (ap), and the mass transfer coefficient kSL. Beyond Njs, ap 
is independent of agitation as the entire solid surface available for mass transfer is exposed, 
but the mass transfer coefficient continues to increase, however at a much lower rate. 
 
The volumetric mass transfer coefficient (kSLap) is primarily affected by the impact of 
agitation on the hydrodynamic environment near the surface of the particle, specifically the 
diffusional boundary layer surrounding the solid. The hydrodynamic environment depends on 
the properties of the solid and fluid. The renewal of the boundary layer depends on the 
intensity of the turbulence around the solid particle, as well as the convective velocity 
distribution in the vessel. Typically, as the agitation increases, the volumetric mass transfer 
coefficient (kSLap) increases. If the process is mass transfer controlled, the observed rate of 
reaction increases with increasing impeller speed. However, beyond “just suspended state” 
(Njs) or complete suspension, the observed rate may not increase much with increasing 
impeller speed or mixing intensity, indicating that the overall process is bulk reaction 
controlled. 
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5.3.6.1 Impeller selection85 
There are four types of turbine impellers, which are characterized by the flow patterns and the 
level of shear they create; axial flow, radial flow, hydrofoil and high shear impellers. Recent 
developments in impeller technology have focused on increasing axial flow, at reduced shear. 
 
5.3.6.2 Axial flow impellers 
Axial flow impellers are used for blending solid suspension, solids incorporation, gas 
inducement and heat transfer. Typical examples of this type of impeller include marine 
impeller, pitched blade turbine, Pfuadler retreat curve, Ekato MIG and Ekato INTERMIG. 
The choice of impeller is dependent on the application required. 
 
5.3.6.3 Radial flow impellers  
Similar to axial flow impellers, they may be used for low to medium viscosity fluids and 
multiple phases mixing. However they are more effective for gas-liquid and liquid-liquid 
mixing. Compared to axial flow impellers, they provide increased shear and turbulence with 
lower levels of pumping. Radial flow impellers discharge the fluid outwards towards the 
vessel wall, and with suitably designed baffles; flows are converted to strong top to bottom 
flows, both above and below the impeller. Typical examples of radial flow impellers are Open 
flat blade, Rushton (Disk style), Backswept open, Backswept with disk, Spring impeller, 
Scaba SRGT (see Figure 5.3). 
 
 
Figure 5.3: The R100 Rushton turbine is the impeller traditionally used for gas-liquid 
applications 
 
 
 Chapter Five 108 
5.3.6.4 Hydrofoil impellers 
Hydrofoil impellers were designed for applications where axial flow is important and low 
shear is desired. They have three or four tapered, twisted blades, which are cambered and 
sometimes manufactured with rounded leading edges. The blade angle at the tip is shallower 
than at the hub, which results in a nearly constant pitch across the blade length. This produces 
a more uniform velocity across the entire discharge area. The blade shape also results in a 
lower power number and higher flow per unit power than with a pitched blade turbine. The 
flow is more streamlined in the direction of the pumping, and the vortex systems of the 
impeller are not nearly as strong as those of the pitched blade turbine. The Lightnin A310 (see 
Figure 5.4), Chemineer HE3, and EMI Rotofoil are characterized by a low solidity ratio, 
defined as the projected area of the impeller blades divided by the impeller horizontal cross 
sectional area. They are very efficient impellers for liquid blending and solids suspension. 
Other examples of hydrofoil impellers include the Lightnin A315, Prochem Maxflo and the 
Ekato INTERPROP. The Lightnin A310 impeller was used during the scale up of the 
biocatalytic process. 
 
Figure 5.4: Lightnin A-310 impeller (hydrofoil impeller) 
 
5.3.6.5 High shear impellers 
High shear impellers are operated at high speeds and are used for the addition of a second 
phase (e.g., gas, liquid, solid, powder) in grinding, dispersing pigments and making 
emulsions. Typical examples of high shear impellers include the bar turbine, chemshear 
impeller and sawtooth impeller (see Figure 5.5). 
 
Figure 5.5: (Sawtooth) High shear, typically used for difficult to disperse pigments. 
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5.4 Experimental parameters 
 
5.4.1 Biocatalytic preparation of 5-MU 
 
It was previously demonstrated at small scale (2 ml) that the biocatalytic reaction can be 
successfully carried out using increased guanosine and thymine concentrations of 9% m/m. 
Subsequently a reaction was carried out at 1 L scale using a glass baffled reactor (GBR) and 
radial flow impeller using the increased guanosine and thymine concentrations. The effect of 
scaling up the biocatalytic reaction with respect to guanosine conversion, 5-MU yield and 5-
MU productivity was investigated during this experiment. The material produced would also 
be used for carrying out DSP studies. The experiment was carried out under the conditions 
reported in Table 5.2. Sodium phosphate buffer (830 g, 50 mM, 0.71% m/m) was charged to 
the reactor, followed by guanosine (80.8 g, 0.285 mol), which was easily “wetted” due to its 
relative hydrophilic properties. Thymine (90.2 g, 0.715 mol) was then added in small aliquots 
to the reaction mixture, however the material settled on the liquid surface, possibly due to 
hydrophobic properties and air entrapment in the thymine particles causing it to float as it was 
not easily “wetted” by the aqueous reaction medium. The reaction mixture was heated to 40oC 
and stirred at 1250 rpm using a radial impeller for 1 hour prior to enzyme addition in order to 
prepare a uniform solid liquid suspension and ensure that guanosine and thymine were at 
equilibrium saturation concentrations. The reaction mixture was sampled with time and 
analyzed by HPLC for guanosine (GS), guanine (GN), thymine (TM) and 5-methyluridine (5-
MU). 
 
Table 5.2 : Biocatalytic reaction conducted at increased substrate concentration 
(9%m/m) using a radial flow impeller and glass baffled reactor (GBR)a 
GS conc. 
(%m/m) 
TM conc. 
(% m/m) 
TM:GS 
mole 
ratio 
PNP 
(U)b 
PyNP 
(U)b 
PNP:PyNP 
enzyme ratio 
Time 
(h) 
Temp. 
(oC) 
8.07 9.01 2.5:1 200 200 1:1 100 - 120 40 
Note a: Enzyme batch: PNP 1.87 U.mg-1, PyNP 0.2 U.mg-1; pH 7.5, Buffer conc: 50 mM 
Note b: Additional batches of fresh enzyme were added after 28.5 hours (PNP 200 U, PyNP 200 U) 
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The reaction mixture was sampled in duplicate at hourly intervals during the first 20 hours 
and thereafter as required (see Table 5.3). The mole balance results obtained during the first 
20 hours were inconsistent and this was attributed to the errors associated with sampling of 
solid-liquid slurries. This highlighted the importance of validating the sampling of solid-liquid 
slurries protocol and investigating the effect of reactor configuration, impeller type, agitation 
rate and substrate concentration/substrate loading on analytical results86. (see 5.4.4). The 
results obtained showed that the reaction appeared to cease after 20 hours had elapsed. It was 
postulated that this may be due to the mechanical degradation of the PNP and PyNP enzymes 
due to the high solids loading of 20%, and the high agitation rate of 1250 rpm used. The use 
of a high shear radial flow impeller also contributed to the mechanical enzyme degradation as 
foam formation was observed, which is typically associated with protein denaturation. 
Therefore, fresh batches of PNP (200 U) and PyNP (200 U) were added to the reaction 
mixture after 28 hours, however the results obtained showed (see Table 5.3 and Figure 5.7) no 
significant improvement in guanosine conversion and 5-MU yield. The formation of foam 
may also have been attributed to the presence of air pockets in the thymine solids. In addition; 
the high agitation rates of 1250 rpm required to mix the solid-liquid slurry allowed for 
possible air entrainment from the head space. 
 
 
Figure 5.6: Radial flow impeller (bench-scale biocatalysis) 
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Table 5.3: Biocatalytic reaction at lab-scale using a glass baffled reactor (GBR) and a 
radial flow impeller  
Time 
(h) 
GS conv. 
(%) 
5-MU Sel. 
(%) 
5-MU Yield 
(%) 
Mole bal. 
(%) 
0 0 0 0 0 
20 22.6 91.2 20.6 95.1 
28a 27.6 79.8 22.0 88.6 
30.5 27.6 80.3 22.2 89.1 
96 40.4 69.3 28.0 90.0 
102 38.7 73.2 28.3 90.2 
120 40.8 67.3 27.5 94.6 
Note a: Additional batches of fresh enzyme were added after 28.5 hours (PNP 200 U, PyNP 200 U) 
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Figure 5.7: Biocatalytic reaction at lab-scale using a glass baffled reactor (GBR) and a 
radial flow impeller  
 
The above process constraints highlighted the complexity of the biocatalytic process, whereby 
mild and gentle operating conditions are required for the enzymes to retain activity and 
stability, while due to the low solubility of the substrates (guanosine and thymine) a relatively 
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high agitation rate is required in order to achieve a uniform suspension in order to obtain 
reliable analytical data. 
 
5.4.2 Enzyme batch variability  
 
During the development of the biocatalytic process, several batches of enzymes were 
produced at lab-scale and bench scale of varying quality as the fermentation process was 
optimized. The effect of combinations (see Table 5.4) of varying enzyme quality on the 
biocatalytic process was evaluated throughout the development process. 
 
Table 5.4: PNP and PyNP enzyme batch variability 
Enzyme Specific activity 
U.mg-1 
Enzyme Specific activity 
U.mg-1 
PNP 1.87 PyNP 0.0.659a 
PNP 5.14 PyNP 0.2a 
PNP 5.14 PyNP 1.9a 
PNP 5.14 PyNP 4.27b 
Note a: Lab scale preparations of PNP and PyNP enzyme 
Note b: Bench scale preparations (20 L) using optimized fermentation process 
 
The cause of the lower enzyme quality with respect to specific activity has been reported 
elsewhere and will not be discussed further80. 
 
The effects of the following parameters were investigated at lab-scale (0.1 – 2 L) to improve 
5-MU productivity and scale up of the biocatalytic reaction: 
 
- Effect of agitation rate (250 – 750 rpm) 
- Effect of temperature (40 – 70oC) 
- Enzyme ratio (PNP:PyNP 1:10 versus 10:10) at 40oC and 60oC 
- Effect of enzyme concentration 
- Enzyme loading (100 U, 200 U and 400 U) for PNP and PyNP 
- Effect of increased substrate concentration (13 - 18% m/m) and reactor configuration 
- Effect of particle size 
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- Effect of increasing thymine to guanosine mole ratio from 1:1 to 2.3:1 
- Effect of agitation rate, reactor configuration and concentration 
 
5.4.3 Effect of agitation rate  
 
During the scaling up of the biocatalytic reaction from 2 mL to 1 L, the results obtained were 
not reproducible with respect to guanosine conversion and 5-MU yield. It was postulated that 
this may have been attributed to mechanical degradation of the enzyme. This is due to: 
 
- Increased particulate concentration (20% solids loading) 
- Increased agitation rates of 1250 rpm used and use of a high shear radial flow impeller 
- PyNP enzyme batch variability (0.2 U.mg-1 compared to 0.659 U.mg-1). 
 
Literature studies using Lysozyme87 as a case study have reported that enzyme denaturation 
was found to follow first order kinetics. At agitation speeds of 0 – 700 rpm or impeller tip 
speeds of 0 – 0.77 m.s-1, the rate deactivation constant kd,obs  was found to be proportional to 
the power imparted to the impeller. As a result, deactivation is dependent on efficient 
collisions between active and inactive enzyme molecules, converting active enzyme 
molecules into inactive enzyme molecules. Furthermore the rate of deactivation was 
dependent on the area between the liquid and glass wall, air surface or Teflon (PTFE) surface. 
Hydrophobic PTFE and air surface increased lysozyme deactivation significantly when 
compared to glass. Furthermore, as the hydrophobic surface of inactive enzymes increased, 
this exacerbated lysozyme inactivation and aggregation. 
 
The challenges of developing a feasible biocatalytic process for the preparation of 5-MU 
using thymine and guanosine are listed below, demonstrating the process constraints and 
limitations of the physio-chemical properties of the substrates on the process: 
 
 Chapter Five 114 
- Use of a solid-liquid slurry medium was necessary because of the low solubility of 
substrates (guanosine and thymine) to increase 5-MU reactor productivity. 
- The physical properties of substrates complicated the situation where guanosine 
exhibited hydrophilic tendencies and was easily “wetted” by phosphate buffer and 
settled to the bottom of the reaction vessel, while thymine exhibited hydrophobic 
properties and floated on the top of the phosphate buffer surface. 
- The use of high agitation rates was necessary to obtain a uniform solid-liquid 
suspension and thus reliable sampling and analytical data, while minimizing 
mechanical enzyme degradation. Therefore optimization of the operating conditions 
with respect to agitation rate, solids loading concentration and reactor configuration 
had to be done without compromising the reaction performance. 
 
The effect of agitation rate at 250, 500 and 750 rpm on the biocatalytic reaction was 
investigated using a reduced substrate concentration of 1.5% m/m, minimizing the effects of 
enzyme degradation due to the high concentration of solids previously used. The type of 
impeller used was also changed from a radial flow impeller to an A-310 Lightnin hydrofoil 
impeller which was selected based on the criteria reported in Section 5.3.6.1 - 4 and based on 
recommendations from an impeller vendor88. The experiments were carried out under the 
conditions reported in Table 5.5. It should be noted that the PyNP enzyme having a low 
specific activity of 0.2 U.mg-1 was used during this study. 
 
 
Table 5.5: Effect of agitation rate on the biocatalytic reaction 
GS 
(%m/m) 
TM 
(%m/m) 
TM:GS 
mole ratio 
PNP 
U 
PyNP 
U 
PNP:PyNPa 
enzyme ratio 
Agitator speed 
(rpm) 
1.48 1.53 2.32 : 1 200 199 1.00 : 1 750 
1.48 1.53 2.32 : 1 200 199 1.00 : 1 500 
1.52 1.57 2.31 : 1 199 199 1.00 : 1 250 
Note a: Batch #2 enzyme PNP 0.659 U.mg-1, PyNP 0.2 U.mg -1; Temp: 40ºC 
 
The results obtained (Figure 5.8) show that the overall guanosine conversion and 5-MU yield 
at 24 hours were similar irrespective of the agitation rate used. Samples were taken in 
between baffles, 2 - 3 centimetres from the reactor wall and at a liquid depth 50% below the 
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reaction medium surface. However, the error associated with sampling accuracy and precision 
decreased as the agitation rate was increased from 250 to 750 rpm. This variation may be 
attributed to the difference in physical and chemical properties of guanosine and thymine 
(such as hydrophobic and hydrophilic properties), density, shape of particles and size of 
particles. To determine the uniformity of the solid-liquid slurry, sampling of the reaction 
mixture for a given reactor configuration should be carried out at various positions within the 
reactor geometry. This will give the variation in the solid liquid slurry composition. This was 
not conducted during the current study as reasonable mole balances (between 90 – 110%) 
were obtained. 
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Figure 5.8: Effect of agitation rate on the biocatalytic reaction 
 
The reaction performance obtained at 1 L using a glass baffled reactor (GBR) and Lightnin A-
310 impeller was similar to the results obtained at small scale (2 mL) where a guanosine 
conversion of 90% and 5-MU yield of between 50 – 60% was obtained. 
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5.4.4 The effect of agitation rate and substrate concentration on analytical accuracy, 
precision using the A-310 Lightnin impeller and glass baffled reactor 
 
The optimization and scale up of the biocatalytic process by increasing the guanosine and 
thymine substrate concentration from 1.5 - 8% m/m the effect of agitation rate, concentration 
was investigated in order to gain an understanding of the errors associated with the sampling 
of solid liquid slurries. The physicochemical properties such as solubility, hydrophillicity, 
hydrophobicity, particle size and shape, density of solids relative to the medium, reactor 
configuration, (reactor geometry and impeller type) position of where sample is taken all play 
a role in determining the precision and accuracy of obtaining a representative sample form the 
solid-liquid slurry. 
 
A series of tests were conducted using the glass baffled reactor and the A310 impeller, while 
maintaining the thymine concentration (1.5% m/m) and guanosine concentration at (1.5% 
m/m) the agitation rate was increased from 250 to 750 rpm (see Figure 5.9). The results 
obtained showed as expected the accuracy and precision increased as the agitation rate 
increased 
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Figure 5.9: Effect of increasing agitation rate on sampling accuracy and precision 
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The study was repeated whereby the thymine and guanosine concentrations were increased 
with a corresponding increase in agitation rate from 750 rpm to 1200 rpm (see Figure 5.10) 
show that reasonable accuracy and precision with respect to guanosine and thymine were 
obtained at 4 - 5% m/m concentration, while stirring at 750 rpm. The results obtained showed 
that the extent of error increased at the higher substrate concentrations (8% m/m). The actual 
guanosine and thymine feed concentrations based on the mass of substrates added were 7.70% 
m/m and 7.87% m/m respectively. The analytical results obtained showed an increase in error 
with respect to accuracy and precision as the reactor concentration solids loading increased 
(16%). In order to improve the uniformity of the suspension more energy would have to be 
put into the system (increase agitation rate, add additional impellers), however increasing the 
agitation rate further was not practical. During subsequent studies an additional A310 impeller 
was added, while maintaining the agitation rate at 1250 rpm. 
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Figure 5.10: Effect of increasing substrate concentration and agitation rate 
 
In summary as the agitation rate increased, while maintaining a constant substrate 
concentration (1.5% m/m), the errors associated with the sampling of solid-liquid slurries 
decreased, resulting in improved analytical precision. Further increases in substrate 
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concentration (4.5 – 8.0% m/m) and solids loading required increased agitation rates to 
maintain reasonable slurry uniformity and while minimizing errors associated with the 
sampling of solid liquid slurries. The process requirement to obtain reliable analytical data, 
while ensuring mechanical enzyme degradation does not take place due to high shear rates 
(reactor configuration/impeller type) and due to the high solids loading required further 
investigation. 
 
5.4.5 Effect of reaction temperature (40 – 70oC) 
 
The small-scale (2 mL) biocatalytic results obtained showed that the reaction may be carried 
out at reaction temperatures between 40 - 60oC over a 24 hour period. Subsequently, a series 
of experiments were carried out at 1 L lab-scale investigating the effect of reaction 
temperature (40oC, 50oC, 60oC and 70oC) on the rate of the biocatalytic reaction. The 
experiments were conducted using the conditions reported in Table 5.6 and the reactor 
configuration (GBR) used during the investigation into the effect of stirring on the 
biocatalytic reaction performance. The increased agitation rate of 750 rpm was used due to the 
improvement in sampling accuracy and precision. It should be noted that the PyNP enzyme 
having a low specific activity of 0.2 U.mg-1 was used during this study. 
 
Table 5.6: Effect of reaction temperature (40 – 70oC) 
Temp. 
(oC) 
GS 
(%m/m) 
TM 
(%m/m) 
TM:GS 
mole ratio 
PNP 
U 
PyNP 
U 
PNP: PyNPa 
enzyme ratio 
40 1.48 1.53 2.32 : 1 200 199 1.00 : 1 
50 1.49 1.56 2.34 : 1 204 204 0.99 : 1 
60 1.49 1.55 2.30 : 1 204 202 1.01 : 1 
70 1.55 1.59 2.29 : 1 200 200 1.00 : 1 
Note a: Batch #2 enzyme PNP 0.659 U.mg-1, PyNP 0.2 U.mg-1. Reactions were conducted at 1 L scale; Agitator 
speed: 750 rpm.  
 
The results obtained showed a significant increase in the rate of reaction (see Figure 5.11) as 
the temperature was increased from 40 - 60oC due to Arrhenius behaviour. However, further 
increases in reaction temperature to 70oC were not successful due to thermal degradation of 
the PNP and PyNP enzymes. The results obtained (reported in Table 5.7) show that overall 
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guanosine conversions of > 90% and 5-MU yields of between 50 – 60% were obtained. The 
increase in reaction temperature from 40 – 60oC demonstrated a decrease in the reaction time 
from 18 to 5 hours, concomitant with increased 5-MU reactor productivity from 0.37 - 1.67 
g.L-1.h-1. The effect of lower PyNP enzyme specific activity of 0.2 U.mg-1 had a far greater 
impact on the reaction performance with respect to the overall 5-MU yield as similar results 
were obtained irrespective of the reaction temperature. However, the effect of rate 
enhancement due to the increase in reaction temperature was unequivocally demonstrated. 
The maximum 5-MU productivity of 1.67 g.L-1.h-1 was lower than the required reactor 
productivity of 20 g.L-1.h-1 due to the low 5-MU yield (50 – 60%) obtained and relatively low 
concentration of guanosine (1.5% m/m) and thymine (1.5% m/m) used during the 
investigation. 
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Figure 5.11: Effect of reaction temperature on the biocatalytic reaction 
 
Table 5.7: Effect of reaction temperature (40 – 70oC) 
Temp. 
(oC) 
GS conv. 
(%) 
5-MU sel. 
(%) 
5-MU yield 
(%) 
Mole bal. 
(%) 
5-MU prod. 
(g.L-1.h-1) 
Time 
(h) 
40 78.3 61.7 48.3 96.3 0.37 18 
50 90.8 62.3 56.5 92 1.10 7 
60 96.6 64.0 61.9 100 1.67 5 
70 32.5 10.3 3.36 95.3 0.23 2 
 Chapter Five 120 
 
To summarize, increasing the reaction temperature from 40 - 60oC had an impact on the 
following process parameters: 
 
- Increased solubility of substrates present in the supernatant phase of the reaction 
medium, thus increasing the amount of substrate available in solution for the reaction. 
The effect of temperature on substrate solubility, discussed in Section 5.7.2 showed the 
guanosine solubility increased from < 0.1% m/m to 2.5% m/m while the thymine solubility 
increased from 0.1% m/m to 1% m/m over the temperature range 40 – 80oC. 
 
- Increased kinetic rate of the biocatalytic reaction and thus reactor productivity. 
The apparent activation energy (EA) was not elucidated during this investigation, due to the 
complexity of the biocatalytic process, but the effect on enhanced rate due to the increase in 
reaction temperature is unambiguous.  
 
- Possibly increasing the rate of the dissolution of substrates (guanosine and thymine) 
The rate of dissolution of solids is a mass-transfer process and will not be discussed further 
here. Investigation into this aspect is described in Section 5.3.2. 
 
- Effect on the enzyme stability and activity. 
The results obtained showed that the biocatalytic reaction was carried out at the non-optimum 
thermal stability of the PNP and PyNP enzymes. Should the enzyme thermal stability limit the 
development of the process, this may be circumvented by increasing the enzyme loading or 
using an enzyme fed batch protocol. The effect of increasing the enzyme loading on the 
techno-economics of the process will have to be evaluated. 
 
- R-1-P thermal stability 
The effect of temperature on the stability of the reaction intermediate R-1-P was not 
investigated during this study, but it has been reported that R-1-P was far more reactive to 
undergo acidic and spontaneous hydrolysis89. The effect of temperature on R-1-P stability is 
expected to be significant since the commercial (ex. Sigma Aldrich cat no 83866) bis-
cyclohexylamine salts required storage at -20oC. 
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5.4.6 Effect of PNP and PyNP enzyme ratio, enzyme loading and reaction temperature 
(40 – 60ºC) on biocatalytic reaction performance 
 
The effect of increasing the PyNP enzyme loading 10 x was investigated in an attempt to 
overcome the low thermal stability and low specific activity of the PyNP enzyme (0.2 U.mg-1) 
of this particular batch of enzyme. The experiments were conducted at a reduced scale of 100 
ml in a round bottom flask to minimize the amount of PyNP enzyme used from 10 g to 1 g. 
The experiments were carried out under the conditions reported in Table 5.8 showing the 
variation in PNP: PyNP enzyme ratio from 1:10 to 10:10 and increasing the reaction 
temperature from 40 – 60oC. 
 
Table 5.8: Effect of enzyme ratio, enzyme concentration and temperaturea 
GS conc. 
(%m/m) 
TM conc. 
(%m/m) 
GS:TM 
mole ratio 
Temp. 
(oC) 
PNP 
U 
PyNP 
U 
PNP:PyNP 
enzyme ratio 
1.58 1.57 2.23:1 40 22 198 1:9.07 
1.58 1.56 2.21:1 40 201 199 1.01:1 
1.53 1.61 2.36:1 60 20 199 1:9.80 
1.58 1.58 2.24:1 60 199 199 1.01:1 
Note a: PNP 5.14 U.mg-1 and PyNP 0.2 U.mg-1 
 
The results obtained (Figure 5.12) show that irrespective of the enzyme ratio used (PNP:PyNP 
1:10 versus 10:10) at 40oC, no adverse effect on reaction performance was observed with 
respect to guanosine conversion (> 90%). However a significantly lower 5-MU yield of < 
10% was obtained compared to 5-MU yields previously observed (50%). The results obtained 
show a high initial rate of guanosine conversion irrespective of the PNP loading (20 U versus 
200 U) within the first 30 minutes, followed by a period of significantly slower rate of 
guanosine conversion. The increase in PNP enzyme from 20 U to 200 U significantly 
enhanced the rate of conversion, with a guanosine conversion of 90% observed after 500 
minutes compared with a guanosine conversion of 96% obtained after 300 minutes. It should 
be mentioned that the difference in the lower 5-MU yield observed may possibly be attributed 
to heterogeneity of the PyNP enzyme solid used, as lower quantities of PyNP enzyme (1 g 
versus 10 g) were used during these studies. 
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The difference in the rate of guanosine conversion observed may also be attributed to enzyme 
kinetics and the rate of dissolution of substrates on this scale, as typically the rate of reaction 
may be increased by increasing the enzyme loading. 
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Figure 5.12: Effect of temperature (40oC) and enzyme ratio on reaction performance. 
 
The above experiments were repeated at 60oC using the conditions reported in Table 5.8. The 
results obtained (Figure 5.13) show a significant improvement in the rate of guanosine 
conversion (> 90%, within 60 minutes) irrespective of the PNP loading (20 U versus 200 U). 
The increase in rate may be attributed to an increase in the solubility of thymine and 
guanosine at this temperature (60oC) and increased kinetic rate of reaction. The rate of 
guanosine conversion was unchanged irrespective of the PNP enzyme loading. A 5-MU yield 
of 30 - 40% was obtained which was similar to yields obtained previously using this 
particular batch of enzyme. Although the PyNP enzyme is less stable than the PNP enzyme, 
the results obtained demonstrated that the biocatalytic reaction could be carried out (albeit at 
low 5-MU yields) by using increased PyNP enzyme loading. As a similar rate of guanosine 
conversion and 5-MU formation were observed, a significant build-up in the concentration of 
R-1-P was not expected. 
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Figure 5.13: Effect of temperature (60oC) and enzyme ratio on reaction performance. 
 
The observed increased 5-MU yield (30 - 40%) at 60oC compared to 40oC where the 5-MU 
yield obtained was less than 10% may possibly be attributed to the following factors: 
 
- Due to the low specific activity of the PyNP enzyme, the enzyme composition was not 
fully characterized; increased temperatures assisted in completely dissolving the 
enzyme and resulted in an improved reaction performance. 
- The increased temperature may have reduced or destroyed the activity of unknown 
competitive enzymes, such as transferases and / or hydrolases90, thus reducing the 
effect of a competing enzyme(s) adversely affecting the 5-MU yield. 
- Although the rate of guanosine conversion was increased irrespective of the enzyme 
loading, the rate of 5-MU formation was similar. This may possibly be attributed to 
thermal deactivation of the PyNP enzyme at the increased temperature of 60oC. 
- The effect of R-1-P stability at elevated temperatures has not been determined and 
thus the synthesis reaction may have been adversely affected using less active PyNP 
enzyme. 
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In summary, the overall guanosine conversion of > 90% was attained irrespective of the PNP 
enzyme loading used (20 U versus 200 U). The results obtained show that increasing the 
reaction temperature from 40oC to 60oC significantly increases the rate of guanosine 
conversion as shown in Figure 5.12 and Figure 5.13. 
 
A 5-MU yield of less than 10% was obtained at 40oC irrespective of the PNP and PyNP 
enzyme loading (20 U versus 200 U), while at the elevated temperature of 60oC the 5-MU 
yield was between 30 - 40%. This was attributed to an increase in reaction temperature, 
increasing the solubility of the substrates and enzymes and the reduction in background 
activity of competing enzyme(s) such as hydrolases and / or transferases. 
 
5.4.7 Effect of increased substrate concentration and reactor configuration 
 
The effect of carrying out the biocatalytic reaction using milder agitation conditions at 100 
mL scale using a round bottom flask/stirrer bar system, compared to the glass baffled reactor / 
A-310 Lightnin impeller, was investigated while increasing substrate concentrations. The 
experiment was carried out under the conditions reported in Table 5.9, and repeated using the 
glass baffled reactor (GBR) and Lightnin A-310 impeller to investigate the effect of reactor 
configuration on scaling up the reaction to 1 L. The enzyme loading was maintained at 1:1 
using the ten fold increase in enzyme loading due to the low PyNP enzyme’s specific activity 
of 0.2 U.mg-1 and low thermal stability. 
 
 
Figure 5.14: Axial flow impeller (bench-scale biocatalysis) 
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Figure 5.15: Glass Baffled reactor (GBR) and A-310 Lightnin axial flow impeller 
 
Table 5.9: Effect of increased substrate concentration, enzyme loading and reactor 
configuration 
GS conc. 
(%m/m) 
TM conc. 
(%m/m) 
GS:TM 
mole ratio 
Temp. 
(oC) 
PNPa 
U 
PyNPa 
U 
PNP:PyNP 
enzyme ratio 
9.07b 9.18 2.27:1 60 208 200 1.03:1 
8.85c 9.03 2.29:1 60 2053 2013 1.01:1 
13.0b 13.0 2.25 : 1 60 204 199 1.03 : 1 
Note a: PNP 5.14 U.mg-1 and PyNP 0.2 U.mg-1 
Note b: Reaction carried out in round bottom flask (RBF) / stirrer bar, Agitation rate 1250 rpm 
Note c: Reaction carried out in glass baffled reactor / Lightnin A310 impeller, Agitation rate 1250 rpm 
 
The results obtained demonstrate that a significant improvement in guanosine conversion of > 
90% and 5-MU yield of 80% was achieved. In addition to this, 5-MU productivity was 
increased from 1 g.L-1.h-1 to 3 g.L-1.h-1. The results demonstrate that it is possible to improve 
the 5-MU yield using PyNP enzyme having a low specific activity of 0.2 U.mg-1. The 
improvement may be attributed to the biocatalytic reaction operating under a different solid-
liquid mass transfer regime concomitant with an increase in the enzyme loading from 0.2 
U.ml-1 to 2 U.ml-1. 
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As shown in Figure 5.16, a significant improvement in the reaction performance with respect 
to guanosine conversion and 5-MU yield using increased substrate concentrations (9% m/m) 
was observed irrespective of the type of reactor configuration used (RBF versus GBR). The 
reactions were complete within 25 hours, and due to the increased substrate concentration 
used, increased 5-MU productivities of 2 to 3 g.L-1.h-1 were obtained. Although this is lower 
than the required productivity of 20 g.L-1.h-1, this represents a significant improvement from 
the 1.67 g.L-1.h-1 previously observed. 
 
The results show no substrate and / or product inhibition with the increase in substrate 
concentration from 1.5% m/m to 9% m/m, and there was no observable decrease in enzyme 
activity or stability due to mechanical degradation caused by the high particulate 
concentration or high agitation rates used. The increased enzyme loading may have offset the 
impact of these variables on the enzyme’s stability and activity. The improved reaction 
performance with respect to 5-MU productivity was attributed to the use of a solid-liquid 
slurry system, whereby the concentration of substrates was maintained at an optimum 
compared with systems using a completely dissolved substrate. It has been reported that a 6-
fold increase in productivity was possible using the solid-liquid slurry system91 due to the 
above solid-liquid phenomena, (based on modelling studies). 
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Figure 5.16: Effect of reactor configuration (RBF versus GBR) 
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The effect of increasing substrate concentration and solids loading on 5-MU productivity is 
influenced by the reactor configuration and level of solid suspension required. A series of 
qualitative tests were conducted in a round bottom flask to investigate the feasibility of 
increasing the guanosine and thymine concentration from 9% m/m to 15% m/m. The results 
obtained showed that stirring was not possible at increased guanosine and thymine 
concentrations above 13% m/m due to the high solids loading of 40%. An experiment was 
conducted using a solids loading of 35% under the conditions reported in Table 5.9. 
 
The results obtained (Figure 5.17) show significant improvements in reaction performance 
with respect to guanosine conversion and 5-MU yield. A guanosine conversion of 73%, 5-MU 
yield of 62% and 5-MU reactor productivity of 9 g.L-1.h-1 was observed after 8 hours. The 5-
MU productivity obtained was within 50% of the target productivity of 20 g.L-1.h-1. The 
overall guanosine conversion and 5-MU were above 90% after 25 hours and although a lower 
overall 5-MU productivity of 4.5 g.L-1.h-1 was observed, the results obtained demonstrated the 
scope for process improvement. 
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Figure 5.17: Effect of increasing substrate concentration using a RBF 
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The effect of agitation rate under mild conditions using the RBF / stirrer bar configuration 
was investigated. The experiments were conducted at 250 and 1000 rpm and the agitation rate 
increased intermittently during sampling from 250 – 1000 rpm, and reduced to 250 rpm. The 
experiments were also carried out using an improved quality of PyNP enzyme with a specific 
activity of 1.9 U.mg-1.The experiments were carried out under the conditions reported in 
Table 5.10. 
 
Table 5.10: Effect of agitation rate and enzyme batch variability 
GS conc. 
(%m/m) 
TM conc. 
(%m/m) 
GS:TM 
mole ratio 
Temp. 
(oC) 
PNPa 
U 
PyNPa 
U 
Agitation rate 
(rpm) 
9.15 8.99 2.21:1 60 203 200 250 
8.95 8.91 2.24:1 60 2031 1907 1000 
Note a: PNP 5.14 U.mg-1 and PyNP 1.9 U.mg-1 
 
The results obtained (Figure 5.18) show that irrespective of the agitation rate used, 
significantly improved guanosine conversions of 90% and 5-MU yields of 85% were attained 
after 8 hours. Significantly improved 5-MU productivities between 8 – 12 g.L-1.h-1 were 
observed at reaction times between 5 and 8 hours based on the target 5-MU productivity (20 
g.L-1.h-1). The improvement in 5-MU productivity was attributed to the improvement in PyNP 
enzyme specific activity. 
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Figure 5.18: Effect of agitation rate (250 – 1000 rpm) and reactor configuration. 
 
5.4.8 Effect of increased substrate concentration and reactor geometry 
 
Subsequently a series of experiments were conducted to investigate the feasibility of scaling 
up the reaction to 1 L while increasing the substrate concentration from 13% m/m to 19.5% 
m/m using a fed batch protocol. The thymine to guanosine mole ratio was decreased from 
2.3:1 to 1.75:1 due to the increase in substrate concentration. The effect of reactor 
configuration on reaction performance was also evaluated. The experiments were carried out 
under the conditions reported in Table 5.11. As has been shown, an increased substrate 
concentration and RBF/stirrer bar configuration demonstrated a significant improvement in 
reaction performance (Figure 5.17). The improvement was attributed to the increase in 
enzyme concentration, use of a slurry system and milder agitation conditions. 
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Table 5.11: Effect of changing substrate concentration and reactor configurations 
GS conc. 
(%m/m) 
TM conc. 
(%m/m) 
GS:TM 
mole ratio 
Temp. 
(oC) 
PNPa 
U 
PyNPa 
U 
Solids loading 
(%) 
13.0 13.0 2.25 : 1 60 204 199 34.6b 
13.5 10.5 1.75 : 1 60 2005 1997 31.5c 
13.5 - 19.5 10.7 - 15.3 1.78 : 1 60 2023 2000 31.3 - 48.8c 
13.0 10.2 1.76 : 1 60 1987 1950e 30.4d 
Note a: PNP 5.14 U.mg-1 and PyNP 0.2 U.mg-1 
Note b: RBF/Stirrer bar reactor, 1250 rpm 
Note c: Glass baffled reactor (GBR)/Lightnin A-310 impeller, 1250 rpm 
Note d: Labmax reactor/Anchor stirrer, 300 – 400 rpm.  
Note e: An additional 2000 U of PyNP was added after 7 hours reaction time. 
 
Subsequently two experiments were conducted whereby the experimental conditions were 
maintained under similar conditions to the RBF experiment, except that the reaction was 
carried out in a glass baffled reactor, using two A-310 Lightnin impellers due to the increased 
solids loading. The above reaction was repeated and the substrate concentration increased 
from 13.5 – 19.5% m/m using a fed batch protocol. The results obtained are shown in Figure 
5.19 and it is evident that the reaction was not successfully scaled up using the glass baffled 
reactor and Lightnin A-310 impellers (x 2) as a guanosine conversion and 5-MU yield of 40 - 
50% was observed. The results obtained during the fed batch protocol were also lower as a 
guanosine conversion and 5-MU yield of 20% was observed. The results obtained also show 
an increase in the variability of analytical results, due to the errors associated with sampling 
of the solid liquid slurry. The low guanosine conversion and 5-MU yield may be attributed to 
mechanical degradation of the enzyme due to an additional Lightnin A-310 impeller being 
added and the increased solids loading. This effect was exacerbated as the substrate 
concentration was increased using the fed batch protocol. During this experiment, the solids 
loading was increased from 31.3% - 48.8%. To conclude, using a GBR/Lightnin A-310 
reactor configuration and increased substrate concentration of 13% m/m was not successful 
due to severe agitation conditions used compared to the RBF/stirrer bar system. The results 
obtained demonstrated the importance of agitation under mild conditions; therefore an 
experiment was conducted using an anchor stirrer and non-baffled Labmax reactor. 
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Figure 5.19: Effect of increased substrate concentration using fed batch procedure (13 – 
19.5% m/m, fed – batch, FB) and using a glass baffled reactor / Lightnin A-310 impeller 
(x 2,One Pot (OP) procedure at constant concentration ( 13% m/m) 
 
The experiment conducted using the Labmax reactor / anchor stirrer reactor configuration (see 
Figure 5.20 and Figure 5.21) employed the experimental conditions reported in Table 5.11. 
The experiment was conducted under similar conditions used during the RBF/stirrer bar 
experiment. It was postulated that previous reactions carried out using the GBR reactor and 
high substrate concentrations, were not successful due to the low thermal and mechanical 
stability and activity of the PyNP enzyme, therefore an additional aliquot of PyNP enzyme of 
2000 U was added after 7 hours during the Labmax experiment. The results obtained are 
shown in Figure 5.22. The reaction went to completion after 24 hours and no increase in rate 
of 5-MU formation due to the additional amount of PyNP added after 7 hours was observed. 
The rates of guanosine conversion and 5-MU formation were similar and the reaction appears 
to be operating under solid-liquid mass transfer conditions. The reaction was carried out using 
a non-baffled Labmax reactor and anchor stirrer at 300 – 400 rpm. At this agitation rate the 
extent of vortex formation was not significant. The results confirm the advantages of using 
milder agitation conditions; however the use of a non-baffled reactor resulted in lower 5-MU 
productivities due to inefficient mixing using this system. 
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A direct comparison between the various reactor configurations was difficult due to the 
different conditions used with respect to agitation speed, agitator type, agitator size, agitator 
position and reactor configuration (baffled/non baffled). The physical characteristics and 
dimensions of the different reactor configurations and impellers are shown in Section 5.3.4.5 
and 5.3.6.1 Due to the variability in operational conditions, an empirical understanding of the 
effect on reactor configuration was gained during this study. 
 
 
Figure 5.20: Labmax reactorTM 
 
 
Figure 5.21: Anchor stirrer used in Labmax reactorTM 
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Figure 5.22: Effect of increased substrate concentration and alternative reactor 
configuration (Labmax / Anchor stirrer) 
 
5.4.9 Effect of increased enzyme concentration  
 
The effect of increasing 5-MU reactor productivity by increasing the substrate concentration 
and reaction temperature was discussed in Sections 4.2.10 - 4.2.14. An alternative method of 
improving the reactor productivity was to investigate the effect of enzyme concentration on 
the reaction performance. The experiments were conducted to determine if the rate of reaction 
was limited by the rate of substrate dissolution or if the rate of the reaction may be enhanced 
by varying the enzyme concentration. The experiments were carried out using the conditions 
reported in Table 5.12 at various enzyme concentrations. 
 
The results obtained are reported in Figure 5.23 and show similar rates of guanosine 
conversion irrespective of the PNP concentration at 100 U and 200 U. Subsequent increases 
in the PNP concentration to 400 U showed a significant increase in the rate of guanosine 
conversion as the phosphorolysis reaction was complete within 7 hours. Increasing the PyNP 
enzyme concentration from 100 U to 400 U had little effect on the rate of 5-MU formation 
which was similar irrespective of the enzyme concentration used. In addition, similar rates of 
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phosphorolysis reaction and synthesis reaction were observed while maintaining the PNP: 
PyNP enzyme ratio at 1:1 irrespective of the enzyme concentration used. 
 
Table 5.12: Effect of increased enzyme concentration 
GS conc. 
(%m/m) 
TM conc. 
(%m/m) 
GS:TM 
mole ratio 
Temp. 
(oC) 
PNPa 
U 
PyNPa 
U 
PNP:PyNP 
enzyme ratio 
8.98b 9.20 2.30:1 60 102 100 1.02:1 
9.07b 9.18 2.27:1 60 208 200 1.03:1 
9.00b 9.17 2.29:1 60 409 400 1.02:1 
Note a: PNP 5.14 U.mg-1 and PyNP 0.2 U.mg-1 
Note b: Reaction carried out in round bottom flask (RBF) / stirrer bar, Agitation rate 1250 rpm 
 
Although a high rate of guanosine conversion was observed using the highest PNP and PyNP 
enzyme concentrations of 400 U, a lower overall 5-MU yield was observed. Although the 
increased enzyme concentration increased the rate of guanosine conversion, this did not 
translate into increased rates of 5-MU formation and 5-MU yield. It was postulated that a 
synthesis reaction equilibrium was set up, resulting in the lower 5-MU yield being observed. 
Due to the possibility of a reaction equilibrium being set up, thermal instability of the PyNP 
enzyme and possible mechanical degradation of the enzyme system, all future experiments 
were conducted using the intermediate enzyme concentrations of PNP (200 U) and PyNP 
(200 U). 
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Figure 5.23: Effect of enzyme concentration 
 
5.4.10 Effect of thymine to guanosine mole ratio 
 
A series of experiments were then conducted based on the initial results (see Section 4.2.6) 
investigating the effect of thymine to guanosine mole ratio on the rate of the biocatalytic 
reaction performance. The experiments were conducted under the conditions reported in 
Table 5.13. 
 
Table 5.13: Effect of thymine to guanosine mole ratio 
GS conc. 
(%m/m) 
TM conc. 
(%m/m) 
GS:TM 
mole ratio 
Temp. 
(oC) 
PNPa 
U 
PyNPa 
U 
PNP:PyNP 
enzyme ratio 
9.07 9.18 2.27:1 60 208 200 1.03:1 
9.19 7.16 1.75:1 60 202 201 1.00:1 
9.42 4.21 1:1 60 210 181 1.16:1 
Note a: PNP 5.14 U.mg-1 and PyNP 0.2 U.mg-1 
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The results obtained (Figure 5.24) show no adverse effect on the guanosine conversion as 
guanosine was the limiting reagent, however as the thymine to guanosine mole ratio was 
decreased from 2.3: 1 to 1:1 a decrease in 5-MU yield from 80 – 63% was observed. It was 
postulated that this may be attributed to the following effects: 
 
- Operating above the solubility limit of thymine at a specific temperature would ensure 
that thymine concentrations in the supernatant are at saturation. This in turn ensures 
that the reaction between R-1-P and thymine takes place under optimal conditions, 
minimizing the possibility of R-1-P decomposing to ribose and phosphate ion. 
- Should the reaction be taking place at the interfacial boundary between the surface of 
the solid and the bulk solution, an increase in the amount of thymine particles would 
result in an increase in the rate of reaction. 
- An excess of thymine would minimize the adverse effect of the PyNP enzyme on the 
synthesis reaction equilibrium. 
- The rate of dissolution of thymine and guanosine, which is a solid-liquid mass transfer 
process, is not expected to influence the rate of reaction significantly. (see Section 
5.3.2) 
- Use of lower activity PyNP enzyme (0.2 U.mg-1) 
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Figure 5.24: Effect of thymine to guanosine mole ratio 
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When, this process was re-evaluated using PyNP enzyme of increased activity (from 1.9 
U.mg-1 to 4.27 U.mg-1), no adverse effect was observed. The experiment was carried out using 
the conditions reported in Table 5.14. 
 
Table 5.14: Effect of reducing thymine to guanosine mole ratio and enzyme loading 
GS conc. 
(%m/m) 
TM conc. 
(%m/m) 
GS:TM 
mole ratio 
Temp. 
(oC) 
PNPa 
U 
PyNPa 
U 
PNP:PyNP 
enzyme ratio 
9.20 4.72 1.15:1 60 2051 2016 1.02:1 
Note a: PNP 5.14 U.mg-1 and PyNP 4.27 U.mg-1, Reaction time: 24 hours. 
 
0
10
20
30
40
50
60
70
80
90
100
0 5 10 15 20 25 30
Time (h)
G
S 
co
n
v.
/5
-
M
U 
yie
ld
 
(%
)
0
2
4
6
8
10
12
14
16
18
20
5-
M
U 
pr
o
d.
 
(g/
L/
h)
GS conv. 5-MU yield 5-MU prod.
 
Figure 5.25: Effect of reduced thymine to guanosine mole ratio (1.15: 1) 
Entry 1,Table 5.14 
 
The reaction was carried out using a slight molar excess of thymine to limit the extent of the 
reverse synthesis reaction equilibrium. The results obtained (see Figure 5.25) showed no 
adverse effect on guanosine conversion, 5-MU yield and productivity. 
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5.4.11 Effect of increased substrate concentration, enzyme batch variability and enzyme 
loading 
 
Subsequently, a series of reactions were conducted investigating the effect of increasing the 
substrate concentration from 9% m/m to 13% m/m and lowering the enzyme loading from 
2000 U to 1000 U using the PyNP enzyme batch having a specific activity of 4.27 U.mg-1. 
The experiments were carried out under the conditions reported in Table 5.15. 
 
Table 5.15: Effect of new PyNP enzyme batch, substrate and enzyme concentration 
GS conc. 
(%m/m) 
TM conc. 
(%m/m) 
GS:TM 
mole ratio 
Temp. 
(oC) 
PNPa 
U 
PyNPa 
U 
PNP:PyNP 
enzyme ratio 
9.20 4.72 1.15:1 60 2051 2016 1.02:1 
13.0 6.44 1.12:1 60 2007 1986 1.01:1 
9.08 4.49 1.11:1 60 1008 984 1.02:1 
Note a: Reaction carried out over 24 hours, PNP 5.14 U.mg-1, PyNP 4.27 U.mg-1 
 
It was previously observed that enzyme batch variability had an adverse impact on the 
reaction performance with respect to 5-MU yield. Prior to scaling up the biocatalytic reaction 
to 10 – 20 L scale, a batch of PyNP enzyme was prepared having a specific activity of 4.27 U. 
mg-1. Therefore a series of experiments were conducted to establish the effect of this 
improved enzyme on reactor productivity. 
 
It was previously discussed that the reactor productivity may be increased by increasing the 
substrate concentration, reaction temperature and enzyme loading. During the current 
experiment the effect of increasing substrate concentration from 9% to 13% m/m was 
evaluated. The results obtained show (see Figure 5.26) that similar 5-MU productivity’s were 
observed irrespective of the substrate concentration used; however significantly lower 
guanosine conversions and 5-MU yields were observed using the increased substrate 
concentration of 13% m/m. The reaction was essentially complete after 7 hours using the 
lower guanosine concentration of 9% m/m. 
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Figure 5.26: Effect of increased substrate concentration and optimal PyNP enzyme  
 
Although the enzyme loading was not a significant cost contributor to the overall process 
economics, a reaction was conducted whereby the enzyme loading was reduced from 2000 to 
1000 U, while maintaining constant substrate concentration. The results obtained reported in 
Figure 5.27, show that reducing the enzyme loading from 2000 U to 1000 U had an adverse 
effect on the guanosine conversion, 5-MU yield and productivity. The experiment shows that 
the rate of guanosine conversion and 5-MU yield were operating under enzyme limited 
conditions. 
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Figure 5.27: Effect of reduced enzyme loading 
 
Based on the results observed, the biocatalytic reaction was scaled up using the lower 
substrate concentration of 9% m/m, lower thymine to guanosine mole ratio of 1.15:1 and 
maintaining the PNP and PyNP enzyme loading at 2000 U each. 
 
5.4.12 Effect of particle size on the rate of the biocatalytic reaction 
 
It has been reported in the literature that the rate of dissolution can be a limiting factor, and 
methods to circumvent or minimize this by decreasing the particle size, increasing the 
agitation power and using co-solvents may be considered92. The effect of pre-heating the 
reaction mixture to 100oC for 2 – 3 hours on reducing the substrate particle size and 
increasing the rate of reaction was investigated during this experiment. The experiment was 
carried out using the conditions reported in Table 5.16. It should be noted that PyNP enzyme 
of increased specific activity of 1.9 U.mg-1 was used during this investigation. 
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Table 5.16: Effect of particle size on the rate of the biocatalytic reaction 
GS conc. 
(%m/m) 
TM conc. 
(%m/m) 
GS:TM 
mole ratio 
Temp. 
(oC) 
PNPa 
U 
PyNPa 
U 
PNP:PyNP 
enzyme ratio 
8.98 8.87 2.20:1 60 203 198 1.02:1 
Note a: PNP 5.14 U.mg-1 and PyNP 1.9 U.mg-1 
 
Guanosine had the consistency of larger granular particles, while thymine had the consistency 
of a fine powder. Particle size analysis of guanosine and thymine confirmed this, with mean 
particle sizes of 63.3 and 21.4 µm respectively. Particle size analysis of solid mixtures of 
guanine and thymine recovered on completion of the biocatalytic reaction showed a reduced 
mean particle size of between 9.80 – 14.2 µm. However, similar results (Figure 5.28) were 
obtained, irrespective of the pre-heating protocol used and thus the effect of further reductions 
in particle size were negligible on the rate of reaction. 
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Figure 5.28: Effect of particle size on the rate of reaction 
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5.5 Bench-scale 
 
The biocatalytic reaction was carried out at bench scale (10 L) using the CR-16 reactor to 
investigate the reproducibility and robustness of the biocatalytic process. The 5-MU produced 
during this bench-scale study was used to prepare a β-thymidine market sample. The 
reproducibility experiments were carried out using the conditions reported in Table 5.17. 
 
Table 5.17: Effect of reaction reproducibility and reactor configuration 
GS conc. 
(%m/m) 
TM conc. 
(%m/m) 
GS:TM 
mole ratio 
Temp. 
(oC) 
PNPa 
U 
PyNPa 
U 
PNP:PyNP 
enzyme ratio 
9.31b 4.79 1.15:1 60 19597 16048 1.22:1 
9.30b 4.79 1.15:1 60 15961 16031 0.99:1 
9.31b 4.79 1.15:1 60 15995 16021 0.99:1 
9.31c 4.79 1.15:1 60 32031 31933 1.00:1 
Note a: PNP 5.14 U.mg-1 and PyNP 4.27 U.mg-1, Reaction time: 24 hours. 
Note b: CR-16 reactor, Note c: CR-26 reactor 
 
Figure 5.29: Biocatalysis reactor (CR-16, 10 L) 
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5.5.1 Reaction reproducibility 
 
The results obtained (Figure 5.30 – 25) show that the biocatalytic reaction was reproducible 
and robust with respect to guanosine conversion and 5-MU yield. The reaction was complete 
within 10 hours, compared with 7 hours at lab-scale, and as a result the 5-MU productivity at 
bench-scale decreased to 7 g.L-1.h-1 from 10 g.L-1.h-1 observed at lab scale. These results may 
be attributed to the biocatalytic reaction operating under different mass transfer regimes, due 
to different reactor configurations and operating conditions. It was initially proposed that a 5-
MU productivity of 20 g.L-1.h-1 was required to ensure the process was viable, however, it 
was shown that the effect of improving the reactor productivity above 10 g.L-1.h-1 had a 
negligible effect on the costs associated with the process (see Sections 7.4.1.1 and 7.6 - 7.6.3). 
A summary of the biocatalytic reaction reproducibility is reported in Table 5.18:. 
 
Table 5.18: Biocatalytic reaction reproducibility  
Exptl. ref GS conv. 
(%) 
5-MU sel. 
(%) 
5-MU yield 
(%) 
5-MU yield 
(%)a 
Mole bal. 
(%) 
Reproducibility test 1 92.9 99.3 92.2 84.6 109.0 
Reproducibility test 2 94.3 96.9 91.4 84.9 107.6 
Reproducibility test 3 96.9 83.7 81.1 85.1 95.2 
X, Average (%) 94.7 93.3 88.2 84.9 103.9 
SD 2.03 8.41 6.21 0.30 7.61 
RSD 2.14 9.01 7.04 0.36 7.32 
RSD: Relative standard deviation, SD/X * 100 
Note a: 5-MU yield normalized 
 
The normalized 5-MU yield results (compensating for variation in mole balances) show the 
reaction to be robust and reproducible. 
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Figure 5.30: Guanosine conversion (reproducibility experiments) : 5-MU yield 
(reproducibility experiments) 
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Figure 5.31: 5-MU productivity (reproducibility experiments) 
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The results obtained demonstrated that the reaction was reproducible and robust using the CR-
16 reactor. The effect of the following variables on the biocatalytic reaction performance was 
then evaluated: 
 
- Effect of reactor configuration (one pot versus two pot) and impeller type (anchor 
stirrer versus retreat blade). 
The optimal biocatalytic reaction is currently carried out using a one-pot procedure, however 
due to the high thymine to guanosine mole ratio’s used of 2.3:1; this results in a more 
complex DSP requiring the recycling and recovery of thymine. Carrying out the 
phosphorolysis and synthesis reaction in separate vessels would result in a simplified DSP. 
 
The reaction was initially conducted using an anchor stirrer at 10 L scale in the CR-16 reactor. 
In order to further establish the robustness of the process the optimal biocatalytic reaction was 
carried out using the CR-26 reactor at 20 L scale. The reactors have similar geometries except 
the CR-26 reactor has a retreat blade fitted. 
 
- Effect of recycling a mixture of guanine and thymine on the biocatalytic reaction 
performance. 
A thymine to guanosine mole ratio of 2.3:1 was used in the biocatalytic reaction, resulting in 
the recovery of a mixture of guanine and thymine. An experiment was conducted to determine 
the feasibility of recycling this mixture (ex. hot filtration) to ensure optimal use of thymine. 
 
5.5.2 Effect of reactor impeller: anchor stirrer, (CR-16, 10 L) versus retreat blade 
(CR-26, 20 L). 
 
The effect of scaling the reaction to 20 L and using a different type of impeller (retreat blade 
in a CR-26 reactor) was then investigated to determine the robustness of the biocatalytic 
reaction. The results obtained showed that similar guanosine conversions, 5-MU yields and 
productivities were observed irrespective of the reactor and impeller used. The results 
demonstrated that the biocatalytic reaction is robust with respect to different types of reactor 
and impeller configurations (see Figure 5.32). 
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Figure 5.32: Effect of impeller type (anchor stirrer versus retreat blade) 
 
5.6 Effect of external process parameters on process economics and biocatalytic 
reaction 
 
5.6.1 Effect of recycling guanine/thymine mixture 
 
Carrying out the biocatalytic reaction using a guanosine and thymine concentration of 
9% m/m and increased thymine to guanosine mole ratio of 2.3:1 resulted in mixtures of 
guanine and thymine being isolated. Previous attempts at reducing the thymine to guanosine 
mole ratio to 1:1 resulted in a lower 5-MU yield of 60%. The process economics require 
guanine to be recovered and sold to off-set raw material costs of thymine and guanosine. Thus 
the separation, isolation and recovery of guanine and thymine were critical to the success of 
the process. Based on the differential solubility of guanine and thymine in water, separation 
may be facilitated by using a hot water wash and conducting a hot filtration to recover 
guanine. The disadvantage of this process is that a significant amount of water is required due 
to thymine’s (0.8% m/m at 80oC) low solubility. In addition, removal of water from the 
filtrate to recover thymine would have to be carried out, requiring additional process facilities. 
This offsets any advantage gained from using the increased guanosine and thymine 
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concentration of 9% m/m. An alternative methodology was therefore investigated to 
determine if the guanine and thymine mixture (1:1) may be used in subsequent biocatalytic 
reactions. The experiment was carried out using the conditions reported in Table 5.19. 
 
Table 5.19: Effect of recycling guanine and thymine 
GS conc. 
(%m/m) 
TM conc. 
(%m/m) 
GS:TM 
mole ratio 
Temp. 
(oC) 
PNPa 
U 
PyNPa 
U 
PNP:PyNP 
enzyme ratio 
9.44 4.72 1.15:1 60 1994 1990 1:1 
Note a: PNP 5.14 U.mg-1 and PyNP 4.27 U.mg-1 
 
Under these conditions, the rate of the biocatalytic reaction was slower (5-MU productivity 
1.5 g.L-1.h-1) and a lower guanosine conversion of 67% and 5-MU yield of 54% was achieved 
(Figure 5.33). This may be attributed to the high solids loading (21%) leading to mechanical 
degradation and possible competitive product inhibition of the PNP enzyme93. Therefore the 
recycling of the guanine/thymine mixture was not viable. 
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Figure 5.33: Effect of recycling guanine and thymine mixture (1:1) 
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5.6.2 Effect of two pot protocol and investigation into R-1-P stability. 
 
It was reported that the biocatalytic reaction may be conducted using a two pot protocol or a 
one pot protocol. It was reported that the two pot procedure94 is the most commonly used, 
whereby a heterocyclic base may be glycosylated with isolated R-1-P using a nucleoside 
phosphorylase. Typically, using the two pot procedure with in-situ generation of R-1-P leads 
to the formation of equilibrium mixtures of the substrates and products, from which the 
nucleoside product must be isolated. It was also reported that the purine or pyrimidine base 
released from the glycosyl donor may be a potent competitive inhibitor in the next reaction. 
The current methodology of using a purine nucleoside donor and pyrimidine base as an 
acceptor requires the presence of PNP and PyNP to circumvent the inhibition problems, as the 
released purine base does not inhibit the PyNP enzyme95. The advantage of using the two pot 
procedure is that it allows for optimization of the separate reactions with respect to phosphate 
ion concentration, conditions for PNP and PyNP enzyme stability and activity characteristics, 
and it simplifies the current biocatalytic process DSP. The two pot procedure produces 
guanine during the phosphorolysis reaction, which may be easily separated from the reaction 
mixture by conducting a hot filtration. Thymine and PyNP enzyme could then be added to the 
filtrate containing R-1-P to produce 5-MU. A phosphorolysis experiment was conducted 
using a guanosine concentration of 1.5% m/m, sodium phosphate buffer (50 mM) and PNP 
enzyme (200 U, 5.14 U.mg-1) to investigate the de-coupling of the biocatalytic reaction. 
During the phosphorolysis reaction the effect of R-1-P stability was also evaluated as it was 
believed that R-1-P was unstable leading to low 5-MU yields. 
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Figure 5.34: Phosphorolysis reaction (decoupling procedure, two pot procedure) 
 
The results obtained show that the phosphorolysis reaction did not go to completion, with 
guanosine conversion of 44% and guanine yield of 33% obtained. During the phosphorolysis 
reaction, guanosine produces R-1-P and guanine in equimolar ratio’s. The reaction was 
sampled and analysed for guanine and guanosine by HPLC and ribose by ion 
chromatography. The stability of R-1-P was determined by sampling the supernatant, splitting 
the sample into two equal portions of 0.1 µL and diluting the one with a known amount of 
hydrochloric acid (1 M, 0.9 µL) and analysing for ribose. Thus, the untreated sample would 
give an indication of the decomposition rate of R-1-P into ribose and phosphate under the 
reaction conditions used. The acid treated sample would give an indirect indication of the 
amount of R-1-P present in the reaction mixture. Similar levels of guanine and ribose (acid 
treated sample) were observed indicating a level of reliability in analytical methods (HPLC 
and IC) to predict the levels of R-1-P based on guanine formation or treatment of the sample 
with acid to decompose R-1-P to ribose and phosphate ion. The results obtained show that R-
1-P is stable under the biocatalytic reaction conditions based on the background ribose 
detected and ribose due to R-1-P detected after the acid quench. The formation of guanine 
was expected to drive the reaction to completion due to the low solubility of guanine and the 
low conversion of guanosine (44%) was unexpected. However, this may possibly be 
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attributed to product inhibition due to R-1-P and guanine in the absence of the PyNP 
enzyme93. The effect of using a relatively low phosphate ion concentration (50 mM, 0.6% 
m/m) may also have had an adverse effect on the phosphorolysis reaction equilibrium90. The 
use of the two pot protocol would be more labour intensive compared to the one pot protocol 
and based on the above results was not pursued further. 
 
5.7 Downstream processing (DSP) 
 
5.7.1 Introduction 
 
The isolation and purification of a product from a dilute stream typically adds significantly to 
the product’s selling price. In general, product isolation is based on physical differences of the 
components such as solubility and boiling points, the greater the difference the more facile the 
separation. The development of the DSP for this process was based on the composition and 
concentration of the feed stream and the reaction performance. The development of the DSP 
process was also based on economic and process targets of the product, and this is affected by 
selling price and the end-use of product. Should 5-MU (55 $/kg) be the primary product for 
re-sale, a far more stringent process specification would be required. However, we intended to 
use 5-MU to prepare β-thymidine (150 – 175 $/kg), and the criteria used to define the 5-MU 
specification was based on the removal of components that would have an adverse effect on 
the β-thymidine preparation.  
 
5-Methyluridine may be used to prepare either stavudine or β-thymidine. The starting material 
should be free from water and solvents such as alcohols as water sensitive reagents such as 
mesyl chloride and acetyl bromide are used during this synthesis. Should wet 5-MU material 
be used, larger excesses of reagents would be required, leading to by-product formation and 
increased waste treatment costs. The process also requires removal of guanosine from the feed 
stream as guanosine may undergo similar reactions to 5-methyluridine, producing a mixture 
of by-products and adding to the complexity of the DSP. The removal of thymine from the 
feed stream was also required as the separation of thymine from the β-thymidine product 
would be difficult. Synthetic mixtures were used to develop the DSP process initially, and 
then implemented using real mixtures from a biocatalytic reaction. 
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Based on the above criteria the 5-MU produced would need to meet the following in-house 
specification: 
 
- Free of solvent and water (< 5% m/m) 
- Removal of guanosine (< 1% m/m) 
- Removal of thymine (< 1% m/m) 
- Removal of inorganic contaminants’, such as phosphate buffer salts. 
 
5.7.2 Isolation and purification of 5-MU from a dilute feed stream 
 
The biocatalytic reaction was initially carried out using dilute solutions of thymine (< 0.5% 
m/m) and guanosine (< 1% m/m) using a thymine to guanosine mole ratio of 1:1. The impact 
of reaction performance with respect to guanosine conversion (30 – 70%) and 5-MU yield (30 
– 70%) on the organic feed composition is reported in Table 5.20. The presence of 
components used to control the reaction medium pH such as Trizma base and phosphate 
buffer were also initially present in the process feed stream. However, screening experiments 
conducted demonstrated that the reaction may be successfully carried out using only a 
phosphate buffer to control pH, thus reducing the complexity of the DSP mixture. 
 
Table 5.20: Biocatalytic reaction organic composition (dilute feed streams) 
Initial reaction composition Composition (ex. biocatalytic reaction) for DSP 
GS conc. 
% m/m 
TM conc. 
% m/m 
GS conc. 
% m/m 
TM conc. 
% m/m 
GN conc. 
% m/m 
5-MU conc. 
% m/m 
0.71a 0.32 0.50a 0.22 0.11 0.19 
0.71b 0.32 0.21b 0.09 0.26 0.45 
Note a: Composition based on a guanosine conversion and 5-MU yield of 30% 
Note b: Composition based on a guanosine conversion and 5-MU yield of 70% 
 
Based on the organic components solubility (see Figure 5.35) it was proposed that the 
following procedure be used to carry out the isolation and recovery of 5-MU: On completion 
of the reaction, the reaction mixture should be heated to 90oC and filtered hot to recover 
guanine for re-sale. The reaction mixture should be cooled to 4oC, and filtered cold to recover 
excess thymine. The 5-MU present in the filtrate may then be recovered after water removal. 
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Figure 5.35: Thymine, Guanine, Guanosine and 5-MU solubility in phosphate buffer 
 
Table 5.21: Biocatalytic feed composition 
Component Solubility at 15 - 20oC 
% m/m 
Composition (ex. biocatalytic reaction) for 
DSP 
  GS conv. (30%) 
5-MU yield (30%) 
GS conv. (70%) 
5-MU yield (70%) 
Guanosine (GS) 0.01 0.50 0.21 
Thymine (TM) 0.15 0.22 0.09 
Guanine (GN) 0.001 0.11 0.26 
5-MU 7 0.19 0.45 
 
As guanine and guanosine have a low aqueous solubility, removal of these components was 
not expected to be problematic. Furthermore, the required biocatalytic process target of a 
guanosine conversion of 90% should result in negligible amounts of guanosine (0.0708% 
m/m) present in the process stream. It was proposed that guanosine levels less than 0.1% m/m 
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would not have an adverse effect on the β-thymidine process. However, the purification of 5-
MU from thymine was considered a priority. 
 
5.7.3 Purification of 5-MU from a dilute feed stream using ion exchange 
 
A series of synthetic tests were conducted to determine the feasibility of separating thymine 
and 5-MU using an adsorbent ion exchange resin. This would circumvent the requirement to 
remove water as the organic components would be selectively adsorbed, allowing the 
inorganic salts to pass through the column. The organic components would then be removed 
by selective elution using a mixture of alcohol/water. This procedure was based on a literature 
procedure using boranate affinity chromatography96 which had reportedly been used for the 
separation of 5-MU and thymine. A series of adsorbent ion exchange resins were evaluated 
for this process (XAD 4 and XAD 16, ex. Rohm and Haas). Feed concentrations below < 
0.1% m/m may be applied directly to the column, however increasing the feed concentration 
above 0.2% m/m, required pre-treatment with base to increase the solubility. The qualitative 
results obtained show that irrespective of the type of adsorbent resin used, separation of 
thymine and 5-MU was not possible (Figure 5.36). Based on these results obtained no further 
work was conducted using ion exchange as a separation methodology. 
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Figure 5.36: Separation of 5-MU and thymine using an adsorbent ion exchange resin 
 
5.7.4 Isolation and purification of 5-MU from a concentrated feed stream 
 
At this stage we determined that carrying out the biocatalytic reaction using low substrate 
concentrations would not result in an economically viable process, due to the low amounts of 
5-MU recovered (1.9 – 4.5 g.L-1). Based on the market requirements, 226 tpa of 5-MU would 
be required to produce 100 tpa of β-thymidine. Consequently this would have a significant 
impact on the 5-MU capex and production costs (229 $/kg) attributable to low reactor 
productivity (0.18 g.L-1
.
h-1) requiring the use of increased reactor size (168 m3) and large 
quantities of water (22 200 tons) to be processed during the recovery of 5-MU. Based on the 
large quantities of water and the difficulty associated with the removal of water, the process 
was not considered to be viable based on environmental and economic factors. Subsequently 
increasing the substrate concentration and reaction performance with respect to guanosine 
conversion and 5-MU yield were the main objectives of improving the 5-MU productivity and 
isolation of the product. 
 
To this end, a biocatalytic reaction was carried out using the conditions reported in Table 
5.22, using an increased molar ratio of thymine to guanosine of 2.24:1. The advantage of 
using an excess of thymine have been discussed in Sections 4.2.6 and 5.4.10, and the results 
showed that a guanosine conversion of 90% and 5-MU yield of 75% were obtained. The 
variation in composition of the reaction mixtures on the DSP was then investigated. 
 
Table 5.22: Isolation of 5-MU using a concentrated feed stream. (1.5% m/m) 
GS 
% m/m 
TM 
% m/m 
Na2HPO4 
% m/m 
NaH2PO4 
% m/m 
Guanine 
% m/m 
5-MU 
% m/m 
1.501a 1.501 0.596 0.096 - - 
0.071b 0.892 0.596 0.096 0.721 1.23 
Note a: Biocatalytic feed concentration 
Note b: Concentration (ex. biocatalytic reaction) 
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The isolation of 5-MU was carried out according to the following procedure: 
 
- Heat the reaction mixture to reflux (95oC) and filter hot to recover guanine. 
- Allow the reaction mixture to cool to room temperature (20 - 30oC) and then cool to 
4oC.  
- Conduct a cold filtration to recover the excess thymine. 
- Water was then removed at 60 - 80oC under vacuum, and the wet crude 5-MU residue 
recovered. 
 
The isolation of crude 5-MU was carried out as shown in Figure 5.37. The results indicated 
are based on qualitative HPLC data (area %), and demonstrate the feasibility of obtaining pure 
guanine, thymine and 5-MU. Isolation of the 5-MU may be carried out by evaporation of 
water, or alternatively by crystallization, which circumvents the requirement to remove 
significant quantities of water (1 L of water to recover 10 g of 5-MU). Preliminary results 
show that an un-optimized 5-MU recovery of 50% was achieved using the crystallization 
method. The low recovery may be attributed to the low concentration of 5-MU present in the 
feed stream and warrants further investigation should the concentration of 5-MU in the feed 
stream increase significantly. Based on the 5-MU solubility curve in phosphate buffer, a 5-
MU recovery of 93% should be possible. 
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Hot filtration (80oC)
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"Wet" crude 5-MU (90.6% Area)
inorganic salts
 
 
Figure 5.37: Isolation and purification of crude 5-MU 
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5.7.5 Summary of lab-scale development leading to an optimized bench-scale process 
 
As discussed previously, improvements in the reactor productivity were achieved using 
increased substrate concentrations of guanosine (9% m/m) and thymine (9% m/m). The 
reactions were carried out using the excess thymine to guanosine mole ratio of 2.3:1. 
However, using the DSP protocol described in Figure 5.37, a mixture of guanine and thymine 
were recovered during the hot filtration. The disadvantage of this process would be associated 
with the additional cost of re-cycling the guanine thymine mixture in the biocatalytic reaction 
or possibly recovering the thymine by carrying out a water wash. The low solubility of 
thymine in water (shown in Figure 5.35), suggests that significant quantities of water would 
be required to accomplish this, only to be removed later by evaporation, thus negating the 
improved reaction performance and reduced reactor size for the biocatalytic reaction. An 
attempt was then made to carry out the biocatalytic reaction using a 1:1 mixture of guanine 
and thymine by mass, to assess the feasibility of recycling the guanine/thymine mixture 
isolated during the hot filtration. The results obtained showed that the reaction was not 
successful as a guanosine conversion of only 67% and 5-MU yield of 54% were achieved 
after 30 hours. Therefore the feasibility of using the recycled mixture of guanine and thymine 
was not considered viable. 
 
Further investigations showed that the biocatalytic reactions conducted at concentrations 
above 3% m/m with respect to guanosine and thymine resulted in mixtures of thymine and 
guanine being recovered. Attempts were made to decouple the phosphorolysis reaction and 
syntheses reaction using a two-pot methodology, thus circumventing the recovery of mixtures 
of guanine and thymine. However, the results obtained showed that the phosphorolysis 
reaction was not successful due to possible product inhibition, low phosphate concentration 
and reaction equilibrium as a guanosine conversion of 44% and guanine yield of 33% was 
achieved after 24 hours. 
 
Subsequently an improvement in PyNP enzyme specific activity from 1.9 to 4.27 U.mg-1 was 
achieved during the enzyme fermentation and isolation. A base case biocatalytic reaction was 
carried out using the lower thymine to guanosine mole ratio of 1.15:1 at guanosine 
concentrations of 9% m/m and thymine concentrations of 4.7% m/m. The results obtained 
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showed that a guanosine conversion of 90% and 5-MU yield between 80 – 90% was achieved 
using the above conditions. Due to the increase in 5-MU concentration, the DSP procedure 
used in Figure 5.37 was modified slightly and is shown in Figure 5.38. Crude 5-MU from two 
different feed streams was isolated and purified using this protocol. 
 
The results obtained using the above protocol demonstrated that guanine was quantitatively 
isolated and recovered. The average guanine recovery of 98.4% + 11.4 and average purity of 
88.9% m/m + 1.17 was achieved. The variation in results may be attributed to the errors 
associated with the sampling and analysis of a heterogeneous solid. The results obtained 
indicate that guanine (27 $/kg) may be recovered at a relatively high purity and sold to offset 
the guanosine and thymine raw material input costs. 
 
The results obtained reported in Figure 5.39 demonstrate that 5-MU mole balance was 96.3% 
and the recovery of crude 5-MU was 87.3% at a purity of 61.2 – 89.9% m/m. As expected the 
5-MU ex. water crystallization (57% of the total 5-MU, 89.9% m/m) was purer than the 
material obtained after the water stripping (30% of the total 5-MU, 61.2% m/m). The results 
obtained also showed that 5-MU (9% of the total 5-MU) present in the guanine hot filter-cake 
ex. biocatalytic reaction was not recovered. Further optimisation of the process and recovery 
of 5-MU from this process feed stream would potentially increase the recovery of crude 5-
MU to 96.3%. 
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Figure 5.38: Isolation of crude 5-MU using an increased concentration of 5-MU 
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A typical isolation and purification of crude 5-MU from the different feed streams was 
reported in Figure 5.39. The results obtained show that the 5-MU recovery (89.6 – 102%) at a 
5-MU purity between 85 – 100% m/m) and 5-MU mole balance between (96.9 – 110%) was 
achieved. The variance in results obtained maybe attributed to the sampling and analysis of a 
heterogeneous solid. Typically 5-MU purity was increased from 50 – 60% m/m to at least 
90% m/m using the isobutanol protocol. 
 
Although the results obtained show that the material from the water crystallization had a 
relatively high purity (90% m/m), both sources of “crude” 5-MU were treated using the 
isobutanol purification procedure to prepare a consistent batch of 5-MU material used in the 
preparation of DABT. 
 
It was initially proposed that an organic solvent such as isobutanol may be used to separate 5-
MU from inorganic phosphate salts, subsequently it was also found that 5-MU and thymine 
may be separated based on their differential solubility in isobutanol (see Figure 5.40). 
 
The procedure was carried out by dissolving the crude 5-MU in the required amount of 
isobutanol and heating the slurry to reflux 110oC for 2 – 3 hours. The slurry mixture was then 
filtered hot to remove the inorganic salts and organics such as thymine. The filtrate containing 
5-MU was then allowed to crystallize from isobutanol and 5-MU recovered by carrying out a 
cold filtration. The material was then dried in a vacuum oven at 55oC. 
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Figure 5.39: Isolation and purification of 5-MU using isobutanol. 
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Figure 5.40: 5-MU and thymine solubility in isobutanol 
 
5.8 Conclusions 
 
5.8.1 Biocatalytic process 
 
In summary, a biocatalytic process has been developed where guanosine yields above 90% 
(94.7 ± 2.03%) and 5-MU yields between 80 – 90% (88.2 ± 6.21%) have been achieved and 
average 5-MU productivity of 7 - 11 g.L-1.h-1. The results obtained have shown that the 
biocatalytic process has been carried out at increased guanosine (9% m/m) and thymine (4.8% 
m/m) concentrations using the reduced thymine to guanosine mole ratio of 1.15:1 at bench-
scale (10 - 20 L). Based on the above results, the feasibility of carrying out 5-MU production 
at a commercial scale to prepare β-thymidine has been successfully demonstrated. Although 
the 5-MU productivity achieved was lower than the initial target product of 20 g.L-1.h-1, the 
impact on cost of production was negligible above 10 g.L-1.h-1. The impact of carrying out the 
reaction using the lower thymine to guanosine mole ratio also had a significant impact on 
improving the DSP, since no recovery of excess thymine was required. The effect of 
improved PyNP enzyme specific activity (4.27 U.mg-1) was key to the improved reaction 
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performance with respect to guanosine conversion, 5-MU yield and productivity using the 
lower thymine to guanosine mole ratio of 1.15:1. 
 
5.8.2 DSP 
 
The isolation and purification of 5-MU from the biocatalytic reaction using the isobutanol 
procedure showed 5-MU was recovered >90% at a purity between 85 - 100% m/m and the 
material was of a suitable quality to be used in the subsequent preparation of β-thymidine 
market sample without adversely effecting the chemical transformations. On completing the 
DSP the overall yield of 5-MU was 80%. A detailed techno economic model is reported in 
Chapter 7 demonstrating the effect of guanosine conversion, 5-MU yield and productivity on 
the processes commercial viability. 
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CHAPTER SIX 
 
6 Preparation of β-thymidine from 5-methyluridine 
 
6.1 Introduction 
 
The preparation of β-thymidine (dT) from 5-MU was investigated using the process shown in 
Scheme 6.1. The process entailed conversion of 5-MU to 3',5'-di-O-acetyl-2'-bromothymidine 
(DABT) using acetyl bromide97, followed by dehydrohalogenation of the DABT using a 
Nickel catalyst to produce 3',5'-di-O-acetyl-thymidine (DAT). The DAT was then treated with 
sodium methoxide to remove the acetyl protecting groups producing β-thymidine98. 
 
O
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Scheme 6.1: Preparation of β-thymidine from 5-methyluridine97,98 
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6.2 Preparation of DABT 
 
The integration of the biocatalytic and the chemical reactions, specifically the preparation of 
DABT from 5-MU was the main emphasis of this investigation. The reaction proceeds via the 
3',5'-di-O-acetylanhydrothymidine (DAAT) intermediate and can result in the formation of 
by-products, thymine (TM), 2',3',5'-tri-O-acetylmethyluridine (TAMU) and 3'-O-acetyl-2',5'-
dibromothymidine (ADBT) as shown in Scheme 6.2. A preliminary attempt at reproducing 
the reported DABT yield of 97% was not successful with a DABT yield of 59.3% obtained 
either using the reported procedure or a variation of the reported procedure. The variation in 
the reported procedure related to decreasing the acetyl bromide to 5-MU mole ratio from 5.7:1 
to 3.5:1; in principle a minimum mole ratio of 3:1 is required. The low DABT yield was 
attributed to by-product formation. The literature procedure also uses a relatively low 5-MU 
concentration of 2.5% m/m. The low substrate concentration may thus result in low reactor 
productivities. Thus a series of experiments were conducted to improve the DABT yield, 
while lowering the amount of by-product formation and increasing reactor productivity. 
During the investigation into the preparation of DABT from 5-MU, the effect of the following 
process variables on increasing DABT yield and reactor productivity while minimizing by-
product formation were evaluated: 
 
- Effect of water and hydrobromic acid on reaction performance 
- Effect of acetic acid on reaction performance 
- Effect of temperature (55oC versus 77oC)  
- Effect of substrate concentration (2.5% m/m - 7.5% m/m) and mode of operation (one 
pot versus semi fed batch) 
- Effect of phosphate salts on the DABT yield and biocatalytic reaction DSP 
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Scheme 6.2: Preparation of DABT from 5-MU99 
 
The formation of thymine due to acidic cleavage of the nucleoside99 while undergoing 
acetylation, has also been reported exacerbating the lower yields of DABT. 
 
The preparation of DABT from 5-MU has been postulated to take place via the mechanism100 
shown in Scheme 6.3. 
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Scheme 6.3: The preparation of DABT may proceed via the following mechanism 
 
An alternative mechanism was also proposed and is shown in Scheme 6.4. 
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Scheme 6.4: Preparation of DABT (alternative mechanism) 
 
It was reported that the mode of by-product formation may be attributed to the presence of 
water or alcohol preventing acetylation at the 5'-position. Based on the above proposed 
mechanisms, in-situ water formation takes place, thus contributing to the extent of by-product 
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formation. The literature protocol uses an excess of acetyl bromide to 5-MU (5.83:1) and thus 
may be used as a water scavenger during the course of the reaction. The mechanism proposed 
for the formation of ADBT as shown in Scheme 6.5 proceeds via two alternative pathways 
consisting of cyclic O- bridged intermediates. 
 
The formation of by-products 2',3',5'-tri-O-acetylmethyluridine (TAMU) and 3'-O-acetyl-2',5'-
dibromothymidine (ADBT) was undesirable101, as the by-products would undergo similar 
reactions to DABT resulting in complex DSP in the preparation of d4T from 5-MU. In 
addition it has been was reported that the by-products could not be removed effectively by 
suitable industrial methods such as extraction and re-crystallization. 
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Scheme 6.5: Formation of ADBT by-product100 
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6.3 Process specifications and analysis 
 
Due to the lack of analytical standards for the by-products TAMU and ADBT a qualitative in-
house HPLC specification was set as follows: 
 
Product area percent DABT: > 90% 
Total by – product (predominantly TAMU and ADBT): < 10% 
An analytical standard of the DABT product was prepared and used for quantitative analysis 
and for determining product yields. 
 
6.4 Results and Discussion 
 
6.4.1 Preparation of 3', 5’-di-O-acetyl-2'-bromothymidine (DABT), base case reaction 
 
During this experiment, the literature procedure97 was repeated, except using a lower mole 
equivalent of acetyl bromide (3.51 : 1 versus 5.83 : 1). Theoretically a minimum of three mole 
equivalents of acetyl bromide is required to obtain a 100% conversion of 5-MU to DABT. It 
has been reported that the use of acetyl bromide above a 4:1 ratio results in an increase in by-
product formation, and lower than 1:1 will not result in a complete reaction. The literature 
DSP procedure involves distilling excess solvent and acetyl bromide from the mixture, 
followed by dissolving the residue in DCM and washing with water. In our experiment, the 
DSP was modified in that excess acetyl bromide was quenched by the slow addition of 
methanol (exothermic reaction) producing hydrobromic acid and acetic acid. The acidic 
mixture was neutralized using solid sodium bicarbonate, filtered to remove solids and solvent 
removed under vacuum. The crude organic residue was dissolved in DCM and washed with 
water to remove inorganic salts. It was prudent to quench the excess acetyl bromide and 
neutralize the hydrobromic acid produced using sodium bicarbonate, to minimize possible 
acidic cleavage of the product during evaporation of the solvent, resulting in thymine 
formation and lower DABT yields. The DABT produced was used to prepare DAT under 
basic catalytic hydrogenation conditions and thus the use of a crude acidic product would 
have an adverse effect on the reaction performance. Presumably, the literature protocol of 
dissolving the product in DCM and washing with water was used to remove acidic residues 
from the crude DABT product. 
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The reaction mixture was sampled with time and the results are reported in Table 6.1. The 
complexity of the reaction system is highlighted as three additional unidentified reaction 
intermediates and / or by-products were formed during the initial stages of the reaction (t = 10 
- 30 minutes).The reaction mixture slurry became homogenous during the course of the acetyl 
bromide addition and the results obtained show that the total by-products produced by the end 
of the reaction were less than 10% (8.54%, LC area, TAMU and ADBT), however the amount 
of DABT product produced was less than the required 90% (83.6%, LC area). Quantitative 
analysis showed that a DABT yield of 59.3% was achieved. It was not possible to distinguish 
between thymine and 5-MU by HPLC due to co-elution under the conditions used. 
 
Table 6.1: Base case reaction using modified DSP procedure and lower AcBr mole 
equivalents  
Time 
(min.) 
5-MU 
Thymine 
DAAT 
Int. 
TAMU 
by-product 
1 
DABT 
Product 
ADBT 
by-product 
2 
Unidentified 
By products 
10 14.7 45.9 4.35 7.63 ND 27.5 
30 ND 12.4 4.71 57.6 ND 35.8 
60 1.16 12.4 5.73 77.4 2.22 - 
120 0.94 11.8 6.80 76.6 2.17 - 
- 0.82 12.1 5.98 77.0 1.99 - 
- ND 6.25 6.45 83.6 2.09 - 
All results given as % total area 
Experimental conditions: 5-MU conc. 2.48, AcBr : 5-MU mole ratio 3.51 : 1, AcBr addition time (min.): 15 
minutes, Temp. (oC) 77 – 38 over 120 minutes,  
Note a: Reaction mixture composition before DSP (liquid sample) 
Note b: Reaction mixture composition after DSP (solid organic residue) 
 
It was postulated that the lower DABT yield may be attributed to incomplete conversion of 
3',5'-di-O-acetylanhydrothymidine (DAAT) into DABT (see Scheme 6.2), with the reaction 
temperature cooling from 77 – 38°C during the course of the reaction. During the DSP 
process, complete removal of acetonitrile was not possible due to product foaming under high 
vacuum. The presence of acetonitrile may have also increased the miscibility of the DCM and 
aqueous phases resulting in DABT product losses and consequently lower yields. 
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The results obtained also show low levels of “thymine” (0.82%, LC area), indicating that the 
degree of acidic cleavage was not significant in contributing to the lower DABT yield 
observed. 
 
6.4.2 Effect of Temperature 
 
6.4.2.1 Staggered heating profile 
Based on the results obtained in the initial experiment, we speculated that a higher 
temperature may be required to facilitate complete conversion of the DAAT reaction 
intermediate into DABT. An experiment was conducted using a staggered reaction 
temperature profile (55 – 77°C) to minimize by-product formation and ensure complete 
conversion of the reaction intermediate DAAT to DABT. During this experiment, the acetyl 
bromide addition time was increased from 15 minutes to 30 minutes and the reaction mixture 
temperature maintained at 50 – 60°C for 1 hour and before heating to reflux (77°C) for 2 
hours. It has been reported that the use of high reaction temperatures (80°C)101 may result in 
the formation of DABT either via direct bromination of the 5'-hydroxy intermediate or 
indirectly via the O2-5'-anhydro compound. The qualitative results obtained (see Table 6.2) 
show that the reaction had performed to the required in-house qualitative product 
specification (Product Area: 90%, By-products area < 10%). A significant improvement in 
DABT yield of 83.8% was also noted. The results also show that it is possible to convert the 
DAAT reaction intermediate into DABT using the staggered temperature profile. Upon 
completion of the reaction, the mixture was maintained at reflux for an additional hour in 
order to determine product stability at this temperature. The area % results obtained show no 
significant change in reaction profile, and thus heating the acidic mixture did not result in 
product degradation. 
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Table 6.2: Effect of temperature on reaction performance 
Time 
(min.) 
5-MU 
Thymine 
DAAT 
Int. 
TAMU 
by-product 1 
DABT Product ADBT 
by-product 2 
30 0.75 55.5 7.61 24.7 1.46 
60 0.66 41.0 6.89 46.2 2.66 
120 0.66 0.66 4.58 89.0 4.20 
180 0.51 ND 4.34 88.8 4.96 
- ND ND 4.12 88.1 5.41 
All results are given as percent of total area.  
Experimental conditions: 5-MU conc. 2.51, AcBr : 5-MU mole ratio 3.43 : 1, AcBr addition time (min.): 30 
minutes, Temp. (oC) 50-60 (1 hour), 77 (2 hours) 
Note a: Reaction mixture composition before DSP (liquid sample) 
Note b: Reaction mixture composition after DSP (solid organic residue) 
 
6.4.2.2 Reaction at reflux (77°C) 
 
The literature protocol was repeated at 77°C in an attempt to increase the rate of reaction and 
thus the reactor productivity The results obtained (reported in Table 6.3) are similar to the 
staggered heating experiment (see Table 6.2). The reaction performance shows that the 
qualitatively the in-house product specification was met (Product area 90%: total by-products 
< 10%) see Table 6.3. A DABT yield of 83.7% was once again achieved. The experiments 
differ in that the reaction was completed in 1 hour at reflux (77°C) versus 3 hours using the 
staggered temperature profile of 50 - 60°C for 1 hour, and then 77°C for 2 hours. In addition, 
in this experiment the molar ratio of acetyl bromide to 5-methyluridine was increased from 
3.5:1 to 5.6:1. Thus the results obtained show that both protocols were suitable, however the 
impact of increased reactor productivity and cost of using increased acetyl mole equivalents 
on the process economics will have to be evaluated. 
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Table 6.3: Base case reaction as per literature procedure 
Time 
(min.) 
5-MU 
Thymine 
DAAT 
Int. 
TAMU 
by-product 1 
DABT Product ADBT 
by-product 2 
30 0.64 2.35 8.20 80.6 2.98 
60 0.78 ND 6.71 88.6 2.20 
- 0.59 ND 7.88 85.3 1.77 
- 0.44 ND 10.0 86.1 2.34 
- - - 6.42 90.0 1.91 
All results are given as percent of total area.  
Experimental conditions: 5-MU conc. 2.56, AcBr : 5-MU mole ratio 5.61 : 1, AcBr addition time (min.): 30 
minutes, Temp. 77 (1 hour). 
Note a: Reaction mixture composition before DSP (liquid sample) 
Note b: Reaction mixture composition after DSP (solid organic residue) 
 
6.5 Influence of water and acetic acid on by-product formation 
 
6.5.1 Effect of Water 
 
Although a significant improvement in DABT yield was obtained during the experiments 
described above, further investigations into the formation of by-products were conducted. It 
has been reported that water or an alcohol has an adverse effect on DABT formation, by 
preventing acetylation of the 5'-position resulting in ADBT formation (see Scheme 6.5). 
Water is produced in-situ during the course of the reaction, and an experiment was conducted 
where excess water (0.83 g water per 10 g 5-MU, 1.2:1 mole equivalents with respect to 5-
MU) was dosed into the reaction mixture to investigate the effect on by-product formation. 
The mole ratio of acetyl bromide to 5-MU was also increased from 3.5:1 to 4.5:1 to account 
for acetyl bromide quenching due to the presence of water. Owing to the fact that acetyl 
bromide reacts violently with water, producing hydrogen bromide gas and acetic acid 
decomposition products, acetyl bromide was added slowly to the reaction mixture. Due to the 
low levels of water present, gas evolution was observed, but there was no significant increase 
in reaction temperature. The results obtained (reported in Table 6.4) show a decrease in the 
amount of DABT product formed with a concomitant increase in by-product formation. The 
overall yield of DABT was 73.0%. 
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Table 6.4: Effect of water and hydrobromic acid on the reaction performance 
Time 
(min.) 
5-MU 
Thymine 
DAAT 
Int. 
TAMU 
by-product 1 
DABT Product 
 
ADBT 
by-product 2 
30 2.39 54.8 6.93 12.0 1.37 
60 1.35 38.6 10.5 38.0 4.32 
120 1.43 0.53 11.1 75.2 7.24 
- ND 0.63 9.31 77.4 7.28 
All results are given as percent of total area.  
Experimental conditions: 5-MU conc. 2.52, AcBr : 5-MU mole ratio 4.49 : 1, AcBr addition time (min.): 30 
minutes, Temp. (oC) 50-60 (1 hour), 77 (1 hour) 
Note a: Reaction mixture composition before DSP (liquid sample) 
Note b: Reaction mixture composition after NaHCO3 neutralization 
 
This confirmed that the presence of water has an adverse effect on the reaction performance, 
resulting in increased by-product formation. 
 
6.5.2 Effect of Acetic Acid on the Reaction Performance  
 
The by-products of acetyl bromide decomposition are hydrogen bromide and acetic acid. The 
difficulties associated with obtaining a dry source of hydrogen bromide gas and dosing in an 
accurate amount of hydrogen bromide gas (at the reaction temperature 50 - 80°C) limited the 
investigation of this acetyl bromide decomposition by-product on the reaction performance. 
As a result, we only studied the effect of acetic acid on this reaction. Subsequently, a reaction 
was conducted whereby an excess of glacial acetic acid was added to the reaction mixture to 
determine the effect on the reaction performance with respect to product (DABT) and by-
product formation. An aliquot of acetic acid (2.24 g, 37.3 mmol ex. Saarchem) was dosed into 
the reaction mixture. The qualitative results obtained (Table 6.5) were similar to those 
observed during the experiment conducted with excess water (see Table 6.4). However, a 
DABT yield of 81.7% was achieved, indicating the presence of additional acetic acid did not 
have as much of an adverse effect on the reaction performance as the excess water did. 
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Table 6.5: Effect of acetic acid on the reaction performance  
Time 
(min.) 
5-MU 
Thymine 
DAAT 
Int. 
TAMU 
by-product 1 
DABT Product ADBT 
by-product 2 
30 1.33 52.4 6.63 19.8 1.68 
60 ND 34.9 6.22 46.4 4.06 
120 ND ND 4.02 83.6 6.39 
- ND ND 6.35 82.2 6.74 
All results are given as percent of total area.  
Experimental conditions: 5-MU conc. 2.51, AcBr : 5-MU mole ratio 3.45 : 1, AcBr addition time (min.): 30 
minutes, Temp. (oC) 50-60 (1 hour), 77 (1 hour) 
Note a: Reaction mixture composition before DSP (liquid sample) 
Note b: Reaction mixture composition after NaHCO3 neutralization 
 
6.6 Reactor productivity  
 
An increase in substrate concentration, while maintaining similar reaction times (1 - 2 hours) 
and DABT yields above 80% should result in an increase in reactor productivity. In order to 
assess the feasibility of applying this to our process, a one pot protocol increasing the 
substrate concentration to 7.5% m/m and semi fed batch protocol increasing the substrate 
concentration from 2.5% m/m to 7.5% m/m were evaluated. The semi-fed batch reactions 
were conducted using incremental increases in 5-MU concentration of 2.5% m/m. 
 
6.6.1 Effect of increasing substrate concentration (one pot versus fed-batch) 
 
Due to the relatively low substrate concentration of the base case reaction (2.5% m/m 5-MU), 
attempts were made to increase the substrate concentration to 7.5% m/m. This would increase 
the reactor productivity and consequently reduce the reactor size. 
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Table 6.6: Effect of substrate concentration on reaction performance (one-pot) 
Time 
(min.) 
5-MU 
Thymine 
DAAT 
Int. 
TAMU 
by-product 1 
DABT Product 
 
ADBT 
by-product 2 
15 11.4 48.8 6.30 4.38 0.33 
30 1.40 44.3 8.77 31.4 4.34 
60 1.64 25.6 9.22 52.1 6.15 
120 2.36 0.44 7.19 79.2 7.50 
- ND ND 6.45 82.4 9.50 
All results are given as percent of total area. 
Experimental conditions: 5-MU conc. 7.47, AcBr : 5-MU mole ratio 3.45 : 1, AcBr addition time (min.): 30 
minutes, Temp. (oC) 50-60 (1 hour), 77 (1 hour) 
Note a: Reaction mixture composition before DSP (liquid sample) 
Note b: Reaction mixture composition after DSP (solid organic residue) 
 
The results obtained (see Table 6.6) show that an increase in by-product formation and 
reduction in product formation was observed with an increased substrate concentration of 
7.5% m/m. The increased by-product formation may occur as a result of increased 
concentrations of reaction intermediates being present reacting via alternative pathways, 
resulting in a lower DABT yield of 59.7%. Thus the increase in substrate concentration from 
2.5 – 7.5% m/m as a means to increase reactor productivity was not feasible. 
 
6.6.2 Effect of Increasing the Substrate Concentration From (2.5 – 7.5% m/m) using a 
Semi-Fed Batch Mode of Substrate Addition  
 
The effect of increasing the substrate concentration (2.5% m/m – 7.5% m/m) using a semi-fed 
batch system was then evaluated. During the fed batch experiments, fresh batches of 5-MU 
were dosed into the reaction sequentially, each addition incrementally increasing the 5-MU 
concentration from 2.5 – 7.5% m/m. The results obtained are reported in Table 6.7 - Table 
6.9. The results obtained are similar to the initial experiment (see Table 6.2, base case 
experiment). The product meets the required in-house specification (Product Area: 90%, By-
products area < 10%). 
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Table 6.7: Effect of fed batch on reaction performance (2.5% m/m) 
Time 
(min.) 
5-MU 
Thymine 
DAAT 
Int. 
TAMU 
by-product 1 
DABT  
Product 
ADBT 
by-product 2 
30 0.69 58.6 6.93 28.2 1.40 
60 0.62 37.5 6.57 51.1 2.24 
120 0.77 ND 4.79 90.1 3.48 
All results are given as percent of total area.  
Experimental conditions: 5-MU conc. 2.50, AcBr : 5-MU mole ratio 3.48 : 1, AcBr addition time (min.): 30 
minutes, Temp. (oC) 50-60 (1 hour), 77 (1 hour) 
 
This was then repeated with 5-MU concentration increasing from 2.5% m/m to 5.0% m/m 
during the experiment. The results reported in Table 6.8 show that the amount of DABT 
product decreased from 90.1% to 87.1%, while the by-product levels appear to be fairly 
constant (9 - 10%). The presence of traces of what is believed to be thymine was also 
observed. 
 
Table 6.8: Effect of fed batch on reaction performance (2.5% m/m – 5%m/m) 
Time 
(min.) 
5-MU 
Thymine 
DAAT 
Int. 
TAMU 
by-product 1 
DABT  
Product 
ADBT 
by-product 2 
30 1.20 21.1 5.76 63.4 2.68 
60 1.30 13.4 5.75 73.4 3.62 
120 1.76 0.16 4.55 87.0 4.60 
All results are given as percent of total area.  
Experimental conditions: 5-MU conc. 4.89 (2.5), AcBr : 5-MU mole ratio 3.49 : 1, AcBr addition time (min.): 30 
minutes (60 minutes total), Temp. (oC) 50-60 (1 hour), 77 (1 hour), (total time 240 minutes), 
 
In order to validate the trend, the procedure was repeated while increasing the effective 
substrate concentration from 5.0% m/m to 7.5% m/m. The results obtained (see Table 6.9) 
show that DABT product decreased further from 87.1% to 85%, and the amounts of by-
products have increased to ~ 15%. The quantitative DABT yield was also significantly lower 
at 54.3%. Based on these results, the use of a semi-fed-batch mode of operation did not 
circumvent the problem of increased by-product formation. 
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Table 6.9: Effect of fed batch on reaction performance (5% m/m – 7.5%m/m) 
Time 
(min.) 
5-MU 
Thymine 
DAAT 
Int. 
TAMU 
by-product 1 
DABT  
Product 
ADBT 
by-product 2 
30 1.84 9.78 5.68 73.3 4.57 
60 1.93 4.92 5.70 79.1 5.30 
120a 1.95 0.16 4.59 84.0 6.53 
-
b ND ND 8.16 85.0 6.86 
All results are given as percent of total area. 
Experimental conditions: 5-MU conc. 7.15 (2.5), AcBr : 5-MU mole ratio 3.13 : 1, AcBr addition time (min.): 30 
minutes (90 minutes total), Temp. (oC) 50-60 (1 hour), 77 (1 hour), (total time 360 minutes),  
Note a: Reaction mixture composition before DSP (liquid sample) 
Note b: Reaction mixture composition after DSP (solid organic residue) 
 
Attempts to increase the reactor productivity were not successful by increasing the substrate 
concentration from 2.5 - 7.5% m/m using either the one pot or fed batch protocol. Therefore it 
was recommended that the 5-MU concentration used during the preparation of DABT be 
maintained at 2.5% m/m. 
 
6.7 Integration of the biocatalytic and chemical processes 
 
During the development of the overall process, integration of the biocatalytic and chemical 
processes was required. During the optimization of the chemical process, synthetic 5-MU 
mixtures were used to investigate the parameters affecting the preparation of DABT. 
Subsequently synthetic mixtures having a composition based on the optimized biocatalytic 
process were prepared (guanosine conversion > 90%, 5-MU yield 75%). This was necessary 
in order to define the in-house specification of 5-MU, and determine the DSP requirements to 
produce material of similar quality to the 5-MU sourced from commercial suppliers. 
 
Based on the above criteria an in-house specification was set up for the reagents to be used in 
subsequent chemical transformations. In addition, the presence of impurities having an 
adverse effect on subsequent chemical transformations were identified. These essentially 
resulted in increased complexity of DSP to isolate the final product β-thymidine. Therefore 
the 5-MU produced during the biocatalytic reaction must meet the following specifications: 
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- The 5-MU product must be dry i.e. free of solvent and moisture (< 5% m/m), as any 
water or solvent (alcohols) present may quench acetyl bromide in the subsequent 
chemical reaction leading to by-product formation. 
- Complete removal of guanosine (< 1% m/m) is required, as guanosine would undergo 
similar reactions to 5-methyluridine during the preparation of DABT adding to the 
complexity of the DSP process. 
- Complete removal of thymine is required, as it is difficult to separate thymine from β-
thymidine, without additional DSP process steps. The possibility of removing thymine 
during the DABT DSP may be possible depending on the levels of thymine present. 
 
In order to meet these requirements, the purification of 5-MU (ex. biocatalytic reaction) 
involved hot filtration to recover guanine, followed by a cold filtration to recover thymine and 
then water removal to recover a crude mixture of 5-MU and inorganic phosphate buffer salts. 
An experiment was then conducted using a synthetic mixture of 5-MU and inorganic 
phosphate buffer salts to investigate the effect on DABT yield and to determine if further 
purification and separation of the phosphate salts was required. 
 
6.7.1 Effect of Phosphate Salts on the Reaction Performance 
 
During this experiment, a synthetic mixture of 5-MU and phosphate buffer salts (ex. 
biocatalytic reaction di-sodium hydrogen phosphate (5.19 g, 36.6 mmol ex. Saarchem) and 
sodium di-hydrogen phosphate (0.82 g, 6.83 mmol ex. Saarchem)) were prepared and 
subjected to the standard reaction conditions. The purpose of this experiment was to 
determine if the presence of phosphate salts has any detrimental effect on reaction 
performance with respect to DABT yield, and if any additional 5-MU purification was 
required. The results show (see Table 6.10) that the presence of phosphate salts had an 
adverse effect on the reaction performance, as the amount of DABT produced was lower 
(71.2%, LC area) and the formation of a major by-product TAMU was observed (27.0%, LC 
area). No quantitative analysis (DABT yield) was carried out due to the high level of by-
product formation. The high level of TAMU by-product formed may be attributed to acetyl 
bromide being quenched by basic phosphate salts, resulting in increased levels of acetic acid 
and sodium acetate. Due to the basic nature of the phosphate salts, any hydrobromic acid 
produced as a result of the acetyl bromide quench would also be neutralized, producing 
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sodium bromide salts. Thus the formation of the di-brominated by-product ADBT was not 
observed, as low levels of active “bromine” were present in the reaction medium. Based on 
these results, investigation into the separation of phosphate salts and 5-MU was conducted. 
The separation of 5-MU from inorganic phosphate was achieved using an isobutanol process, 
as described in Section 5.7.5. 
 
Table 6.10: Effect of phosphate salts on the reaction performance 
Time 
(min.) 
5-MU 
Thymine 
DAAT 
Int. 
TAMU 
by-product 1 
DABT  
Product 
ADBT 
by-product 2 
30 ND 25.7 34.1 40.1 ND 
60 ND 10.3 30.2 59.5 ND 
120a ND ND 27.9 71.2 ND 
All results are given as percent of total area. 
Experimental conditions: 5-MU conc. 2.50, AcBr : 5-MU mole ratio 7.35 : 1, AcBr addition time (min.): 30 
minutes, Temp. (oC) 50-60 (1 hour), 77 (1 hour). di-sodium hydrogen phosphate (5.19 g, 36.6 mmol ex. 
Saarchem) and sodium di-hydrogen phosphate (0.82 g, 6.83 mmol ex. Saarchem) 
Note a: Reaction mixture composition before DSP (liquid sample) 
 
5-MU (ex. biocatalytic reaction, real material) and purified using the isobutanol process was 
used to evaluate the effect on the DABT yield. The results obtained showed no adverse effect. 
 
 
6.8 Conclusions 
 
The preparation of DABT presented challenges with respect to low DABT yields, increased 
by-product formation and low reactor productivity. The preparation of DAT and β-thymidine 
were carried out under the conditions reported in Sections 8.5.2 - 8.5.4. The results obtained 
showed that comparable yields of β-thymidine (80%) from DABT were achieved98. 
 
 
 
 
 
 Chapter Six 182 
6.8.1 DABT preparation 
 
A general procedure for the preparation of DABT from 5-MU was established and a 
maximum DABT yield of 84% was achieved (see Section 6.4.2) using one of the following 
experimental protocols: 
 
- Staggered reaction temperature profile of 55 – 77oC over 2 hours lower acetyl bromide 
to 5-MU mole ratio (3.5:1) 
- Reaction at reflux (77oC) for 1 hour and using an increased acetyl bromide to 5-MU 
mole ratio (5.83:1). 
 
However the DABT yield achieved was lower than the target yield of 90% and the reported 
literature yield of 97%97. The lower DABT yield also highlighted the complexity of the 
preparation of DABT as subsequent investigators using the current acetyl bromide literature 
protocol found the maximum DABT yield achieved under various conditions to be 63%. The 
impact of the lower DABT yield on the process economics was limited due to the almost 
quantitative conversion of DABT to β-thymidine (overall yield from DABT 81%). The 
overall yield of β-thymidine from DABT was 68% before product isolation. 
 
The impact of reduced reaction time (1 hour versus 2 hours) and respective increase in acetyl 
bromide to 5-MU (5.3:1 versus 3.5:1) on the process economics is discussed in Section 7.9.6. 
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CHAPTER SEVEN 
 
7 Process Techno-Economics 
 
7.1 Introduction 
 
The successful development of a chemo-enzymatic process was a complex and highly 
diversified task encompassing optimization of the fermentation, biocatalysis and chemical 
processes. Successful development and implementation of the process requires the 
identification of and setting of suitable benchmarks within a desirable operating window. (see 
Figure 7.1)102,103,104. The development of a quantitative techno economic model was used to 
identify the effect on commercial viability of the process parameters. 
 
Product yield (%)
Reactor productivty (g/L/h)
Process
requirements
Enzyme
characteristics
Process
operating
window
Techno economics
constraints
 
Figure 7.1: Development of a biocatalytic process operating window 
 
The process requires a high product yield and reaction productivity as highlighted in Table 
7.1, Table 7.2 and Table 7.3. Achieving this in the context of the enzymes thermal, pH and 
activity constraints requires a compromise in operating conditions which has an impact on the 
techno-economics and ultimate commercial viability of the process. In the absence of 
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quantitative process data, the effect of specific process variable assumptions should be clearly 
stated and sensitivity analysis conducted to determine the overall impact on the process 
viability. 
 
7.2 Process parameters (Technical) 
 
During the development of the chemo-enzymatic process, the following technical process 
parameters and targets were identified (Table 7.1 and Table 7.2). 
 
Table 7.1: Biocatalytic preparation of 5-methyluridine 
Parameter Target Achieved 
Guanosine conversion > 90% > 90% 
5-MU yield (reaction) 75% 80 -90% 
5-MU yield (isolated) 75% 72 – 81% 
Guanine recovery 90% 90% 
5-MU productivity 20 g.L-1.h-1 7 – 10 g.L-1.h-1 
 
Table 7.2: Chemical preparation of β-thymidine 
Parameter Target Achieved 
DABT yield  90% 80% 
DABT productivity 20 g.L-1.h-1 27 g.L-1.h-1 
DAT yield  90% 85% 
DAT productivity 20 g.L-1.h-1 73 g.L-1.h-1 
dT yield  90% 100% 
dT productivity 20 g.L-1.h-1 120 g.L-1.h-1 
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7.3 Process parameters (Commercial) 
 
Commercial process parameters and targets were identified (Table 7.3). 
 
Table 7.3: Preparation of β-thymidine from 5-MU 
Parameter Target Achieved 
β-thymidine (commercial 
selling price) 
175 $/kg 109 $/kgc 
β-thymidine  target cost of 
productiona 
87.5 $/kg 86.4 $/kgd 
β-thymidine (market size)b 100 tpa - 
5-MU (commercial selling 
price) 
50 – 55 $/kg  
5-MU target cost of productiona 27.5 $/kg 25 $/kgd 
Note a: 50% of commercial selling price (including raw material cost and variable cost). 
Note b: Estimated market requirement of β-thymidine (100 tpa) for local production of AZT and d4T. 
Note c: Based on achieving optimized isolated yiled of β-thymidine at 90% 
Note d:Based on raw material cost of β-thymidine (excluding reactor costs)  
 
7.4 Biocatalysis 
 
A detailed discussion of various parameters used to benchmark biocatalytic processes was 
discussed in Chapter 3. The specific process criteria used to asses and benchmark this 
biocatalytic process and set up the process operating window will be discussed further. 
 
7.4.1 Performance criteria for the biocatalytic process 
 
In evaluating a biocatalytic process there are performance criteria relating to the biocatalyst 
itself, and to the process. The following criteria are important when determining, evaluating 
or optimizing a route for a process; product yield, biocatalyst productivity, biocatalyst 
stability and reactor productivity. 
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7.4.1.1 Yield 
The chemical yield of the product, calculated as shown in Equation 9 (repeated for 
convenience), is the most important parameter for determining the economics of the process. 
The product yield is inversely proportional to the amount of reactants required per unit of 
product output. Typically, key substrates and other raw materials make up more than 50% of 
the variable cost; therefore a high product yield is required in order to obtain an economically 
viable process.  
 
Equation 9 
ySelectivitxConversionYield =  
 
A product yield much lower than 100% is no longer economically and environmentally 
tolerable in the current market conditions. To define a threshold yield value is difficult, as the 
threshold value seems to correlate inversely with the unit product value of the product. In the 
case of commodity chemicals, chemical yields of 98 - 99% are essential, while in the case of 
fine chemicals, yields of 90 - 95% are acceptable. In the case of extreme performance 
pharmaceuticals, yields > 80% may still appear to be highly attractive, however yields as low 
as 50% have also been encountered. 
 
An acceptable yield also depends on the number of process steps, including isolation, as 
defined by Equation 10 (repeated for convenience). 
 
Equation 10 
n
stepsoverall YieldYield )(=  
 
where n is the number of process steps.  
 
Guanosine conversions above 90% were typically achieved and thus were not a limiting factor 
in the process. However, 5-MU yields as low as 30% were initially obtained. Subsequent 
improvements in the process showed optimized 5-MU reaction yields between 80 – 90%. The 
isolation and purification of the product was demonstrated (see Section 5.7) and the product 
yield over the DSP process (ex. biocatalytic process and isobutanol process) was 90%. Thus 
the overall isolated 5-MU yield obtained was between 72 – 81%. The product yields obtained 
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are superior to 5-MU yields of 74% (prior to carrying out product isolation) reported using 
Erwinia carotovora AJ-2992 micro-organisms29. 
 
The effect of product yield on the 5-MU raw material cost, shown in Figure 7.2 demonstrates 
the significant impact of decreasing the 5-MU raw material cost as the 5-MU yield increases. 
The current selling price of 5-MU is 50 - 55 $/kg is within the required benchmark with 
respect to the variable cost being at least 50% or lower. 
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Figure 7.2: Effect of 5-MU reaction yield on 5-MU raw material cost 
 
A low 5-MU yield of 30% increases the raw material cost of β-thymidine to 231 $/kg, clearly 
an uncompetitive process, therefore the improvement in the 5-MU yield was a pre-requisite 
for developing a cost competitive process to β-thymidine. 
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7.5 PNP and PyNP enzyme  
 
7.5.1 Biocatalyst stability 
 
Typically, where the purity of the biocatalyst is not known, as is the case for applied 
biocatalysis, the enzyme consumption number (e.c.n., see Equation 14, repeated for 
convenience) is used as an expression of biocatalyst stability. 
 
Equation 14 
productofkg
enzymeofg
generatedproductofamount
spentnpreparatioenzymeofamount
nce ==...  
 
The e.c.n. value is dependent on process parameters such as temperature, pH, and 
concentrations of substrate(s) and product(s) and the TTN (see Equation 15, repeated for 
convenience) may then be calculated as follows: 
 
Equation 15 
)/(.)../1000( productenzyme MWMWxnceTTN =  
 
The use of TTN in assessing the operational stability of an enzyme, suffers from the following 
limitation: the number of moles of biocatalyst is not a suitable reference for the complexity 
and cost associated with its manufacture. However based on the enzyme and product cost, the 
contribution of biocatalyst to the overall cost may be readily assessed. 
 
The threshold values for sufficient biocatalyst stability depend on the application, as does the 
value for product yield. However for any application in synthesis, the TTN should exceed 
10 000 and for large-scale processes, values > 1 000 000 are preferable40. 
 
7.5.2 Calculation of enzyme consumption number (e.c.n.) 
 
The enzyme purity used during the bench-scale biocatalytic process was not established. 
However, based on the enzyme specific activities (bench-scale) and optimum purity of 
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enzyme (lab-scale) an extrapolated enzyme purity at bench scale may be calculated (Table 
7.4). 
 
At lab-scale, we used PNP enzyme with specific activity of 26.28 U.mg-1 and at a purity of 
42%. Therefore, percent purity of PNP enzyme in the bench-scale biocatalytic reaction may 
be calculated as follows; 
 
Equation 29 
6.46)42/100()28.26/)14.5((% == xextractcrudeofActivitySpecificPurity  
 
The PyNP enzyme used at lab-scale had a specific activity of 30.69 U.mg-1 at 84% purity. 
Therefore, percent purity of PyNP enzyme in the bench-scale biocatalytic reaction may be 
calculated as follows; 
 
Equation 30 
6.16)84/100()69.30/)27.4((% == xextractcrudeofActivitySpecificPurity  
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Table 7.4: Enzyme characteristics 
Enzyme Specific 
activity  
(U.mg-1) 
Purity 
(%) 
Subunit 
size 
(kDa) 
Hexamer 
size (kDa) 
Enzyme 
mass added 
(g) 
PNP purified 
extract 
26.3 42 25 150  
PyNP (purified 
extract 
30.7 84 28 168  
PNP crude 
extracta 
5.14 46.6 25 150 3.11b 
PyNP crude 
extracta 
4.27 16.6 28 168 3.75b 
Note a: PNP and PyNP enzyme used during biocatalytic reaction 
Note b: The amount of PNP and PyNP enzyme used in the bench-scale reactions equates to 16 000 U per 
enzyme. 
 
The e.c.n. may then be calculated based on the following process performance with respect to 
guanosine conversion and 5-MU yield shown in Table 7.5. 
 
Table 7.5: Process parameters used to calculate e.c.n. 
Parameter  Guanine  Enzyme Enzyme mass (g) 
Guanosine 
conversion (%) 
90 - 
 
PNP 3.11 
Product mass 
(kg) 
- 0.5 - - 
MW  151.13   
5-MU yield 90 5-MU  Enzyme Enzyme mass (g) 
Product mass 
(kg) 
- 0.85 PyNP 3.75 
MW  258.23   
 
Assuming the PNP and PyNP enzyme preparations were 100% pure, the e.c.n. for the 
respective enzymes may be calculated as follows. 
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22.6
5.0
11.3
... ====
productofkg
enzymeofg
generatedproductofamount
spentnpreparatioenzymeofamount
ncePNP  
 
Based on a PNP purity of 46.6%, the amount of PNP enzyme used was 1.45g 
 
99.2
5.0
45.1
... ====
productofkg
enzymeofg
generatedproductofamount
spentnpreparatioenzymeofamount
ncePNP  
 
Similarly the PyNP e.c.n. was calculated at 100% and 16.6% respectively; 
 
41.4
85.0
75.3
... ====
productofkg
enzymeofg
generatedproductofamount
spentnpreparatioenzymeofamount
ncePyNP  
 
73.0
85.0
62.0
... ====
productofkg
enzymeofg
generatedproductofamount
spentnpreparatioenzymeofamount
ncePyNP  
 
The TTN range for each enzyme was then calculated based on the above e.c.n. ranges: 
 
)/(.)../1000( productenzyme MWMWxnceTTN =  
 
160000)13.151/150000()22.6/1000( == xTTN  100% pure PNP enzyme 
 
332000)13.151/150000()99.2/1000( == xTTN  46.6% pure PNP enzyme 
 
148000)23.258/168000()41.4/1000( == xTTN  100% pure PyNP enzyme 
 
891000)23.258/168000()73.0/1000( == xTTN  16.6% pure PyNP enzyme 
 
Based on the benchmark criteria, the TTN should be above 10 000 for synthesis applications 
and preferably above 1 000 000 for large scale processing. The TTN range for the PNP and 
PyNP enzymes were calculated to be between 160 000 – 332 000 and 148 000 – 891 000 
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respectively. The PNP and PyNP TTN’s obtained were significantly above the minimum 
bench mark threshold of 10 000 and at 33% and 89% respectively for the large scale 
manufacture processing. The TTN may be further improved by increasing the enzymes 
specific activity and purity; however this has to be weighed up against the increase in 
development costs. 
 
7.5.3 Enzyme form and source 
 
The development of the biocatalytic process may be limited due to the exorbitant cost of an 
enzyme preparation or lack of commercial availability. The advantage of sourcing a 
commercially available enzyme may be that the enzyme preparation is already in common use 
and the price has declined significantly, having a negligible effect on the process economics. 
The disadvantage however, is that the supplier may change the enzyme preparation process, 
discontinue enzyme production, or change the enzyme matrix, resulting in adverse effects on 
other biocatalytic processes. The alternative of developing a fermentation process to produce 
the desired enzymes at the required levels has advantages and disadvantages. The cost of 
developing the fermentation process requires a multi-disciplinary team of biochemists and 
fermentation specialists. Depending on the enzyme, the process development may be lengthy 
and expensive; however the source of the enzyme and enzyme quality may be controlled in-
house, thus reducing the dependence on external suppliers and risk to the process. The 
enzyme quality may also be improved with time, resulting in process improvements. The 
enzyme may also be licensed out to generate additional income. 
 
The enzymes catalytic characteristics, cost and availability are key process parameters in the 
commercial development of a viable biocatalytic process. Since deficiencies in enzyme 
performance with respect to (thermal, pH and specific activity), prohibitive costs and lack of 
availability may result in non commercialization of the process as the biotransformation 
development process will limited and not commercialized. The form in which the enzyme is 
used is also dependent on the intended application. For example, whole cells versus crude 
purified extracts, or immobilized enzyme which may be recovered and recycled. The 
advantages and disadvantages of the different enzyme forms have been well documented. For 
example, the use of whole cells are relatively more cost effective than carrying out the crude 
enzyme extract purification, however the reproducibility and robustness of the process is 
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improved using the purified crude enzyme extracts. The decision to immobilize the enzyme 
may be related to the cost of the enzyme, requiring that the enzyme be recovered and recycled 
for use in multiple batches. However, the additional cost contribution associated with enzyme 
immobilisation has to be evaluated to determine if any advantage in the process was gained. 
For example, the immobilized enzyme may be recoverable, but due to mass transfer 
limitations, result in lower reactor productivities and increased batch times. 
 
7.5.4 Activity 
 
Specific activity and volumetric activity are used to assess the quality of a catalyst. The 
parameters may be defined as follows; 
 
Specific activity = 1 U. mg protein-1 
Volumetric productivity = 1 U.mL-1 
 
A typical threshold for a useful biocatalyst is 1 U.mg protein-1; however the threshold value 
for a biocatalyst being developed at pilot-plant scale lies much higher at 100 U.mg-1 protein. 
Specific activity may be improved by optimization of the reaction conditions and purification 
process. 
 
Typically, PNP specific activity ranged between 0.659 to 5.27 U.mg-1 and no adverse effect 
on the reaction conditions was observed with guanosine conversions of > 90%. This may also 
be attributed to the non-reversibility of the reaction due to the low solubility of the guanine 
product. However, the PyNP specific activity varied between 0.2 - 4.27 U.mg-1 and this had a 
significant adverse effect on the reaction performance and process operating conditions; 
 
- The 5-MU yield decreased from 90% to 50 – 60% 
- Lower 5-MU yields (60% versus 80%) were obtained as the thymine to guanosine 
mole ratio was decreased from 2.3:1 to 1:1 using the lower quality PyNP enzyme. 
Subsequently it was found that using the improved PyNP enzyme (4.27 U.mg-1), lower 
thymine to guanosine mole ratios of 1.15:1 may be used without adversely affecting 
the 5-MU yield (80 – 90%). This also had a significant impact on simplifying the DSP 
process. 
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7.6 Reactor productivity 
 
Reactor productivity may be affected by numerous and interdependent variables, such as 
enzyme quality, enzyme concentration, reactor configuration, substrate concentration and 
solubility, and reaction temperature to name a few. The assessment of reactor productivity 
that is independent of catalyst is based on the space-time-yield (s.t.y., see Equation 16, 
repeated for convenience) 
 
Equation 16 
]..[]..[)/(... 1111 −−−−= hLgordLkgtimexvolumereactorgeneratedproductofmassyts  
Productivity bench mark criteria: 
 
Space-time yield (s.t.y.): > 0.1 kg.L-1.d-1 > 100 g.L-1.h-1. 
Productivity 15.5 g.L-1.h-1. 
Minimum thresholds for reactor productivity 100 g.-1L.-1.d-1 = 4 g.L-1.h-1 
Well developed processes threshold 500 g.-1L.-1.d-1 = 20 g.L-1.h-1 - 1000 g.-1L.-1.d-1 = 42 g.L-
1
.h-1 
 
The impact on the PyNP enzyme quality (0.2 U.mg-1) with respect to specific activity was 
significant as low product yields and increased thymine to guanosine mole ratio’s of 2.3:1 
were required. The effect of reactor configuration was complex due to the low solubility of 
substrates (< 1.5% m/m) resulting in a high solids loading (13 – 18%), mechanical stability of 
the enzyme and requirement to obtain a uniform slurry for sampling purposes. The previous 
parameters are all affected by the agitation rate and type of impeller used. An increase in s.t.y. 
in the same reactor is equivalent to an increase in reaction rate and may be affected by 
carrying out the following: 
 
- Increasing substrate concentration 
- Increasing enzyme concentration 
- An increase in reaction temperature 
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7.6.1 Substrate concentration 
 
Increasing the substrate concentration, results in a decrease in the size of the reactor and cost 
of production. This results in increased reactor productivity. The guanosine and thymine 
concentrations were initially increased from 1.5 – 13% m/m, the optimal biocatalytic 
concentration of guanosine and thymine was 9% m/m and 4.75% m/m respectively. The 
optimal conditions used a thymine to guanosine mole ratio of 1.15:1. Attempts to increase the 
guanosine and thymine concentration from 9% - 13% m/m, resulted in increased reaction 
times of 8 - 12 hours versus 24 hours. 
 
7.6.2 Enzyme concentration 
 
Limited studies were conducted at lab scale (see Sections 5.4.6 - 5.4.9) whereby the effect of 
enzyme loading was investigated. The results obtained showed that similar rates of reaction 
were obtained at 50% and 200% of the bench mark enzyme loading. In fact, lower 5-MU 
yields (60%) were obtained using the maximum enzyme loading of 200%. This was attributed 
to the effect of PyNP enzyme carrying out the reverse synthesis reaction, resulting in a lower 
5-MU yield. 
 
7.6.3 Temperature 
 
The biocatalytic reaction may be carried out at reaction temperatures between 40 -60°C, 
preferably at 60°C. The increased temperature may be used although the optimum PyNP 
enzyme activity is retained at 40oC. Attempts to increase the reaction temperature to 70°C 
resulted in thermal deactivation. At the outset, the lower reaction temperature of 40°C was 
used due to the limited thermal stability resulting in reactor productivities of 1.5 g.L-1.h-1. 
However, improvements in the fermentation process and enzyme quality, ensured that the cost 
contribution of enzymes (PNP and PyNP) to 5-MU raw material cost is 16% and less than 5% 
to β-thymidine production. Thus, increased levels of enzyme may be added without affecting 
the raw material cost of β-thymidine significantly, to compensate for loss of activity due to 
thermal degradation. The effect of reaction temperature in increasing the solubility of reagents 
available for reaction and increases in the kinetic rate of reaction due to Arrhenius behaviour 
are responsible for the increase in reactor productivity. The rate of substrate dissolution was 
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not considered to be a limiting factor as equilibrium concentrations were reached relatively 
rapidly. It was reported that limits in reactor productivity may be reached due to limits in the 
solubility of substrates. 
 
Based on the low solubility of substrates and low enzyme thermal stability above 60oC, it is 
believed that there is limited scope for improving the reactor productivity based on the high 
solids loading (13%) and current enzyme characteristics. The use of co-solvents, varying the 
pH and surfactants to improve substrate solubility did not have an impact on increasing the 5-
MU yield.  
 
Based on the optimized process, a reactor productivity of 10 g.L-1.h-1 was obtained at lab scale 
and 7 g.L-1.h-1 at bench-scale. The effect of reactor productivity on the 5-MU variable cost is 
shown in Figure 7.3 
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Figure 7.3: Effect of reactor productivity on biocatalytic reactor size 
 
7.7 Process parameters (Commercial constraints) 
 
β-thymidine which may be readily prepared from 5-MU, may itself be prepared from natural 
sources such as salmon milt (although unsustainable) and by fermentation processes 
(uneconomical due to low yields). The preparation of β-thymidine via chemical routes is also 
not viable due to extensive protection/deprotection strategies required and low yields, which 
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contributes to the high β-thymidine selling price. Owing to these limitations, we have 
developed a superior chemo-enzymatic process, producing β-thymidine, a key intermediate in 
the preparation of d4T and AZT. 
 
7.7.1 Market size and requirements and selling price 
 
The initial focus of the investigation was to develop a process to produce 5-MU, which could 
be chemically transformed to produce stavudine. However based on the selling price of 5-MU 
(55 $/kg) it was considered that subsequent chemical transformation of 5-MU into β-
thymidine would add further economic value to the process. At the outset of the project in 
2005, a β-thymidine target price of production at 175 $/kg was considered to be cost 
competitive. However, in the current market conditions the β-thymidine selling price has 
declined significantly to 100$/kg. Within this context the process economics has been 
evaluated. 
 
The techno economics is based on the local requirements for AZT and d4T which would 
require 100 tpa of β-thymidine. 
 
7.8 Raw Material Cost of β-Thymidine Production 
 
The raw material cost of β-thymidine production comprises of the fermentation, biocatalysis 
and chemical transformations costs. A detailed costing of the fermentation process is not 
reported here, only the final cost of production of PNP and PyNP are shown in Table 7.6. 
 
7.8.1 Enzyme production costs 
 
Table 7.6: PNP and PyNP raw material cost 
Enzyme Fermenter Yield 
(U/L) 
Media Cost  
($/L) 
Enzyme Cost  
($/U) 
PNP 26 156 0.50 0.00011 
PyNP 42 396 0.50 0.000070 
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The enzyme production and optimization was carried out by Mr D F Visser and is reported 
elsewhere105. However, a comment on the in-house preparation and significant improvements 
in the enzyme production process is warranted. It was mentioned earlier that one of the 
significant limitations in developing a biocatalytic process was linked to obtaining a cost 
effect and commercially available enzyme of the required enzyme quality. This process was 
successful due to the significant improvement in in-house enzyme production, which 
consistently afforded enzyme with a high specific activity. As discussed above, the total cost 
contribution of enzymes (PNP and PyNP) to 5-MU raw material cost is 16% and less than 5% 
to β-thymidine production, well within the limits of recommended bench marks of 10% of the 
raw material cost106. 
 
7.8.2 Process assumptions 
 
The economic model is based on the following assumptions: 
 
 Total β-Thymidine production 100 tpa 
 Operating Days   300 d 
 Operating Time/d   24 h.day-1 
 Operating Time/a   7200 h.annum-1 
 Throughput    13.9 kg thymidine.h-1 
 Fermenter cost   2500 $.m-3.d-1 
 Reactor cost    1000 $.m-3.d-1 
 
7.8.3 Mass Balance 
 
Based on β-thymidine production of 100 tpa, in a plant size as discussed above, the following 
throughputs and mass balances would apply (see Figure 7.4, Table 7.7and Table 7.8): 
 
C D E
A
B F
Enzyme Production
     
 Biocatalysis        DABT      DAT
    
 Thymidine
 
Figure 7.4: Mass balance flow diagram/process flow sheet 
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Table 7.7: Required throughputs for β-thymidine production of 100 tpa 
Mass Flow (kg/h) 
Stream 
PNP (U/h) PyNP (U/h) GS 5-MU DABT DAT Thymidine 
A 690 005 690 005           
B     43         
C       31       
D         39     
E           26   
F             14 
 
Table 7.8: Mass balance for β-thymidine production of 100 tpa 
Mass Flow (Tpa) 
Stream 
PNP PyNP GS 5-MU DABT DAT Thymidine 
A 4 968 036 4 968 036           
B     311         
C       226       
D         277     
E           190   
F             100 
7.9 Yields, Usages and Productivities 
 
7.9.1 Single Year Techno Economic Model for the production of β-Thymidine 
 
The process targets achieved for the fermentation, biocatalysis and chemical transformations 
used in the techno-economic model are reported in Table 7.9. 
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Table 7.9: Yields, usages and productivities applied to the single year economic model 
Component Value Unit 
Fermentation   
PyNP Enzyme Concentration 42 396 U.L-1 
PNP Enzyme Concentration 26 156 U.L-1 
PyNP Fermenter Productivity 5 512 U.L-1.h-1 
PNP Fermenter Productivity 3 010 U.L-1.h-1 
Biocatalysis   
PyNP Enzyme Usage 16 000 U.kg guanosine-1 
PNP Enzyme Usage 16 000 U.kg guanosine-1 
5-MU 0.80 Mol.mol guanosine-1 
Guanine 0.90 Mol.mol guanosine-1 
Reactor Productivity 7 5-MU kg.m-3.h-1 
DABT Production   
DABT Yield 0.78 Mol.mol 5-MU-1 
Acetonitrile Recycle 90 % 
Reactor Productivity 27.1 DABT kg.m-3.h-1 
DAT Production   
DAT Yield 0.85 Mol.mol DABT-1 
Methanol Recycle 95 % 
Reactor Productivity 73 DAT kg.m-3.h-1 
β-Thymidine Production   
Thymidine Yield (Not Recovered) 1.0 Mol.mol DAT-1 
Guanine Recovery 1.0 Mol.mol guanine-1 
Thymidine Recovery 0.71 Mol.mol thymidine-1 
Thymidine Yield 0.71 Mol.mol DAT-1 
Reactor Productivity 120 Thymidine kg.m-3.h-1 
Isolated Yield (from 5-MU) 47% mol Thy/mol 5-MU 
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7.9.2 Plant Size 
 
The required plant and reactor sizes (based on yields and throughput requirements) would be: 
 
- Total Plant Size  18 m3 
- Fermenter    0.35 m3 
- Biocatalysis reactor   4.5 m3 
- DABT reactor   8.2 m3 
- DAT reactor   2.8 m3 
- Thymidine reactor  1.85 m3 
 
7.9.3 5-Methyluridine production 
 
Table 7.10: 5-MU raw material cost 
Component 
Cost  
($/kg) 
kmol 
Weight 
Usage 
(kmol/kmol 5-
MU) 
Usage 
(kg/kmol 
5-MU) 
Contribution 
($/kg 5-MU) 
Guanosine 22.8 283.24 1.25 354.1 31.26 
Thymine 12.2 126.11 1.25 157.6 7.45 
Phosphate Buffer 0.2 114.55 1.89 216.0 0.17 
PyNP ($/U) 0.000070 16000   5 664 800 1.54 
PNP ($/U) 0.00011 16000    5 664 800 2.50 
Guanine 27.0 151.13 -1.13 -170.0 -17.78 
5-MU   258.23 1.00   25.14 
 
The total cost to manufacture 5-methyluridine is 31.1 $/kg (25.1 $ kg contribution based on 
the raw material cost and 6 $/kg contribution based on plant and operating costs) 
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5-MU may be prepared based on the optimized process in isolated yields of 80%. This 
variable cost equates to 50% of the commercial selling price of 50 - 55 $/kg. Typically, the 
cost of the enzymes should be below 10% of the total raw material costs, the PNP and PyNP 
enzymes contribute 16% to the raw material cost of 5-MU and less than 5% of the β-
thymidine raw material cost. The process benefits from obtaining a sale credit for the guanine 
by-product, which may be used to offset input raw material cost of guanosine and thymine. 
Based on the above process parameters, the development of an economically viable process to 
produce 5-MU has been demonstrated. 
 
7.9.4 Down stream processing 
 
Fine chemicals and API’s are typically produced in limited quantities (1 - 100 tpa) requiring 
that the DSP process should be straight forward. The current process requires filtration or 
centrifugation, distillation and crystallization, equipment typically available in multi purpose 
plants. Typically large costs are associated with the isolation of the product from dilute feed 
streams from bio-processes. Based on the current process, relatively high concentrations of 5-
MU (7 – 10% m/m) may be produced depending on the guanosine input concentration (9 – 
13% m/m, at 90% yield). Thus, isolation of the product is at concentrations comparable to 
chemical processes.  
 
7.9.5 Production of Thymidine from 5-methyluridine 
 
Table 7.11: DABT raw material cost 
Item 
Cost 
($/kg) 
Kmol 
MW 
Usage 
(kmol/kmol 
DABT) 
Usage 
(kg/kmol 
DABT) 
Contribution 
($/kg DABT) 
5-Methyluridine 31.1 258.23 1.28 331.1 25.4 
Acetyl Bromide 6.29 122.95 4.49 551.7 8.56 
Acetonitrile 2.00 41.05 9.36 384.2 1.90 
DABT   405.23 1.00   35.86 
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Table 7.12: DAT raw material cost 
Item 
Cost 
($/kg) 
kmol 
Weight 
Usage 
(kmol/kmol 
DAT) 
Usage 
(kg/kmol 
DAT) 
Contribution 
($/DAT) 
DABT 35.86 405.23 1.18 476.7 52.39 
Sodium Bicarbonate 0.46 84 1.10 92.4 0.13 
Hydrogen 0.25 2 1.18 2.4 0.00 
Methanol 0.25 32.04 6.71 214.9 0.16 
Raney Nickel Catalyst 30.00 58.71 0.60 35.2 3.24 
DAT   326.33 1.00   55.92 
 
Table 7.13: Thymidine raw material cost 
Item 
Cost 
($/kg) 
kmol 
Weight 
Usage 
(kmol/kmol 
Thy) 
Usage 
(kg/kmol 
Thy) 
Contribution 
($/kg Thy) 
DAT 55.92 326.33 1.41 459.6 106.11 
Methanol 0.25 32.04   0.0 0.00 
Sodium methoxide 1.49 54.02 4.23 228.3 1.40 
Thymidine   242.23 1.00   107.51 
 
The experimental results obtained showed a crude isolated DABT yield of 80%, although 
lower than the 97% claimed in literature97 and lower than the target DABT yield of 90%. The 
impact was mitigated by the almost quantitative reaction yields of DAT and β-thymidine 
(80%, lab-scale, 90% bench-scale). 
 
The raw material cost of β-thymidine is 107.5 $/kg (see Table 7.13) and the contribution of 
each of the intermediates DABT and DAT shown in Table 7.11 and Table 7.12. The 
contribution of plant and operating costs is 29 $/kg Therefore the total cost of β-thymidine 
production is 136 $/kg.. The current limit of the process is the relatively low recovery of 
thymidine from the process at 70%. Based on the solubility curve profiles, it is anticipated 
that this may be further optimized to 90%. The raw material cost of thymidine production 
may therefore drop to 109 $/kg (raw material costs and plant operating costs included) from 
136 $/kg. 
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7.9.6 Techno-economic Evaluation 
 
Summarized below is a list (Table 7.14) of the individual cost contribution of components to 
the thymidine raw material cost. The major cost contributor being the guanosine raw material 
used in the biocatalytic reaction. The offset credit of guanine sales offers a significant 
improvement in the overall raw material cost of β-thymidine. Acetyl bromide represents a 
significant cost contribution at 17%, with limited scope of reducing this further as 3.5 mole 
equivalents are currently used in the process and a minimum of 3 mole equivalents are 
required. It was subsequently reported that an alternative process using hydrogen bromide and 
trimethyl ortho formate may be used to prepare DABT in high yields of 90%. A preliminary 
raw material costing should be conducted to compare the alternative trimethyl ortho formate 
process. 
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Table 7.14: Cost contribution of raw materials to final cost of thymidine 
Raw Material 
Requirement 
per annum 
Price 
($/kg) 
Contribution 
($/kg Thy) 
% 
Guanosine 311 Tpa 22.8 70.8 52% 
Thymine 138 Tpa 12.2 16.9 12% 
Phosphate Buffer 189 Tpa 0.2 0.4 0% 
Guanine (output) -149 Tpa 27.0 -40.3 -29% 
Acetyl Bromide 377 Tpa 6.3 23.7 17% 
Acetonitrile 263 Tpa 2.0 5.3 4% 
Sodium Bicarbonate 54 Tpa 0.5 0.2 0.18% 
Hydrogen 1 Tpa 0.3 0.0 0.003% 
Methanol 125 Tpa 0.3 0.3 0.23% 
Raney Nickel Catalyst 20 Tpa 30.0 6.1 5% 
Sodium Methoxide 94 Tpa 1.5 1.4 1% 
Ampillicin 0.031 Tpa 64 0.0 0.01% 
IPTG 0.038 Tpa 1 750 0.7 0.49% 
Trace Element Solution 1.5 Tpa 5 0.1 0.06% 
Yeast Extract 9.2 Tpa 3 0.2 0.18% 
Glucose 10.0 Tpa 2 0.2 0.11% 
NH4NO3 1.5 Tpa 11 0.2 0.13% 
K2HPO4 4.5 Tpa 2 0.1 0.05% 
(NH4)2SO4 0.6 Tpa 1 0.0 0.004% 
Na2HPO4 1.1 Tpa 2 0.0 0.01% 
Citric Acid 0.8 Tpa 1 0.0 0.01% 
MgSO4 0.369 Tpa 2 0.0 0.01% 
   Total 86.4 63% 
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7.10 Conclusion107 
 
This thesis describes the successful development of a chemo-enzymatic process to bench 
scale (10 – 20 L), producing 5-methyluridine (5-MU) in high reaction yields of up to 90% and 
subsequent chemical transformation of 5-MU into β-thymidine at 72% yield based on 5-MU, 
prior to isolation. Currently the process suffers from the low isolated yield of β-thymidine 
(70%). Based on β-thymidine solubility data in methanol and water, it is probable that the 
isolated yield may be increased to 90%. This is vastly superior to the β-thymidine yields 
reported by chemical means of 30% before isolation34 and alternative fermentation 
bioprocesses (7 g.L-1, final product concentration). The low yields and isolation from dilute 
feed streams contribute significantly to the cost of production. 
 
To conclude, the development of the chemo-enzymatic process was a complex and 
challenging process due to the technical and commercial constraints. A discussion follows on 
some of the challenges encountered and how these were circumvented. 
 
Due to the solubility of guanosine and thymine at the optimum reaction temperature (60oC) 
being less than 1% m/m (see Figure 7.5) and the requirement to achieve a reactor productivity 
of at least 7 – 10 g.L-1.h-1, the biocatalytic reaction was carried out under solid-liquid slurry 
conditions. 
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Figure 7.5: Thymine, Guanine, Guanosine and 5-MU solubility in phosphate buffer 
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The enzyme systems limited thermal stability above 60oC, prevented further increases in 
reaction temperature to aid substrate solubility. 
 
It was found that the reactor productivity was enhanced by increasing the guanosine (9 - 13% 
m/m) and thymine (4.5 - 6.5% m/m) concentration and carrying out the reaction at 60oC. 
However, due to the low substrate solubility this increased the solid liquid loading to between 
13 – 20%. The mixing requirements of the system were mild agitation conditions to minimize 
mechanical enzyme denaturation due to the high particulate concentration present in the 
system, while at the same time maintaining a uniform suspension to ensure that the reaction 
was carried out under optimal solid-liquid mass transfer conditions, and that accurate and 
precise analytical data was obtained during the sampling of the solid-liquid slurry. Therefore, 
a compromise in the agitation rate (affected by the reactor configuration) was required to 
ensure that a uniform suspension was achieved resulting in reliable analytical sampling and 
data, while ensuring the enzyme system was not denatured due to excessive agitation or due 
to the high particulate concentration in the reaction medium system. The use of a hydrofoil 
impeller (Lightnin A-310, excellent for solid-liquid mixing and exhibiting low shear 
characteristics), and using a baffled reactor at lab-scale and anchor stirrer or retreat blade 
curve at bench-scale were the most suitable types of agitators used.  
 
The difficulty associated with the down stream process was highlighted due to the relatively 
low solubility of the substrates, and the relatively high solubility of the 5-MU product in the 
aqueous medium. The isolation of the intermediate product guanine was relatively facile due 
to its low solubility (at parts per million at 80oC) in the reaction medium. An increase in the 
substrate concentration also had a significant impact on the amount of material to be 
processed to isolate a particular amount of 5-MU product (1.5% m/m, 10 g/L; 9% m/m, 70 
g/L – 13% m/m, 100 g/L) thus further reducing the cost of 5-MU production.  
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Figure 7.6: Process operating parameters (Temperature, pH and substrate 
concentration 
 
A summary of the process operating window with respect to the enzyme characteristics and 
process operating window is shown in Figure 7.6. A key to the success of the biocatalytic 
process was the improvement in the PNP (5.14 U.mg-1) and PyNP (4.27 U.mg-1) enzyme 
quality with respect to specific activity, which facilitated the decrease in thymine to guanosine 
mole ratio from 2.3:1 to 1.15:1. This had a significant effect on improving the reaction 
performance (lowering the effective solids loading from 26 – 20%) and improvement in the 
DSP process (removing the need to recover or recycle the excess thymine). In addition to this, 
the optimization of the PNP and PyNP enzyme production process resulted in a cost 
contribution to 5-MU of 16%, and a negligible contribution to the final β-thymidine cost of 
production (< 5%). This lower enzyme production cost, allowed for increases in enzyme 
loading, without adversely affecting the process economics. Consequently, operating the 
biocatalytic reaction at 60oC, above the optimal PyNP temperature of 40oC, the rate of PyNP 
enzyme thermal deactivation did not have an adverse effect on the rate of 5-MU product 
formation. 
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Figure 7.7: Process operating parameters (GS conv. /5-MU yield, productivity and 
substrate concentration 
 
7.10.1 Development of a chemo-enzymatic process 
 
The key to developing a chemo-enzymatic process successfully is the development of a model 
based on technical and commercial constraints of the process. The setting up of such a model 
assists with the identification of the most important variables, and determining the extent of 
impact on the overall viability of the process. In terms of commercial constraints, market size 
and commercial selling price should be ascertained as accurately as possible. This allows for 
identification of possible threats to the commercial viability of the process. 
 
With respect to the technical constraints of the process, an operating process window must be 
set up and used to identify the most important variables such as temperature, pH and substrate 
concentration range, and their impact on reaction performance (substrate conversion, product 
yield and reactor productivity. A key feature of this process was the cost efficient “in-house” 
PNP and PyNP enzyme system, and preparation of sufficient quantities of enzyme material to 
validate the process. It has been reported that a challenge to developing a biocatalytic process 
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includes access to inexpensive, bulk quantities of commercially available enzyme to develop 
the process. The “in-house” enzyme development also allowed for chemo-enzymatic process 
development to continue in parallel while improvements in enzyme quality were being made, 
thus reducing overall development time. 
 
Small scale screening (2 ml) allowed for rapid screening of process variables using limited 
amounts of materials which may not be available at the outset of the process. 
 
The integration of the biocatalytic and chemical processes was also important, ensuring that 
the material produced in the biocatalytic reaction did not adversely effect the subsequent 
chemical transformations. Synthetic studies were conducted approximating the composition 
of the reaction mixture to evaluate different DSP options and use test material in subsequent 
chemical transformations. The DSP studies were then validated using material produced 
during the biocatalytic reaction. 
 
The above process was underpinned by access to accurate analytical methods which allowed 
for quantification of the process and setting specification of the final product. During the 
course of the development process the technical and commercial constraints were regularly 
revisited to ensure no significant changes occurred which would have had an overall impact 
on process viability. This allowed the model to be updated regularly and iteratively to identify 
the impact of the latest optimized parameters on the processes viability. 
 
The key to the commercial viability of the β-thymidine process was optimisation of the 
biocatalytic process; a summary of the key performance parameters is shown in Figure 7.7. 
This resulted in the development of a cost competitive process where we can produce β-
thymidine at 109 $/kg (80% isolated yield). A recent request (11 November 2008) for a 
100 kg purchase of β-thymidine from a commercial Chinese supplier108 reported a β-
thymidine cost of 221 $/kg. Typically, a bench mark of a commercially viable process is that 
the raw material cost should be approximately 50% of the commercial selling price. Thus the 
setting of a cost of manufacture of 100 $/kg for β-thymidine was used in the techno economic 
model to drive the development of the process. Based on this information, the current chemo-
enzymatic process to produce β-thymidine at 109 $/kg is far superior to conventional 
chemical and bioprocess technologies used to manufacture β-thymidine The improvement in 
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β-thymidine yield and cost of production may be passed on to further reduce the cost of anti-
retroviral manufacture of stavudine and AZT, thus reducing the cost of HIV/AIDS treatment 
and resulting in broader public access. 
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8 Appendix 
 
8.1 General method small scale (2 mL) 
 
Guanosine (0.030 g, 0.106 mmol and 1.5% m/m), thymine (0.031 g, 0.246 mmol and 1.5% 
m/m) and sodium phosphate buffer (50 mM, 0.6% m/m, pH 7.5 - 8.0, and 1.8 mL) were 
charged to a sample vial (5 mL). Stock solutions of PNP and PyNP enzymes were prepared 
using phosphate buffer and the required aliquots of PNP (30 - 200 µL) and PyNP (30 - 200 
µL) were added to the solution. The PNP/PyNP enzyme ratio was maintained at 1:1 and at 0.1 
U/enzyme loading. 
 
The reaction mixture was stirred using a stirrer bar and heated to the required temperature (40 
- 60oC). The reaction was typically carried out over 24 hours and then worked up, using 10M 
sodium hydroxide solution. The reaction mixture was then quantitatively analysed by HPLC 
for guanosine, guanine, thymine and 5-methyluridine. In cases where the substrate 
concentration was increased from 1.5 - 9% m/m using the fed batch mode of operation, 
thymine and guanosine were added after 24 - 48 hour intervals and reaction times were also 
increased to 260 hours. 
 
The main objectives of carrying out the small scale screening experiments were to investigate 
the operational parameters under which the biocatalytic reaction could be carried out. The 
variation in experimental parameters used during the screening experiments is discussed in 
Chapter 4. 
 
8.2 Lab scale experiments (0.1 - 1.5 L) 
 
Guanosine (107 g, 0.37 mol and 9.20% m/m), thymine (55 g, 0.44 mol and 4.72% m/m) and 
sodium phosphate buffer (1003 g, 50 mM, 0.60% m/m, pH 7.5-8.0) were charged to a 2 L 
round bottom flask equipped with a condenser and thermometer. The reaction mixture was 
heated to 60oC and stirred at 1000 rpm for 1 hour. The reaction mixture was sampled (in 
duplicate) prior to enzyme addition. The required amount of PNP (2000 U) and PyNP (2000 
U) were then added to the reaction mixture and stirred for 24 hours. During the course of the 
reaction, samples were taken (in duplicate) for quantitative analysis of guanosine, guanine, 
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thymine and 5-methyluridine by HPLC. During the lab-scale studies, the effects of the 
operational parameters on the rate of the biocatalytic reaction and scale up of the biocatalytic 
reaction were evaluated. The variation in experimental parameters used during the 
optimization process is discussed in Chapter 4. 
 
8.3 Bench-scale process 
 
8.3.1 Charging the reactor (CR-16) 
 
8.3.1.1 Substrate preparation 
Guanosine (1040 g, 3.67 mol, and 9.3% m/m) and phosphate buffer solution (3300 g, 50 mM, 
and pH 7.5) were charged to the CR-16 reactor while stirring at 100 rpm (anchor stirrer). 
Thymine (535 g, 4.24 mol and 4.8% m/m) and phosphate buffer (1000 g, 50 mM, and 0.60% 
m/m) were pre-mixed to form a paste. The substrates were quantitatively transferred to the 
reactor using the remaining phosphate buffer (5000 g, 50 mM, and pH 7.5). The reactor was 
then heated to 60oC, while stirring. A portion of phosphate buffer (300 g, 50 mM, pH 7.5) was 
retained and used to dissolve and quantitatively transfer the PNP and PyNP enzymes to the 
reactor. The total amount of phosphate buffer added was 9600 g. 
 
8.3.2 Enzyme preparation 
 
The required amount of PNP (3.114 g, 16005 U, specific activity 5.14 U.mg-1) and PyNP 
(3.758 g, 16047 U, specific activity 4.27 U.mg-1) were then dissolved in 100 mL phosphate 
buffer and the reaction mixture sampled (in triplicate, 1 - 3 g) prior to adding the enzyme 
solutions to the reaction mixture. The PNP and PyNP were stored at 4oC, when not in use. 
 
8.3.3 Biocatalytic reaction 
 
The reaction mixture was maintained at 60oC, while stirring at 100 rpm and then sampled at 
hourly intervals over the course of the reaction (24 hours). The reaction was maintained under 
the above conditions until complete. The down stream processing (DSP) was then carried out 
(see Sections 5.7 and 8.4). 
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8.3.4 Sample preparation 
 
The slurry samples were dissolved using a few drops of concentrated 10 M sodium hydroxide 
solution and then diluted to the required volume using deionised water. The samples were 
analyzed by HPLC for guanosine, guanine, thymine and 5-methyluridine. 
 
8.4 Down stream processing  
 
8.4.1 Biocatalytic reaction 
 
The DSP process used to isolate and recover guanine and crude 5-MU is shown in Figure 8.1. 
 
8.4.2 Isolation and recovery of guanine 
 
The hot reaction mixture was centrifuged at 80oC, using a basket centrifuge (10 µm mesh 
filter cloth, 1000 rpm, 30 minutes). The filter cake was washed or reslurried in hot deionised 
water (90oC, 2 - 5 L) and dried further using the 10 µm mesh filter cloth at 1500 rpm for 20 
minutes. The “wet” filter-cake was initially air dried overnight in a fume-cupboard and then 
dried further in a vacuum oven at 55oC for the required time. The drying time was dependent 
on the drying equipment used (centrifuge and vacuum oven) and the final commercial guanine 
product specification with respect to water content. The optimum drying time was determined 
by conducting loss on drying tests or carrying out Karl-Fischer analysis for water content on 
the filter-cake. 
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Biocatalytic reaction
60oC,8 -12 hours
Hot centrifugation (80oC)
wet crude 5-MU solids
Cold filter-cake ex. reaction
wet crude 5-MU solids, inorganic
salts
Crude 5-MU
crystallization
80 - 30oC, 4 hours
30 - 4oC, 2 hours
4oC, 24 - 48 hours
 
Cold filtration (4oC)
Water removal (60 - 80 oC,
vacuum, 8 -10 hours)
Vacuum oven drying, 55 oC
Vacuum oven drying, 55 oC
Vacuum oven drying, 55 oC
Isobutanol DSP
Isobutanol DSP
Crude guanine FC
 
Figure 8.1: Isolation and recovery of guanine and crude 5-methyluridine 
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8.4.3 Isolation and recovery of crude 5-MU 
 
Crude 5-MU was isolated from two different process streams as shown in Figure 8.1 and was 
then purified using an isobutanol process as shown in Figure 8.2. 
 
The crude 5-MU was isolated by allowing the filtrate (ex hot centrifugation) to cool down 
from 80 to 30oC over 4 hours followed by 30 to 4oC over 2 hours. The reaction mixture was 
and then maintained at 4oC for 24 - 48 hours. During the cooling process, the solution was 
stirred at 200 - 300 rpm using an anchor stirrer. The 5-MU crystallized out of solution and 
was recovered by conducting a cold filtration at 4oC. The filter-cake was placed in a fume 
cupboard, air dried overnight and then dried further in a vacuum oven at 55oC for the required 
time. The drying time was dependent on the drying equipment used (centrifuge and vacuum 
oven). The optimum drying time may be determined by loss on drying or carrying out Karl-
Fischer analysis on the filter cake. 
 
The second crop of crude 5-MU was recovered from the filtrate after water removal using a 
Büchi evaporator by gradually heating at 60-80oC for 8 - 10 hours. The crude 5-MU solid 
recovered was dried in the vacuum oven prior to carrying out the isobutanol purification 
procedure. 
 
8.4.4 Hot isobutanol filtration 
 
The crude filter cake was analysed for 5-MU and water content. Based on the solubility of 5-
MU in isobutanol at reflux (3 g 5-MU per 100 g solvent at 105oC) the required amounts of 
crude filter-cake and isobutanol were charged to the GR-15 reactor. The reaction mixture was 
then heated to reflux while stirring for 2-3 hours and then filtered hot to remove inorganic 
salts (phosphate) and organics such as thymine. 
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thymine,guanosine, guanine, 5-MU
and inorganic salts solids
Hot filter-cake ex. IBA
enriched 5-MU residue
Cold filter cake ex. IBA
iso-butanol (IBA)
Dry crude 5-MU
vacuum oven drying, 55 oC
90oC, 2-3 hours
Hot iso-butanol filtration
5-MU crystallization
80 - 30oC,  4 hours
30 - 4oC, 2 hours
4oC, 24 - 72 hours
 
Cold iso-butanol filtration
4oC
Solvent strip
60 - 80oC, 8 - 10 hours
enriched 5-MU residue
vacuum oven drying, 55 oC
 
 
Figure 8.2: Purification of 5-MU using isobutanol (IBA) 
 
8.4.5 5-MU crystallization 
 
The water content present in the filter-cake must be less than 5% m/m, as high levels of water 
result in low 5-MU recoveries. The crude 5-MU was isolated by allowing the filtrate (ex hot 
filtration) to cool down from 80 to 30oC over 4 hours followed by 30 to 4oC over 2 hours. The 
reaction mixture was and then maintained at 4oC for 24 - 72 hours. The purified 5-MU was 
recovered by conducting a cold filtration at 4oC. The solvent was then removed from the 
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filtrate and a second crop of 5-MU recovered. Both streams of crude 5-MU purified using the 
isobutanol procedure. 
 
8.4.6 5-MU product specification 
 
β-thymidine is synthesized out over 3 chemical steps, the first being the preparation of 3',5'- 
di-O-acetyl-2'-bromo-thymidine (DABT) from 5-MU using acetyl bromide. Therefore the 5-
MU prepared in the biocatalytic reaction and used in the subsequent β-thymindine preparation 
must be produced to the following in-house specification: 
 
- The 5-MU product must be dry i.e. free of solvent and moisture (< 5% m/m) since any 
water, or solvents such as alcohols, may react with acetyl bromide leading to lower 
DABT yields and possible by-product formation. 
- Complete removal of guanosine (<1% m/m) is required since guanosine, would 
undergo similar reactions to 5-methyluridine during the preparation of 3',5'- di-O-
acetyl-2'-bromo-thymidine (DABT).  
- Complete removal of thymine is required since it is difficult to separate thymine from 
β-thymidine without additional DSP process steps (water crystallization). However, 
thymine removal may also be conducted during the DABT DSP process where a water 
wash is used to remove hydrobromic acid. This process may only be used at low 
thymine concentrations (0.2% m/m). 
 
8.5 Lab-scale preparation 
 
8.5.1 Preparation of β-thymidine from 5-methyluridine 
 
8.5.1.1 Preparation of 3',5'-di-O-acetyl-2'-bromothymidine (DABT) 
5-Methyluridine (9.91 g, 38.3 mmol, ex. NSTU chemicals) and acetonitrile (389.79g, ex. 
Labscan, HPLC grade) were charged to a 1 L round bottom flask, equipped with a condenser 
and thermometer. The reaction mixture slurry was stirred at 1250 rpm and heated to 77oC. 
Acetyl bromide (16.5g; 134 mmol, ex. Merck) was then charged to a dropping funnel and 
added drop-wise into the reaction mixture over 30 minutes. During the acetyl bromide 
addition, the reaction mixture became homogenous and was then sampled with time. The 
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reaction was carried out for 60 minutes, including acetyl bromide addition time. The samples 
were analyzed by HPLC and worked up in methanol; analysis was conducted as soon as 
possible since the sample degraded overnight. The reaction mixture was quantitatively 
analyzed for DABT, while the by-products 2',3',5'-tri-O-acetylthymidine (TAMU) and 3'-O-
acetyl-2',5'-dibromothymidine (ADBT) were qualitatively analyzed for based on Area % by 
HPLC. 
 
The reaction mixture was then worked up according to the following procedure. The reaction 
mixture was allowed to cool to room temperature (20-22oC) and methanol (4.79g, 149 mmol, 
ex. Saarchem) was charged to a dropping funnel and added drop-wise in order to quench any 
excess acetyl bromide. The reaction mixture was then poured into a beaker containing sodium 
bicarbonate (20g, ex. Saarchem, 10% m/m) in order to neutralize hydrobromic acid generated 
during the course of the reaction and methanol quench, filtered after stirring for 30 minutes 
and pH measured. The solvent was then removed under vacuum at 50 - 60oC and an organic 
residue (19.62 g) recovered. The residue was dissolved in dichloromethane (133 g, 100 ml ex. 
Radchem) and washed with water (2 x 100 ml) in order to remove salts. The aqueous and 
organic phases were partitioned and the organic phase dried using anhydrous magnesium 
sulphate, filtered to remove the hydrated magnesium sulphate, solids washed, and the solvent 
removed under vacuum at 50 - 60oC. Complete removal of solvent was not possible due to 
foaming at high vacuum (1 mbar). The recovered residue (15.39 g) was quantitatively 
analyzed for DABT by HPLC. 
 
An alternative DSP procedure was used at bench-scale, whereby after solvent removal, the 
organic residue was dissolved in dichloromethane (DCM 133 g, 100 ml), the organic phase 
was washed twice using saturated sodium chloride solution (20% m/m, 2 x 100 ml) in order to 
remove hydrobromic acid from the organic phase, this was conducted until the pH in the 
aqueous phase was 4 - 6). 
 
8.5.2 Preparation of 3',5'-di-O-acetyl-thymidine (DAT) 
 
Crude 3',5'-di-O-acetyl-2'-bromothymidine (DABT, purity ~ 80% m/m, 22.0 g, 43.4 mmol 
and 10% m/m), methanol (147 g, 186 ml), sodium bicarbonate (5.0 g, 59.5 mmol) and Nickel 
catalyst (A#5000, Batch no 61059, ~ 5g, 50% m/m, water) were charged to a Parr pressure 
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vessel (250 cm3). The reactor was primed using the following procedure: Evacuated, and 
pressurized to 4 bar (hydrogen), repeating the above procedure twice. The reactor was stirred 
at 700 rpm using a pitched blade impeller and heated to 40oC. The reactor was then 
pressurized to 9 bar using hydrogen gas and maintained at this pressure for (1.5-3 hours). The 
reaction mixture was sampled at hourly intervals, using the following protocol, the sample 
was filtered to remove catalyst and solid sodium bicarbonate using Celite and then diluted 
using methanol. The reaction mixture was quantitatively analyzed for DABT and DAT by 
HPLC. 
 
The reaction mixture was worked up using the following procedure: removal of catalyst and 
excess sodium bicarbonate by Celite filtration, followed by solvent stripping of the methanol 
using a Buchi evaporator (40-80oC) over 2-3 hours to ensure complete removal of solvent. 
The residue was then placed on a high vacuum pump (1 mbar) for at least 4 hours to remove 
residual solvent. The organic residue material was then dissolved in ethyl acetate (~200 cm3) 
and inorganic solids were observed to precipitate out of solution. The reaction mixture was 
dried using magnesium sulphate and the mixture filtered to remove solids. The ethyl acetate 
solvent was then removed using a Buchi evaporator (60 - 80oC) over 2 - 3 hours. 
 
8.5.3 Preparation of β-thymidine (dT) 
 
Crude 3',5'-di-O-acetyl-thymidine (80 - 90% m/m DAT, 1 g, 3.06 mmol and 20% m/m), 
methanol (5 ml, 3.95 g) and sodium methoxide (0.17 g, 3.22 mmol, ex. Sigma Aldrich) were 
charged to a round bottom flask equipped with a condenser and thermometer. The reaction 
mixture was heated to 40oC and stirred at 1000rpm for 1.5 - 3 hours. The reaction mixture was 
semi-quantitatively analyzed for DAT and dT by HPLC. 
 
The reaction mixture was then worked up according to the following procedure. The reaction 
mixture was neutralized using pre-treated Amberlite IR 120 A resin (30 - 50 g) to pH 4-6, and 
then filtered to remove the ion exchange resin. The resin was then washed with fresh 
methanol (200 ml). The filtrates were combined and the solvent removed using a Buchi 
evaporator (60 -80oC) over 2 - 3 hours. The recovered residue was 0.67 g. The crude 
thymidine residue was then re-crystallized from methanol. 
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8.5.4 Amberlite IR-120A, Resin preparation 
 
Resin (100 g) was placed in a glass column and washed with deionised water, until the pH 
was the same as the feed stream pH. The resin was then washed with methanol (~2L), and 
dried under vacuum to remove residual solvent. 
 
Amberlite IR-120 resin was prepared as follows prior to use. The required amount of resin 
(250 ml/250 g) was placed in a beaker and washed with ~ 2L of deionised water. The resin 
was then placed in a glass column (diameter, 50 mm, column length, 300 mm) and washed 
with water until neutral or pH was similar to feed water (ex deionised water unit). The resin 
was then washed with methanol until “dry” (free of water). The resin was then recovered and 
dried under vacuum at room temperature for 6-8 hours. 
 
8.6 Materials 
 
Materials used for syntheses, the source(s) of procurement and the respective grades, are 
listed in Table 8.1 and were used as received. 
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Table 8.1: Reagents used for synthesis 
Component Structure MM 
(g.mol-1) 
Cas No. Supplier Grade/Purity 
Guanosine 
O
HN
N N
N
OHOH
HO
H2N
O
 
283.24 118-00-3 Dayang 
Chemical 
98% m/m 
Thymine 
HN
N
H
O
O
 
126.11 65-71-4 
 
Dayang 
Chemical 
98% m/m 
di-sodium 
hydrogen 
phosphate 
Na2HPO4 141.96  Merck 98% m/m 
Sodium di-
hydrogen 
phosphate 
NaH2PO4   Merck 98% m/m 
Deionised water - - - - - 
5-Methyluridine 
O
OHOH
HO
HN
N
O
O
 
258.23 1463-10-
1 
Dayang 
Chemical 
98% m/m 
Acetyl Bromide 
H3C Br
O
 
122.95 506-96-7 
 
Sigma 
Aldrich 
98%,  
 
Acetonitrile CH3CN
 
41.05 75-05-8 Merck 98% 
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Component Structure MM 
(g.mol-1) 
Cas No. Supplier Grade/Purity 
3',5'-di-O-acetyl-
2'-
bromothymidine 
(DABT) 
 
O
BrOAc
AcO
HN
N
O
O
 
405.23 - Prepared 
in-house 
Crude  
80 - 100% 
m/m 
Dichloromethane CH2Cl2
 
84.93 75-09-2 Merck 98%  
Sodium chloride NaCl
 
58.44 7647-14-
5 
Merck 98% 
Methanol CH3OH
 
32.04 67-56-1 Merck 98%, 
Nickel catalyst Nickel A 5000 
Batch no 61059 
- - Johnson 
Matthey 
AMC 
corporation 
- 
3',5'-di-O-Acetyl-
thymidine (DAT) 
 
O
OAc
AcO
HN
N
O
O
 
326.3 - Prepared 
in-house 
Crude  
80-100% 
Ethyl acetate O
O
 
88.11 141-78-6 
 
Merck 98% 
 
Sodium 
methoxide 
NaOMe
 
54.02 124-41-4 Sigma 
Aldrich 
95% 
Thymidine (dT) 
 
O
OH
HO
HN
N
O
O
 
242.2 50-89-5 
 
- 98% 
Amberlite IR-120   37360- Sigma 98% 
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Component Structure MM 
(g.mol-1) 
Cas No. Supplier Grade/Purity 
Ion exchange 
resin 
75-1 
 
Aldrich  
 
 
8.6.1 Reagents for analysis 
 
The reagents used as standard materials for high pressure liquid chromatography and ion 
chromatography are listed in Table 8.2. 
 
Table 8.2: Reagents used for analysis 
Name Structure MM 
(g/mol) 
Cas No. Supplier Grade/Purity 
Guanine 
HN
N NH
N
H2N
O
 
326.3 - - Crude 
Guanosine 
O
OHOH
HN
N N
N
O
H2N HO
 
283.24 118-00-3 Sigma 
Aldrich 
98% m/m 
Thymine 
HN
N
H
O
O
 
126.11 65-71-4 
 
Dayang 
Chemical 
98% m/m 
Ribose-1-
phosphate 
cyclohexyl amine 
salt 
- 
 
428.46 58459-37-
3 
Sigma 
Aldrich 
99% 
Ribose - 150.13 50-69-1 Sigma 
Aldrich,  
98% m/m 
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Name Structure MM 
(g/mol) 
Cas No. Supplier Grade/Purity 
5-Methyluridine 
O
OHOH
HO
HN
N
O
O
 
258.23 1463-10-1 Sigma 
Aldrich 
99% m/m 
3',5'-di-O-Acetyl-
2'-
bromothymidine 
(DABT) 
 
O
BrOAc
AcO
HN
N
O
O
 
405.23 - - Crude 
3',5'-di-O-Acetyl-
thymidine (DAT) 
 
O
OAc
AcO
HN
N
O
O
 
326.3 - - Crude 
Thymidine (dT) 
 
O
OH
HO
HN
N
O
O
 
242.2 50-89-5 
 
- 98% 
 
 
8.7 Analytical techniques 
 
8.7.1 High Pressure Liquid Chromatography (HPLC) 
 
8.7.1.1 The determination of guanosine, guanine, thymine and 5-methyluridine by HPLC. 
Guanosine, guanine, thymine and 5-methyluridine were quantitatively analysed by HPLC, 
using a Waters Alliance Model 2609 instrument with a Synergi 4u Max-RP 150 x 4.6mm 
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column. Components were detected using a UV detector at 260 nm. Samples were prepared 
by dissolving the required amount of sample in sodium hydroxide (10 M, 0.5 – 1 mL) and 
then made up to the required volume so as to ensure the sample concentration was within the 
linear region of the calibration curve. A summary of the analytical conditions used is reported 
in Table 8.3. 
 
Table 8.3: Instrumental parameters used to analyse organic components  
Instrument Waters 2609 or equivalent 
Column  Synergi 4u Max-RP 150 x 4.6mm 
Flow rate 1 ml/min 
Eluent  Ammonium acetate, (NH4OAc 25mM)  pH 
4.00 
Detection wavelength UV at 260nm 
Injection volume 10µl 
Run Time 20 - 30 minutes 
Temperature ambient 
 
A typical chromatogram is shown in Figure 8.3. 
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Figure 8.3: Determination of guanosine, guanine, thymine and 5-MU by HPLC - Ion 
chromatography. 
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8.7.1.2 Determination of D-ribose 
In order to study the biocatalytic reaction in more detail with respect to the phosphorolysis 
reaction (see Scheme 8.1), an indirect method of ribose-1-phosphate (R-1-P) analysis was 
developed. 
 
O
OHOH
HN
N N
N
O
H2N HO +     PO4
3-
O
OHOH
HN
N NH
N
O
H2N
HO
OPO32-
+
guanosine (GS) guanine (GN) ribose-1-phosphate (R-1-P)
PNP
Water, buffer
 
 
Scheme 8.1: Phosphorolysis reaction of guanosine 
During the guanosine phosphorylation reaction, ribose-1-phosphate (R-1-P) and guanine are produced in 
equimolar amounts; therefore the amount of guanine detected was directly proportional to the amount of R-1-P 
produced. 
 
It was reported in the literature that numerous methods were available to analyze for R-1-P. 
However the methods were not convenient or the equipment was not available to carry out the 
direct method of analysis. In addition to this, due the high cost of the standard R-1-P 
cyclohexylamine salt (~$ 500/10 mg) this also precluded routine analysis of the product. 
 
The indirect method of R-1-P was based on the acidic decomposition of R-1-P to ribose and 
phosphate ion, using the following protocol to validate the analytical method109. 
 
The reaction mixture was sampled and the slurry filtered hot to remove organic solids. The 
sample was placed in a fridge at 4oC, and re-filtered to remove residual organic solids. The 
filtrate was then spilt into two equal portions and one treated with a known amount of 
hydrochloric acid (HCl, ~5% m/m, 100 µl). Both samples were analyzed by ion 
chromatography to determine the ribose content (see Figure 8.4). The product R-1-P was not 
detected using the ion chromatography method. 
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The results obtained for the determination of the amount of ribose showed an 86% correlation 
to the amount of guanine as determined by HPLC analysis. Ribose was analyzed by ion 
chromatography using the conditions summarized in Table 8.4. 
 
Table 8.4: Instrumental conditions used to determine ribose by ion chromatography 
Ion chromatograph Dionex GP40 pump fitted with a TSP AS 
3500 autosampler 
detector: Electrochemical Dionex ED40 
Data handling Dionex Peaknet software or equivalent 
Column Carbo Pac PA10, 4 x 250 mm 
Injection volume 10µl 
Run Time 10.0 minutes 
Temperature ambient 
 
 
Figure 8.4: Ribose detection by ion chromatography 
 
8.7.1.3 Determination of phosphate ions 
 
Phosphate ions were analyzed in the 5-MU filter-cakes by ion chromatography using the 
experimental conditions shown in Table 8.5. 
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Table 8.5: Instrumental conditions used to determine ribose by ion chromatography 
Ion chromatograph Dionex GP40 pump fitted with a TSP AS 
3500 auto-sampler 
Flow rate 1.0 ml.minute-1 
Detector: Suppressed conductivity,100µS/30µS 
Data handling Dionex Peaknet software or equivalent 
Eluent 3.5 mM Na2CO3 : 1.0 mM NaHCO3 
Injection volume 20 µl 
Run Time 14 minutes 
Temperature ambient 
 
A typical ion chromatograph is shown in Figure 8.5 
 
 
Figure 8.5: Analysis of phosphate ion by ion chromatography 
 
8.7.2 Semi-quantitative analysis of reaction intermediates 
 
Due to the lack of availability of analytical standards for 2',3',5'-tri-O-acetylthymidine (TAT) 
and 3'-O-Acetyl-2',5'-dibromothymidine (ADBT), formed during the preparation of β-
thymidine from 5-MU, TAT and ADBT were semi-quantitatively determined by means of 
Area % determination of their respective HPLC peaks (Table 8.6 -Table 8.8). 
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8.7.2.1 Preparation of 3',5'-di-O-acetyl-2'-bromothymidine (DABT) 
 
Table 8.6: Preparation of 3',5'-di-O-acetyl-2'-bromothymidine (DABT) 
Component Retention time (minutes) 
5-MU 5 
DABT 10 
TAT 9 
ADBT 12 
 
8.7.2.2 Preparation of 3',5'-di-O-Acetyl-thymidine (DAT) from 3',5'-di-O-Acetyl-2'-
bromothymidine (DABT) 
 
Table 8.7: Determination of DABT and DAT 
Component Retention time (minutes) 
DABT 10 
DAT 8 
 
8.7.2.3 Preparation of β-thymidine (dT) from3',5'-di-O-Acetyl-thymidine (DAT) 
 
Table 8.8: Determination of dT and DAT 
Component Retention time (minutes) 
DAT 8 
dT 6.5 
 
The analysis of organic components was carried out using a Waters 4.6mm x 250mm Waters 
spherisorb ODS2 5 µm column under a gradient elution program (see Table 8.9) at a flow rate 
of 1 ml. minute-1. The UV detector was set to 254 nm. 
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Table 8.9: Gradient elution program 
Time (minutes) Eluent A (%) Eluent B (%) 
0 90 10 
6 40 60 
10 40 60 
16 20 80 
18 90 10 
20 90 10 
Eluent A: Ammonium acetate (50mM) 
Eluent B: Methanol  
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9 Patent 
 
 
Nucleosides 
 
 
THIS INVENTION relates to nucleosides. It relates in particular to a process for manipulating 
a nucleoside, to a catalytic enzyme, and to a biocatalyst for use in the process. 
 
Modified nucleosides and nucleotides can be used as antiviral therapeutic agents or as 
precursors for such agents. An example of an important nucleoside of this kind is ß-
thymidine. ß-thymidine can be obtained from 5-methyluridine which is, however, a relatively 
expensive intermediate so that the cost of producing the antiretrovirals AZT and stavudine 
there from is correspondingly high. It is thus an object of this invention to provide a means 
whereby 5-methyluridine can be produced more cost effectively. 
 
According to a first aspect of the invention, there is provided a method for manipulating a 
nucleoside, which includes converting guanosine to 5-methyluridine by means of biocatalytic 
transglycosylation, with the biocatalyst comprising a combination of a purine nucleoside 
phosphorylase from Bacillus halodurans, PNPase (BH1531) of sequence ID No 1, or a 
protein with at least 90% sequence similarity thereto, and a pyrimidine nucleoside 
phosphorylase (PyNPase). 
 
In one embodiment of the invention, the pyrimidine nucleoside phosphorylase may be from 
Escherichia coli, particularly E. coli UPase of sequence ID No 2, or a protein with at least 
90% sequence similarity thereto. 
 
In another embodiment of the invention, the pyrimidine nucleoside phosphorylase may be 
from Bacillus halodurans, particularly B.halodurans PyNPase (BH1533) of sequence ID No 
3, or a protein with at least 90% sequence similarity thereto. 
 
The conversion thus involves the transfer of ribose-1-phosphate from the guanosine to a first 
nitrogenous base, thereby to obtain the 5-methyluridine and a second nitrogenous base. In 
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general, the biocatalytic transglycosylation reaction occurs by the transfer of a ribose-1-
phosphate from a nucleoside to a purine or pyrimidine base in the presence of phosphate ions. 
The first nitrogenous base may typically be thymine, while the second nitrogenous base may 
typically be guanine. 
 
The biocatalyst is thus a combination of a purine nucleoside phosphorylase (PNPase), B. 
halodurans PNPase (BH1531), of sequence ID No 1 (associated nucleotide sequence given as 
sequence ID No. 4), or a protein with at least 90% sequence similarity thereto, and a 
pyrimidine nucleoside phosphorylase (PyNPase), E. coli uridine phosphorylase (UPase), of 
sequence ID No 2 (associated nucleotide sequence given as sequence ID No. 5), or B. 
halodurans BH1533 of sequence ID 3 (associated nucleotide sequence given as sequence ID 
No. 6) or a protein with at least 90% sequence similarity to either of these. 
 
The enzymes may be isolated and over-expressed in an E. coli protein expression system. 
 
The B. halodurans may be a strain of gram positive B. halodurans Alk36 bacteria deposited 
under accession number NCIMB41348 on 23 November 2005 at NCIMB Ltd of Ferguson 
Building, Craibstone Estate, Buchsburn, Aberdeen AB21 9YA. Due to the high sequence 
identity between the genomes of B. halodurans Alk36 and B. halodurans C-125, primers for 
the cloning of the purine and pyrimidine nucleoside phosphorylase genes were designed 
according to the sequenced genome of B. halodurans C-125 which is published in the DNA 
Data Bank of Japan (http://www.ddbj.nig.ac.jp). The genes annotated BH1531 and BH1533, 
according to GenBank, encode a purine nucleoside phosphorylase and a pyrimidine 
nucleoside phosphorylase respectively. 
 
The purine nucleoside phosphorylase and pyrimidine nucleoside phosphorylase may be 
heterologously expressed in a suitable host organism such as E. coli. For example, expression 
of PNPase and UPase in E. coli BL21 (DE3) [pMS1531] and E. coli BL21 (DE3) [pETUP] 
respectively can be performed. Production may be achieved by culturing the host organism by 
fermentation either in batch, fed batch or in continuous mode.  
 
Generally, the biocatalyst may be the purified enzymes, active cell lysates, cell pastes, whole 
cells or immobilised forms of each of these. 
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In one embodiment, the biocatalyst may be in the form of a free suspension. However, in 
another embodiment, the biocatalyst may be immobilized on a backbone. Thus, the 
biocatalyst can be in the form of an enzyme structure or particle, such as that described in WO 
2005/080561, or in the form of an emulsion-derived particle as described in ZA 2007/09300 
and in which the enzymes are bonded to lattices of the particles. WO 2005/080561 and ZA 
2007/09300 are incorporated herein by reference thereto. This will permit the biocatalyst to be 
recovered and recycled after completion of the transglycosylation. 
 
The transglycosylation may be performed at between 30°C and 70°C, preferably at between 
40°C and 70°C, typically at 55°C to 65°C. 
 
The transglycosylation may be affected over a pH range of 6 to 11, preferably at a pH of 
between 7 to 8.5. The reaction may be carried out using phosphate buffer, as a reaction 
medium. The phosphate buffer may be at a concentration of 20 - 250 mM, but preferably 25 - 
50 mM.  
 
The initial concentration of the guanosine in the reaction medium, in which the 
transglycosylation is carried out, may be from 1 to 19.5% m/m, preferably from 8 to 13% 
m/m. 
 
The initial concentration of the first nitrogenous base in the reaction medium may be from 1 
to 15% m/m, preferably from 4 to 6% m/m. 
 
The transglycosylation reaction may be carried out using a first nitrogenous base (thymine) to 
first nucleoside (guanosine) ratio from 2.3:1 to 1:1, preferably from 1:1 to 1.15:1. 
 
The molar yield of 5-methyluridine may be between 30 – 90%, and typically 80% - 90%. 
 
The transglycosylation reaction productivity may be between 0.5 and 27 g/l/h, but typically at 
7 - 11 g/l/h.  
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The method may include recovering the 5-methyluridine. In particular, the method may 
include recovering or separating the 5-methyluridine from the second nitrogenous base 
(guanine) using solubility differences. Thus, when the second nitrogenous base is guanine, the 
5-methyluridine is largely soluble and the guanine largely insoluble in the reaction medium at 
the temperatures described above. This facilitates separation thereof. Using this method, 
recoveries of 80 - 90% from the transglycosylation medium are achievable. Together with the 
5-methyluridine reaction yields of 80 - 90%, this gives isolated yields of 5-methyluridine of 
between 64 – 80% from the biocatalytic reaction. 
 
For the biocatalytic reaction, i.e. the transglycosylation reaction, a phosphate buffer may first 
be introduced into a suitable reaction vessel or container, where after guanosine, preferably in 
solid particulate form, and additional phosphate buffer, may be added to the reaction vessel. 
Thymine may be pre-wetted using phosphate buffer, before being transferred to the reaction 
vessel. The various constituents introduced into the reaction vessel constitute a reaction 
medium for the transglycosylation reaction. These substances, in phosphate buffer, may be 
heated in the vessel to the reaction temperature as hereinbefore set out, and maintained at the 
reaction temperature for a period of time, typically about 2 hours, before addition of the 
biocatalyst to the reaction vessel. The biocatalyst components (PNPase and PyNPase/UPase) 
may be pre-dissolved in phosphate buffer prior to addition thereof to the reaction vessel. 
 
The process may include chemically manipulating the 5-methyluridine to obtain therefrom ß-
thymidine. The chemical manipulation of the 5-methyluridine may be effected without any 
purification thereof after it has been obtained by the conversion of the guanosine. 
 
The chemical manipulation of the 5-methyluridine may include reacting the 5-methyluridine 
with hydrogen bromide or acetyl bromide in acetonitrile, as the first step towards obtaining ß-
thymidine (C10H14N2O5). 
 
The process of the invention is thus a process whereby ß-thymidine can be produced 
synthetically. The final yield of the ß-thymidine over the chemical manipulation steps may be 
65 to 80%, typically 70 – 75%. 
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According to a second aspect of the invention, there is provided a catalytic enzyme which 
comprises a purine nucleoside phosphorylase from B. halodurans, PNPase (BH1531) of 
sequence ID No 1, or a protein with at least 90% sequence similarity thereto. 
 
The enzyme may be that obtained by over-expression thereof in an E. coli host. 
 
According to a third aspect of the invention, there is provided a biocatalyst which comprises 
the combination of a pyrimidine nucleoside phosphorylase (PyNPase), and a purine 
nucleoside phosphorylase B. halodurans, PNPase (BH1531) of sequence ID No 1, or a protein 
with at least 90% sequence similarity thereto.  
 
As indicated hereinbefore, the pyrimidine nucleoside phosphorylase may, in one embodiment 
of the invention, be from Escherichia coli, particularly E. coli UPase of sequence ID No 2, or 
a protein with at least 90% sequence similarity thereto. 
 
In another embodiment of the invention, the pyrimidine nucleoside phosphorylase may be 
from Bacillus halodurans, particularly B.halodurans PyNPase (BH1533) of sequence ID No 
3, or a protein with at least 90% sequence similarity thereto.  
 
The invention will now be described in more detail, with reference to the accompanying non-
limiting examples and the accompanying drawings and sequence listings.  
 
9.1 In the drawings 
 
FIGURE 1 shows the results obtained in Example 3, i.e. comparative efficiencies of 
combinations of purine and pyrimidine nucleoside phosphorylases in the production of 5-
methyluridine (5-MU). Lane 1: PNP:rUP; Lane 2: PNP:BH1533; Lane 3: PNP:KP PyNP; 
Lane 4: PNP:BL PyNP; Lane 5: XapA:rUP; Lane 6: XapA:BH1533; Lane 7: XapA:BL 
PyNP; Lane 8: XapA:KP PyNP; Lane 9: BH1531:rUP; Lane 10: BH1531:BH1533; Lane 11: 
BH1531:BL PyNP; Lane 12: BH1531:KP PyNP. 
FIGURE 2 shows (Example 4) over expression of E. coli uridine phosphorylase in E. coli 
BL21, and in which Lane 1: Marker; Lane 2: E. coli BL21 [pET20b] (negative control); Lane 
3 to 8: E. coli BL21 [pETUP] (various constructs).  
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FIGURE 3 shows (Example 4) over-expression of B. halodurans BH1531 in E. coli BL21, 
and in which Lane 1: marker; Lane 2: E. coli BL21; Lane 3: E. coli BL21 [pMS470]; Lane 4: 
E. coli BL21 [pMS1531] (uninduced); Lanes 5 to 10: E. coli BL21 [pMS1531] (various 
constructs) (induced). 
FIGURE 4 shows the effect of pH on the guanosine conversion and 5-methyluridine yield as 
described in Example 6. Clear bars show guanosine conversion (Conv.). Shaded bars show 
5-methyluridine yield. Standard deviations represent the average of three experiments.  
FIGURE 5 shows the effect of temperature on the guanosine conversion and 5-methyluridine 
yield as described in Example 7. The symbol ♦ represents guanosine conversion at 40°C; ∆ 
represents 5-methyluridine yield at 40°C; ▲ represents guanosine conversion at 50°C; ■ 
represents 5-methyluridine yield at 50°C; * represents guanosine conversion at 60°C; ● 
represents 5-methyluridine yield at 60°C; ○ represents guanosine conversion at 70°C; □ 
represents5-methyluridine yield at 70°C. 
FIGURE 6 shows the yield and productivity of the biocatalytic reaction at increased substrate 
concentrations as described in Example 8. The symbol ▲ represents 5-methyluridine reactor 
productivity; ♦ represents guanosine conversion; ■ represents 5-methyluridine yield.  
FIGURE 7 shows the transglycosylation percent recovery and productivity obtained over time 
at 1 l scale, see Example 9. The symbol ▲ represents 5-methyluridine reactor productivity; ♦ 
represents guanosine conversion; ■ represents 5-methyluridine yield.  
FIGURE 8 shows the guanosine conversion rate with reaction time over three replicate 
experiments at 20 l scale as described in Example 9. The symbol ▲ represents guanosine 
conversion 1; ♦ represents guanosine conversion 2;  ■ represents guanosine conversion 3.  
FIGURE 9 shows the 5-methyluridine yield with reaction time over three replicate 
experiments at 20 l scale as described in Example 9. The symbol ▲ represents 
5-methyluridine yield 1; ♦ represents 5-methyluridine yield 2; ■ represents 5-methyluridine 
yield 3.  
FIGURE 10 shows the reactor productivity of 5-methyluridine with reaction time over three 
replicate experiments at 20 l scale as described in Example 9. The symbol ▲ represents 
5-methyluridine reactor productivity 1; ♦ represents 5-methyluridine reactor productivity 2; ■ 
represents 5-methyluridine reactor productivity 3.  
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9.2 Sequence listings 
 
Sequence ID No 1: Amino acid sequence of B. halodurans BH1531  
 
Sequence ID No. 2: Amino acid sequence of E. coli UPase  
 
Sequence ID No. 3: Amino acid sequence of B. halodurans BH1533 
 
Sequence ID No. 4: Nucleotide sequence of the B. halodurans BH1531 gene which encodes 
the protein sequence of sequence ID No. 1 
 
Sequence ID No. 5: Nucleotide sequence of the E. coli UPase gene which encodes the E. coli 
UPase enzyme of protein sequence ID No. 2 
 
Sequence ID No. 6: Nucleotide sequence of the B. halodurans BH1533 gene which encodes 
the protein sequence of sequence ID No. 3 
 
In the Examples hereunder, for the biocatalytic reactions, phosphate buffer is added first to a 
suitable reactor, followed by solid particulate guanosine and additional buffer. Thymine is 
pre-wetted using phosphate buffer prior to transfer to the reaction vessel. These substrates, in 
phosphate buffer, are heated in the reactor at the final reaction temperature for 2 h prior to 
addition of the biocatalysts. The biocatalysts (PNPase and PyNPase) are pre-dissolved in 
phosphate buffer prior to their addition to the reaction vessel.  
 
9.3 Example 1 
Using commercial enzymes, thymidine (a stavudine and AZT precursor) was produced (with 
deoxyguanosine and deoxyinosine as donors), and the reaction equilibrium could be modified 
by the inclusion of xanthine oxidase.  
 
PNPase (from Cellumonas sp.), thymidine phosphorylase (TPase) and xanthine oxidase (XO) 
were purchased from Sigma-Aldrich (Pty) Ltd. The nucleosides were also purchased from 
Sigma-Aldrich (Pty) Ltd.  
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Three ml reactions were set up in 50 mM phosphate buffer, pH 7.4. Varying nucleosides and 
enzymes were incubated at 25°C for one to three hours, with shaking. Samples were taken at 
set time points and analysed using HPLC. All nucleoside stock solutions were made to 50 
mM concentration, with a final concentration in the reaction of 2.5 mM unless otherwise 
stated.  
 
Analysis by HPLC was performed using a Chromolith speed rod 18e Column, and an eluent 
of 5% methanol, 95% of a 0.1% sodium phosphate buffer, pH 7.5. The flow rate used was 0.5 
ml/min. Nucleosides and bases were detected by diode array spectrophotometry at 260 nm. 
Results are given in Table 1. 
 
Table 9.1: Summary of results obtained for reactions 
Rxn Starting reagents Enzymes Expected product 1 
(% total 
peak area) 
1 thymidine 
 
TPase thymine  78.5 
2 thymine,  
2'-deoxyribose-1-phosphate 
TPase thymidine 19.5 
3 inosine 
 
XO, PNPase hypoxanthine plus 
Xanthine 
61.7 
4 hypoxanthine, 
 2'-deoxyribose-1-phosphate 
XO, PNPase 2'-deoxyinosine 33.4 
5 50 mM guanosine, thymine TPase, PNPase  5-methyluridine 0 
6 200 mM guanosine, thymine TPase, PNPase  5-methyluridine 0 
7 100 mM thymine, guanosine TPase, PNPase 5-methyluridine 0 
8 150 mM thymine, guanosine TPase, PNPase 5-methyluridine 0 
9 250 mM thymine, guanosine TPase, PNPase 5-methyluridine 0 
10 inosine, thymine XO, TPase, 
PNPase  
5-methyluridine 0 
11 5-methyluridine 
 
TPase thymine 19.6 
12 2'-deoxyinosine; 50 mM XO, TPase, thymidine 2.7 
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phosphate, thymine 
 
PNPase  
13 2'-deoxyinosine; 25 mM 
phosphate, thymine 
XO, TPase, 
PNPase  
thymidine 3.7 
14 2'-deoxyinosine; 5 mM 
phosphate, thymine 
XO, TPase, 
PNPase  
thymidine 7.2 
15 2'-deoxyinosine; Tris, thymine XO, TPase, 
PNPase  
thymidine 10 
1
 – The product of interest is indicated here.  
 
Reactions 1 and 2 confirmed that the forward and reverse pyrimidine reactions can occur 
when using TPase. Reactions 3 and 4 confirmed that forward and reverse purine reactions can 
occur when using XO and PNPase.  
 
The aim of the inventors was to transfer the ribose group from guanosine to thymine (i.e. from 
a purine to a pyrimidine), yielding 5-methyluridine (Reactions 5 and 6). These reactions were 
unsuccessful as no 5-methyluridine was produced. Reactions 5 to 9 show that the reaction was 
not easily achieved using commercially available enzymes, as no 5-methyluridine was 
produced.  
 
An alternative purine was tried, with thymine and inosine as reagents to generate 
5-methyluridine, with inosine providing ribose-1-phosphate, and hypoxanthine being 
converted to uric acid to prevent the reverse reaction occurring (Reaction 10). The reverse 
reaction of 5-methyluridine to thymine and ribose-1-phosphate was successfully performed 
(Reaction 11).  
 
Altering the buffer conditions used in the formation of thymidine using 2'-deoxyinosine 
allowed for an increase in the relative proportions of thymidine. Decreasing the amount of 
phosphate present, or using a Tris buffer in the reaction allowed for a shift in the equilibrium 
towards the formation of thymidine from thymine and 2'-deoxyribose-1-phosphate, as 
opposed to the breakdown of thymidine to thymine with the release of phosphate (Reactions 
12 to 15).  
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Hence, with the combined PNPase and TPase commercial enzymes, it was not possible to 
perform transglycosylation with ribose-1-phosphate. On this basis, the Inventors decided to 
isolate nucleoside phosphorylases from other sources. 
 
9.4 Example 2 
 
Biomass of E. coli and B. halodurans was obtained by growth of each of the organisms at 
37°C in LB broth. The biomass was disrupted through sonication and the cytosolic fraction 
separated from the cellular debris by centrifugation (13 000 x g). This cytosolic fraction was 
used as the crude extract of each of the organisms. 
 
Three ml reactions were set up in 50 mM phosphate buffer, pH 7.4. Varying nucleosides, 
enzymes and crude extract preparations were incubated at 25°C for one to sixteen hours, with 
shaking. Samples were taken at set time points and analysed using HPLC. All nucleoside 
stock solutions were made to 50 mM concentration, with a final concentration in the reaction 
of 2.5 mM.  
 
Analysis by HPLC was performed using a Chromolith speed rod 18e Column, and an eluent 
of 5% methanol and 95% of a 0.1% sodium phosphate buffer, pH 7.5. The flow rate used was 
0.5 ml/min. Nucleosides and bases were detected by diode array spectrophotometry at 
260 nm. 
 
Through use of the partially purified E. coli or B. halodurans cell extracts (which contained 
intrinsic PNPase and PyNPase activities), it was possible to generate both thymidine and 
5-methyluridine. Both E. coli and B. halodurans crude extracts showed production of 5-
methyluridine using either inosine or guanosine as the ribose-1-phosphate donor. The yields 
of the reactions are summarised in Table 9.2. 
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Table 9.2: Transglycosylations of nucleosides using nucleosidases 
Rxn Starting nucleoside Biocatalyst Product Max Yield 
(%) 
1 Inosine, thymine Crude extract (E. 
coli), XO 
5-methyluridine 38 
2 Inosine, thymine Crude extract (B. 
halodurans), XO 
5-methyluridine 21.8 
3 2'-deoxyinosine, 
thymine 
Crude extract (E. 
coli), XO 
Thymidine 24 
4 2'-deoxyinosine, 
thymine 
Crude extract (B. 
halodurans), XO 
Thymidine 20.5 
5 Guanosine, thymine Crude extract (E. 
coli) 
5-methyluridine 30 
6 Guanosine, thymine Crude extract (B. 
halodurans) 
5-methyluridine 60.2 
7 2'-deoxyguanosine, 
thymine 
Crude extract (E. 
coli) 
Thymidine 49 
8 2'-deoxyguanosine, 
thymine 
Crude extract (B. 
halodurans) 
Thymidine 41.0 
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9.5 Example 3 
A number of enzymes and combinations thereof were tested for the ability to produce 5-
methyluridine by transglycosylation. The enzymes tested were: 
 
Purine Nucleoside Phosphorylases (PNPases) 
- Recombinant E. coli PNP (PNP) 
- Recombinant E. coli Xanthosine phosphorylase (XapA) 
- Recombinant B. halodurans PNP (BH1531) 
 
Pyrimidine Nucleoside Phosphorylase (PyNPases) 
- Recombinant E. coli Uridine phosphorylase (rUP) 
- Native B. halodurans PyNPase (BH1533) 
- Native Klebsiella pneumoniae PyNPase (KP PyNP) 
- Native Bacillus licheniformis PyNPase (BL PyNP) 
 
The total enzyme concentration for each reaction was maintained at 0.004 U/ml. Enzyme 
solutions and assay reagent (100 µl containing 5 mM guanosine and 5 mM thymine in 50 mM 
pH 8.0 phosphate buffer) were aliquoted into a 96-well microtitre plate. The microtitre plate 
was incubated for 1 h at 40oC with shaking at 900 rpm. Reactions were analysed by TLC (5 µl 
spot, 85:15 chloroform:methanol mobile phase, 10 cm UV254 Silica plates). The results are 
given in Figure 1. 
 
In Figure 1, when comparing combinations of purine and pyrimidine nucleoside 
phosphorylases, it is evident that the combinations of PNP:rUP (lane 1) and BH1531:rUP 
(lane 9) gave the highest 5-methyluridine synthesis at 40ºC.   XapA showed little to no 5-
methyluridine production. Similarly, the PyNPases from E. coli (rUP) and B. halodurans 
(BH1533) seemed far superior catalysts when compared to those from K. pneumoniae and B. 
licheniformis. 
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9.6 Example 4 
Expression and purification of Nucleoside Phosphorylases from E. coli and B. 
halodurans 
 
9.6.1 Genomic DNA isolation 
E. coli XL1 blue was grown overnight in a 10 ml culture volume. An aliquot of 1.5 ml of this 
was pelleted, and genomic DNA was isolated using the Qiagen DNeasy plant mini kit 
(Qiagen) using the standard protocol . B. halodurans genomic DNA was isolated similarly. 
The B. halodurans was a strain of gram positive B. halodurans Alk36 bacteria deposited 
under accession number NCIMB43148. 
 
9.6.2 PCR Amplification 
Oligonucleotides to amplify the UPase, PNPase, XapA and TPase genes from E. coli were 
designed based on published sequences (Esipov et al, 2002). Due to the high sequence 
identity between the genomes of B. halodurans Alk36 and B. halodurans C-125, primers for 
the cloning of the purine and pyrimidine nucleoside phosphorylase genes were designed 
according to the sequenced genome of B. halodurans C-125 (GenBank accession number 
BA000004). The genes for the purine nucleoside phosphorylases were annotated as BH1531 
and BH1532 and the gene for the pyrimidine nucleoside phosphorylase was annotated as 
BH1533. PCR was performed using genomic DNA as the template, and using the High 
Fidelity amplification kit (Roche). Again standard protocols were followed. The PCR cycling 
parameters were as follows:  one hold at 95°C for 5 minutes, followed by 30 cycles of 95°C 
for 1 minute, 50°C for 1 minute and 72°C for 1 minute. The resultant product was held at 4°C 
until analysis on a 0.8% agarose gel was performed.  
 
PCR successfully amplified the coding regions of BH1531 and E. coli UPase (Sequence ID 
No. 4, sequence ID No. 5, respectively) with the associated amino acid sequences given in 
sequence ID No. 1 and sequence ID No. 2 respectively.  
 
9.6.3 Cloning of nucleoside phosphorylase genes 
PCR products were ligated into pGEM-T easy (Promega) using standard protocols. Fragments 
encoding the genes of interest were removed using various restriction enzymes (Table 9.3) 
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and ligated into restricted pET20b (Novagen). The resultant plasmid constructs were 
confirmed by sequencing. Correct constructs were transformed into E. coli BL21 using 
electroporation for subsequent expression analysis.  
 
Table 9.3: Cloning strategy for the generation of constructs expressing various 
nucleoside phosphorylases 
Gene Organism Clone name  Restriction enzymes 
up E. coli pETUP NdeI, SalI 
BH1531 B. halodurans pMS-1531 NdeI, HindIII 
 
9.6.4 Expression of nucleoside phosphorylases 
A single colony of E. coli BL21 expressing either BH1531 or UPase was inoculated into 5 ml 
LB broth containing 100 µg/ml ampicillin (final concentration). This culture was grown 
overnight at 37°C with shaking. One ml of the culture was diluted 1 in 100 into fresh LB 
broth. This fresh culture was grown at 37°C until the OD600 reached 0.4. Expression of the 
nucleoside phosphorylases (Figures 2 and 3) was induced using 1 mM IPTG (final 
concentration) for between 3 to 14 hours.  
 
9.6.5 Production and preparation of nucleoside phosphorylases 
Batch fermenters (Braun Biostat C) containing GMO 20 medium were inoculated with 800 ml 
inoculum. The composition of the GMO 20 medium was as follows:  
K2HPO4, 14.6 g/l; (NH4)2SO4, 2 g/l; Na2HPO4, 3.6 g/l Citric Acid, 2.5 g/l; MgSO4, 1.2 g/l; 
NH4NO3, 5 g/l and Yeast extract, 20 g/l.  
Glucose 30.0 g/l and trace element solution, 5 ml/l were sterilized separately and added to the 
fermenters before inoculation. The trace element solution consists of the following: 
CaCl2.2H2O, 0.4 g/l; FeCl3.6H2O, 16.7 g/l; MnCl2.4H2O, 0.15 g/l; ZnSO4.7H2O, 0.18 g/l; 
CuCl2.2H2O. 0.125 g/l; CoCl2.6H2O, 0.18 g/l; Na2EDTA, 20.1 g/l.   
Ampicillin (100 mg/ml filter sterilised stock) was added to the medium to give a final 
concentration of 100 µg/ml).  
Antifoam was aseptically added to the fermentation medium on demand. 
The pH of the fermentations was maintained at pH 7.2 with 33% m/v NH4OH and 20% m/v 
H2SO4.  
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The temperature was maintained at 37ºC and the aeration set to 1 v/v/min. The initial 
agitation was set at 300 rpm and ramped up (automatic cascade) to control the pO2 above 30% 
saturation. Growth, enzyme activity and glucose utilisation were followed by taking 10 ml 
samples at 1 hourly intervals. Enzyme expression was induced by addition of IPTG to a final 
concentration of 0.5 mM when the OD660 reached a value of between 7 and 8 OD Units. The 
broth (20 l) was harvested 4 hours after induction and cooled to 4oC. The biomass was 
separated from the supernatant by continuous centrifugation (Beckman Avante, JCF-Z rotor, 
14000 x g). The resultant pellet was resuspended in 2 litres 50 mM phosphate buffer, pH 8.0 
and cells disrupted using a Constant Systems Cell Disruptor (2 passes at 20 kpsi). Cellular 
debris was removed by centrifugation (Beckman Avante, JA-10 rotor, 14000 x g). The 
resultant protein solution was lyophilised in the presence of 2% m/v maltose, 1% PEG 8000 
(cryo-protectants). The lyophilisation procedure on a Vertis Genesis 25 l, was as follows: -
35oC for 10 h; ramp to -5oC over 5 h; hold at -5oC for 5 h; ramp to 15oC over 20 h; hold at 
15oC until dry. 
 
9.7 Example 5 
The use of B. halodurans PNPase and E. coli PyNPase for the production of 5-
methyluridine. 
 
Guanosine (0.030 g, 0.106 mmol and 1.5% m/m), thymine (0.031 g, 0.246 mmol and 1.55% 
m/m) and sodium phosphate buffer (50 mM, 0.6% m/m, pH 7.5-8.0, ~1.8 ml) were charged to 
a sample vial (~ 5 ml). Stock solutions of PNPase and PyNPase enzymes were prepared using 
phosphate buffer and the required aliquots of PNPase (~30-200 µl) and PyNPase (~30-200 µl) 
added. The PNPase/PyNPase enzyme ratio was maintained at 1:1 at the following enzyme 
loading: PNPase, 0.27 U and PyNPase 0.27 U. The reaction mixture was stirred using a stirrer 
bar and heated to the required temperature (40oC). The reaction was typically carried out over 
24 hours and then worked up, using sodium hydroxide solution (NaOH 10 M). The reaction 
mixture was then quantitatively analysed by HPLC for guanosine, guanine, thymine and 5-
methyluridine. Typical results obtained show that a guanosine conversion > 90% and 
5-methyluridine yield ~ 80% were achieved under the above conditions.  
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9.8 Example 6 
The influence of pH on the production of 5-methyluridine by a combination of B. 
halodurans PNPase and E. coli PyNPase. 
 
Experimental conditions similar to those described in Example 5 were used, except the pH of 
the reaction was altered to determine the operating range for this reaction. In order to obtain 
the desired pH, either 50 mM phosphate or carbonate buffer was used in combination with di-
sodium hydrogen phosphate salt. Results are shown in Figure 4. 
 
9.9 Example 7 
The influence of temperature on the production of 5-methyluridine by a combination of 
B. halodurans PNPase and E. coli PyNPase. 
 
Guanosine (15 g, 0.0530 mol and 1.5% m/m), thymine (15.4 g, 0.122 mol and 1.54% m/m) 
and sodium phosphate buffer (50 mM, 0.6% m/m, pH 7.5-8.0, 969 g) were charged to a glass 
baffled reactor (2 l). Stock solutions of PNPase and PyNPase enzymes were prepared using 
phosphate buffer and the required aliquots of PNPase (10 - 30 ml) and PyNPase (10 – 30 ml) 
added. The PNPase/PyNPase enzyme ratio was maintained at 1:1 at the following enzyme 
loading: PNPase, 200 U and PyNPase 200 U. The reaction mixture was stirred using a stirrer 
bar and heated to the required temperature (40 - 70oC). The reaction was typically carried out 
over 24 hours and then worked up, using sodium hydroxide solution (NaOH 10 M). The 
reaction mixture was then quantitatively analysed by HPLC for guanosine, guanine, thymine 
and 5-methyluridine. Results are shown in Figure 5. 
 
9.10 Example 8 
Preparation of 5-methyluridine, using B. halodurans PNPase and E. coli PyNPase at 
60ºC at high substrate concentration. 
 
Guanosine (17.5 g 61.8 mmol, 12.9% m/m), thymine (17.4 g, 138 mmol, and 12.9% m/m) and 
phosphate buffer (101 g, 50 mM, pH 7.5 - 8) were charged to the reactor. The reaction 
mixture was heated to 60oC and stirred at 1000 rpm using a magnetic stirrer bar. The required 
amounts of PNPase (204 U) and, PyNPase (199 U) were then charged to the reactor. The 
reaction was conducted over 24 hours The 5-methyluridine productivity over the course of the 
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reaction was between 4.5 -14 g/l/h. A guanosine conversion (> 90%), 5-methyluridine yield 
(~90%) and 5-methyluridine productivity (~4.5 g/l/h) was obtained after 24 hours. Results are 
shown in Figure 6. 
 
9.11 Example 9 
The optimal biocatalytic reaction 
 
Phosphate buffer (1620 g, 50 mM, pH 7.5-8) was added to a suitable reactor, followed by 
guanosine solids (1040.09 g, 3.67 mole, 8.9% m/m) and then an additional 986 g phosphate 
buffer. Thymine (535.04 g, 4.2 mole, 4.8% m/m) was pre-wetted using 50 mM phosphate 
buffer (2000 g, pH 7.5-8) and then transferred to the reaction vessel. The balance of the 
phosphate buffer (5794 g) was then added to the reactor. The reaction mixture was stirred at 
100 rpm using an anchor stirrer and heated to 60°C for 2 h prior to addition of the 
biocatalysts. During the heating procedure the required amount of PNPase (3.1119 g, 
16006 U) and PyNPase (3.752 g, 16013 U) were pre-weighed and pre-dissolved in phosphate 
buffer, (~200 g, including rinse volumes). The reaction was conducted over 24 hours, 
however the reaction is typically complete within 8-12 hours at the required guanosine 
conversion (>90%) and 5-methyluridine yield (~80-90%).  
 
The optimal biocatalytic reaction was performed at scales ranging from 1 l (Figure 7) to 20 l 
(Figures 8 – 10). Replicate reactions to demonstrate the reproducibility and robustness of the 
20 l reaction were performed and these results are shown in Figures 8-10.  
 
9.12 Example 10 
The purification of 5-methyluridine 
 
The reaction mixture was centrifuged hot (> 90oC) in order to recover guanine (~90%) at a 
purity ~90% m/m. Crude 5-methyluridine was then recovered by carrying out a water 
crystallization and water stripping process. The crude 5-methyluridine residues were then 
dried and further purified using a hot isobutanol filtration and crystallization process to 
remove inorganic salts (phosphate) and other organics such as thymine. The recovery of 5-
methyluridine over the DSP process was ~90% at a purity > 90% m/m. 
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The overall isolated 5-methyluridine yield was between 64 - 80%.  
 
9.13 Example 11 
The synthesis of thymidine 
 
9.13.1 Preparation of 3',5'-Diacetyl-2'-bromothymidine (DABT) 
To 5-methyluridine (10.0 g, 39 mmol) in a 3-necked round bottom flask fitted with a 
thermometer, reflux condenser and dropping funnel, was added acetonitrile (389 g). This 
slurry was heated to reflux and acetyl bromide (27.32 g, 222 mmol, 5.7 equivalents) was 
added dropwise over 30 min. During the course of addition, the solids dissolved to leave a 
yellow solution. The reaction was heated for an additional 30 min and then solvent was 
removed under reduced pressure through a NaOH solution trap and a solid NaOH trap. The 
residue was taken up in dichloromethane and this was washed twice with brine. The organic 
layer was dried over MgSO4 (2 g), filtered and solvent removed to leave DABT as a beige 
residue (90% yield). 
 
9.13.2 Preparation of 3',5'-Diacetylthymidine (DAT) 
DABT prepared above was dissolved in methanol sufficient to give a 20% reaction 
concentration. For example, 16.1 g solid from reaction above was dissolved in MeOH (64.4 g) 
and transferred to a Parr reactor. Sodium bicarbonate (4.6 g, 1.5 equivalents) and Ni catalyst 
A-5000 (4.5 g, 15% m/m catalyst loading, assume 50% slurry) were added. The H2 pressure 
was set at 9 bar and the initial temperature was set to 35ºC. The reaction is exothermic and 
cooling was employed in the first 30 min of reaction. After this time the reaction temperature 
was set to 40ºC. After 3 h the reaction was stopped and filtered through celite (Celite 535 is 
preferred) to remove catalyst. Solvent was removed and the residue was taken up in ethyl 
acetate (90 ml). At this stage, a white solid precipitated from the ethyl acetate solution, which 
was removed by filtration. Solvent was removed in vacuo to leave DAT as a beige residue 
(90% yield).  
 
9.13.3 Preparation of Thymidine 
To the DAT prepared above was added MeOH (37 ml) and NaOMe (1.4 g, 1.1 equivalents). 
The reaction was warmed at 40ºC for 2 h. After this time additional MeOH was added (50 ml) 
and Amberlite resin (IR-120, 30 g) was added and stirred at room temperature. The beads 
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were removed by filtration and the solvent was removed in vacuo to leave thymidine as a 
white solid (90% yield). Recrystallisation from MeOH gave rise to a product of high purity 
(>98%). 
 
9.14 Example 12 
The synthesis of thymidine from 5-methyluridine obtained directly from the biocatalytic 
reaction after drying only, without further purification 
 
9.14.1 Preparation of 3',5'-Diacetyl-2'-bromothymidine (DABT) 
To 5-methyluridine (12.5 g of 80% m/m purity, 39 mmol) in a 3-necked round bottomed flask 
fitted with a thermometer, reflux condenser and dropping funnel, was added acetonitrile (389 
g). This slurry was heated to reflux and acetyl bromide (27.32 g, 222 mmol, 5.7 equivalents) 
was added dropwise over 30 min. During the course of addition, the solution became green in 
colour and remained slightly turbid. The reaction was heated for an additional 30 min and 
then solvent was removed under reduced pressure through a NaOH solution trap and a solid 
NaOH trap. The residue was taken up in dichloromethane and this was washed twice with 
brine. The solvent was removed to leave DABT as a dark brown residue (85% yield). 
 
9.14.2 Preparation of 3',5'-Diacetylthymidine (DAT) 
DABT prepared above was dissolved in methanol sufficient to give a 20% reaction 
concentration and transferred to a Parr reactor. Sodium bicarbonate (4.6 g, 1.5 equivalents) 
and Ni catalyst A-5000 (4.6 g, 15% m/m catalyst loading, assume 50% slurry) were added. 
The H2 pressure was set at 9 bar and the initial temperature was set to 35ºC. The reaction is 
exothermic and cooling was employed in the first 30 min of reaction. After this time the 
reaction temperature was set to 40ºC. After 3 h the reaction was stopped and filtered through 
celite (Celite 535 is preferred) to remove catalyst. Solvent was removed, the residue was 
taken up in ethyl acetate (90 ml) and MgSO4 (2.5 g) was added. At this stage, a white solid 
precipitated from the ethyl acetate solution, which was removed by filtration. Solvent was 
removed in vacuo to leave DAT as a dark brown residue (71% yield).  
 
9.14.3 Preparation of Thymidine 
To the DAT prepared above was added MeOH (37 ml) and NaOMe (1.4 g, 1.1 equivalents). 
The reaction was warmed at 40ºC for 2 h. After this time additional MeOH was added (50 ml) 
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and Amberlite resin (IR-120, 30 g) was added and stirred at room temperature. The beads 
were removed by filtration and the solvent was removed in vacuo to leave thymidine as a 
white solid (91% yield). Recrystallisation from MeOH gave rise to a product of high purity, 
with a melting point of 187.8ºC.  
 
9.15 Example 13 
 
Preparations of B. halodurans PNPase and E. coli PyNPase were immobilised (separately and 
co-immobilised) on polyethyleneimine backbone particles (ZA 2007/09300). In each case 200 
µl of the enzyme preparation (100 µl of each preparation for co-immobilization) was added to 
200 µl of backbone (5 mg/ml) and made up to 1.0 ml with deionised water. The solutions 
were incubated with mild agitation for 30 min. The particles were then washed 3 times with 
deionised water. The immobilised PNPase showed an activity of 0.26 U/mg particle (1 U was 
the amount of enzyme required to liberate 1 µmol uric acid per minute from inosine in the 
presence of xanthine oxidase) while the immobilised PyNPase showed an activity of 0.055 
U/mg particle (1 U was the amount of enzyme required to liberate 1 µmol uracil from uridine 
in 1 minute). The co-immobilised preparation showed 1.13 and 1.49 U/mg of particle for 
PNPase and PyNPase respectively. 
 
 
9.16 Summary 
Biocatalysts can provide a high reaction rate, high stereo-selectivity and regio-selectivity. 
There can also be a reduction in synthetic steps in synthesis and product isolation due to 
specificity (fewer by-products to separate out, protection steps eliminated). The multimeric 
enzymes PNPase and UPase/PyNPase are used simultaneously in this invention to synthesise 
nucleosides. 
 
The use of low phosphate levels in the biocatalytic transglycosylation reaction of the 
invention allows for the shifting of the equilibrium of the reaction towards the formation of 
the products rather than the ribose phosphate intermediate.  
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The efficient transglycosylation of nucleosides is important for generation of thymidine and 
5-methyluridine, which are, as indicated hereinbefore important precursors in the formation of 
the anti-retrovirals (ARV) AZT and stavudine.  
 
Purine nucleoside phosphorylase (PNPase) is used to remove the ribose-1-phosphate moiety 
from the guanosine nucleoside. The ribose-1-phosphate is then transferred to thymine by 
pyrimidine nucleoside phosphorylase (PyNPase) to generate 5-methyluridine. Hence a two 
enzyme biocatalyst system is, in accordance with the invention, used to achieve nucleoside 
transformation effectively. In accordance with the invention, the purified enzymes are used 
together to synthesise 5-methyluridine from the cheap starting material, guanosine. The 
process used involves the enzymatic cleavage of guanosine into the insoluble guanine, and the 
highly soluble ribose-1-phosphate by PNPase. The ribose-1-phosphate is then covalently 
bound to thymine by the UPase to give 5-methyluridine. Results show a greater than 80% 
yield, and typically around 80-90% yield of 5-methyluridine from guanosine.   
 
5-Methyluridine is a relatively expensive intermediate in the formation of AZT or stavudine. 
By decreasing the cost of this intermediate, it is feasible to decrease the cost of several anti-
retroviral drugs. The use of biocatalysts allows for the highly specific catalysis with low by-
product formation. The use of the selected B. halodurans enzymes allows for improved yields 
and reaction kinetics.  
 
The invention thus provides a high yield and rapid chemo-enzymatic process for the 
preparation of β-thymidine from guanosine and thymine. Preparation of the intermediate 5-
methyluridine is achieved in good yield by biocatalytically converting guanosine and thymine 
into 5-methyluridine and guanine using the enzymes purine nucleoside phosphorylase and 
pyrimidine nucleoside phosphorylase. The catalytic enzymes are produced by over-expression 
of an E. coli pyrimidine nucleoside phosphorylase and a B. halodurans purine nucleoside 
phosphorylase in E. coli hosts. High yield production of both biocatalysts has been 
demonstrated in batch fermentation of the respective strains. The combination of these two 
enzymes yielded 80-90% 5-methyluridine from guanosine with typical productivities of 7-11 
g/l/h at 60ºC. Subsequent chemical conversions of 5-methyluridine gave rise to high-purity β-
thymidine in three steps.  
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9.17 Claims 
 
1.  A process for manipulating a nucleoside, which includes converting guanosine 
to 5-methyluridine by means of biocatalytic transglycosylation, with the biocatalyst 
comprising a combination of a purine nucleoside phosphorylase from Bacillus halodurans, 
PNPase (BH1531) of sequence ID No 1, or a protein with at least 90% sequence similarity 
thereto, and a pyrimidine nucleoside phosphorylase (PyNPase). 
 
2.  The process of Claim 1, wherein the pyrimidine nucleoside phosphorylase is 
from Escherichia coli, being UPase of sequence ID No 2, or a protein with at least 90% 
sequence similarity thereto. 
 
3.  The process of Claim 1, wherein the pyrimidine nucleoside phosphorylase is 
from Bacillus halodurans, being PyNPase (BH1533) of sequence ID No 3, or a protein with 
at least 90% sequence similarity thereto. 
 
4.  The process of Claim 2, wherein the purine nucleoside phosphorylase and 
pyrimidine nucleoside phosphorylase are those produced by batch fermentation of 
Escherichia coli JM109 (DE3) [pMS1531] and Escherichia coli BL21 (DE3) [pETUP] 
respectively. 
 
5.  The process of any one of Claims 1 to 4 inclusive, wherein the 
transglycosylation is performed at a temperature between 30°C and 70°C. 
 
6.  The process of any one of Claims 1 to 5 inclusive, wherein the 
transglycosylation is effected at a pH in the range of 6 to 11. 
 
7.  The process of any one of Claims 1 to 6 inclusive, wherein the molar yield of 
5-methyluridine is 80% to 90%. 
 
8.  The process of any one of Claims 1 to 7 inclusive, wherein the 
transglycosylation reaction productivity is between 0.5 and 27 g/l/h. 
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9.  The method of any one of Claims 1 to 8 inclusive, wherein the biocatalyst is 
immobilized on a backbone. 
 
10.  The process of any one of Claims 1 to 9 inclusive, which includes chemically 
manipulating the 5-methyluridine, to obtain therefrom ß-thymidine. 
 
11.  The process of Claim 10, wherein the chemical manipulation of the 
5-methyluridine is effected without any purification thereof after it has been obtained by the 
conversion of the guanosine. 
 
12.  A process according to Claim 10 or Claim 11, wherein the chemical 
manipulation of the 5-methyluridine includes reacting the 5-methyluridine with hydrogen 
bromide or acetyl bromide in acetonitrile. 
 
13.  A catalytic enzyme which comprises a purine nucleoside phosphorylase from 
Bacillus halodurans, PNPase (BH1531) of sequence ID No 1, or a protein with at least 90% 
sequence similarity thereto. 
 
14.  A catalytic enzyme according to Claim 13, which is that obtained by over-
expression thereof in an Escherichia coli host. 
 
15.  A biocatalyst which comprises the combination of a pyrimidine nucleoside 
phosphorylase (PyNPase) and a purine nucleoside phosphorylase from Bacillus halodurans, 
PNPase (BH1531) of sequence ID No 1, or a protein with at least 90% sequence similarity 
thereto. 
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9.18 Abstract 
 
A method for manipulating a nucleoside includes converting guanosine to 5-methyluridine by 
means of biocatalytic transglycosylation. The biocatalyst comprises a combination of a purine 
nucleoside phosphorylase from Bacillus halodurans, PNPase (BH1531) of sequence ID No 1, 
or a protein with at least 90% sequence similarity thereto, and a pyrimidine nucleoside 
phosphorylase (PyNPase). 
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Figure 9.1: The results obtained in Example 3, i.e. comparative efficiencies of 
combinations of purine and pyrimidine nucleoside phosphorylases in the production of 
5-methyluridine. 
Lane 1: PNP:rUP; Lane 2: PNP:BH1533; Lane 3: PNP:KP PyNP; Lane 4: PNP:BL PyNP; Lane 5: XapA:rUP; 
Lane 6: XapA:BH1533; Lane 7: XapA:BL PyNP; Lane 8: XapA:KP PyNP; Lane 9: BH1531:rUP; Lane 10: 
BH1531:BH1533; Lane 11: BH1531:BL PyNP; Lane 12: BH1531:KP PyNP. 
 
 
 
 
Figure 9.2: Overexpression of E. coli uridine phosphorylase in E. coli BL21 
FIGURE 9.2 shows (Example 4) overexpression of E. coli uridine phosphorylase in E. coli BL21, and in which 
Lane 1: Marker; Lane 2: E. coli BL21 [pET20b] (negative control); Lane 3 to 8: E. coli BL21 [pETUP] (various 
constructs).  
 
 
 
    1      2    3     4     5    6    7     8 
 1       2      3      4       5      6      7        8       9    10     11     12            
Thymine 
Guanine 
Guanosine 
5-methyluridine 
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Figure 9.3: Over-expression of B. halodurans BH1531 in E. coli BL21 
FIGURE 9.3 shows (Example 4) over-expression of B. halodurans BH1531 in E. coli BL21, and in which Lane 
1: marker; Lane 2: E. coli BL21; Lane 3: E. coli BL21 [pMS470]; Lane 4: E. coli BL21 [pMS1531] (uninduced); 
Lanes 5 to 10: E. coli BL21 [pMS1531] (various constructs) (induced). 
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Figure 9.4: Effect of pH on the guanosine conversion and 5-methyluridine yield 
FIGURE 4 shows the effect of pH on the guanosine conversion and 5-methyluridine yield as described in 
Example 6. Clear bars show guanosine conversion (Conv.). Shaded bars show 5-MU yield. Standard deviations 
represent the average of three experiments.  
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Figure 9.5: Effect of temperature on the guanosine conversion and 5-methyluridine yield 
FIGURE 5 shows the effect of temperature on the guanosine conversion and 5-methyluridine yield as described 
in Example 7. The symbol ♦ represents guanosine conversion at 40°C; ∆ represents 5-MU yield at 40°C; ▲ 
represents guanosine conversion at 50°C; ■ represents 5-MU yield at 50°C; * represents guanosine conversion at 
60°C; ● represents 5-MU yield at 60°C; ○ represents guanosine conversion at 70°C; □ represents 5-MU yield at 
70°C. 
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Figure 9.6: The yield and productivity of the biocatalytic reaction at increased substrate 
concentrations 
FIGURE 6 shows the yield and productivity of the biocatalytic reaction at increased substrate concentrations as 
described in Example 8. The symbol ▲ represents 5-MU reactor productivity; ♦ represents guanosine 
conversion; ■ represents 5-MU yield.  
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Figure 9.7: The transglycosylation percent recovery and productivity obtained over time 
at 1 l scale 
FIGURE 7 shows the transglycosylation percent recovery and productivity obtained over time at 1 l scale, see 
Example 9. The symbol ▲ represents 5-MU reactor productivity; ♦ represents guanosine conversion; ■ 
represents 5-MU yield.  
 
0
10
20
30
40
50
60
70
80
90
100
0 5 10 15 20 25 30
Time (h)
G
S 
co
n
v
.
 
(%
)
 
Figure 9.8: The guanosine conversion rate with reaction time 
FIGURE 8 shows the guanosine conversion rate with reaction time over three replicate experiments at 20 l scale 
as described in Example 9. The symbol ▲ represents guanosine conversion 1; ♦ represents guanosine conversion 
2;  ■ represents guanosine conversion 3.  
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Figure 9.9: The 5-methyluridine yield with reaction time 
FIGURE 9 shows the 5-methyluridine yield with reaction time over three replicate experiments at 20 l scale as 
described in Example 9. The symbol ▲ represents 5-MU yield 1; ♦ represents 5-MU yield 2; ■ represents 5-MU 
yield 3.  
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Figure 9.10: The reactor productivity of 5-methyluridine with reaction time 
FIGURE 10 shows the reactor productivity of 5-methyluridine with reaction time over three replicate 
experiments at 20 l scale as described in Example 9. The symbol ▲ represents 5-MU reactor productivity 1; ♦ 
represents 5-MU reactor productivity 2; ■ represents 5-MU reactor productivity 3.  
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9.19 Sequence Listing 
 
Sequence ID No. 1 : BH1531 amino acid sequence 
 
MLNVTQLQEATTFIQQQIETKPTIGLILGSGLGILADEIEQPVKVPYSDIPHFPVSTVQGHA
GQLVIGMLEGKQVIAMQGRFHFYEGYSLEVVTFPVRVMKALGVEQIIVTNAAGGVNESFEAG
DLMIIRDHINNMAQNPLIGPNDEAFGVRFPDMSNAYSERLRTLAKEKGNTLNLKLQEGVYVA
NTGPVYETPAEVRMIRKLGGDAVGMSTVPEVIVARHAGLEVLGISCISNMAAGILPQPLSHD
EVIETTERVRQDFLNLVKAIVKDM# 
 
Sequence ID No. 2 : E.coli UPase amino acid sequence 
 
MSKSDVFHLGLTKNDLQGATLAIVPGDPDRVEKIAALMDKPVKLASHREFTTWRAELDGKPV
IVCSTGIGGPSTSIAVEELAQLGIRTFLRIGTTGAIQPHINVGDVLVTTASVRLDGASLHFA
PLEFPAVADFECTTALVEAAKSIGATTHVGVTASSDTFYPGQERYDTYSGRVVRHFKGSMEE
WQAMGVMNYEMESATLLTMCASQGLRAGMVAGVIVNRTQQEIPNAETMKQTESHAVKIVVEA
ARRLL# 
 
Sequence ID No. 3: BH1533 amino acid sequence 
 
MRMVDLIEKKRDGLALTKEEIDFIISGYTNGDIPDYQMSAFAMAIFFQDMTADERAYLTMAM
AESGDQIDLSGIEGVKVDKHSTGGVGDKTTIALAPLVASVGVPVAKMSGRGLGHTGGTIDKL
ESIAGFNVEIPTERFLELVNKNKLAVVGQTANLTPADKKLYGLRDVTATVNSIPLIASSIMS
KKIASGANAIVLDVKTGSGAFMKELEQSKELAEAMVEIGNNLGRQTMAVISDMNQPLGWAVG
NALEVKEAIDMLRGEGPDDLRELCLTLGSHMVFLAKQATSVADARQKLEEAISSGKALDTLK
TFISAQNGDPSVVDNPQLLPTAQFQIEVKAEENGHVASIVADRIGTAAMVLGAGRATKESDI
DLSVGIVLKKKMGESVQAGETLAILHANKEDVQEVIDRVIKAYHISPDPVAKPTLIYEEIH# 
 
Sequence ID No. 4 : BH1531 nucleotide sequence 
 
ATGCTTAACGTAACTCAATTGCAAGAAGCGACTACATTTATTCAACAGCAAATAGAAACAAA
ACCAACGATCGGTTTAATTTTAGGTTCTGGTTTAGGGATTTTAGCTGATGAGATCGAACAGC
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CGGTGAAAGTTCCTTACAGTGACATTCCACATTTTCCTGTCTCTACCGTCCAAGGACATGCG
GGCCAGCTTGTGATCGGCATGCTTGAAGGAAAGCAAGTGATTGCGATGCAAGGGCGATTTCA
TTTTTATGAAGGCTACAGCCTTGAGGTTGTCACATTCCCTGTCCGCGTCATGAAAGCTCTAG
GTGTAGAACAAATCATTGTCACAAATGCAGCGGGCGGTGTGAACGAATCGTTCGAAGCGGGT
GACCTAATGATCATTCGCGACCATATTAACAACATGGCACAAAACCCACTAATTGGGCCGAA
TGATGAGGCGTTCGGCGTACGTTTTCCGGATATGTCAAATGCCTACTCTGAGCGCTTACGAA
CGTTAGCGAAGGAAAAGGGAAACACGTTGAATCTCAAGCTACAGGAAGGGGTCTATGTTGCG
AACACAGGTCCTGTTTATGAAACCCCTGCTGAAGTGCGGATGATTCGAAAACTTGGCGGAGA
TGCTGTAGGTATGTCAACCGTACCAGAAGTCATTGTCGCTCGTCATGCAGGACTTGAGGTTC
TTGGAATTTCATGTATTTCTAACATGGCGGCAGGAATTTTACCACAGCCTTTATCACATGAT
GAAGTCATTGAAACAACGGAACGAGTGAGGCAAGACTTTCTTAATCTTGTCAAAGCAATCGT
TAAAGACATGTAA 
 
Sequence ID No 5 : E. coli UPase nucleotide sequence  
 
ATGTCCAAGTCTGATGTTTTTCATCTCGGCCTCACTAAAAACGATTTACAAGGGGCTACGCT
TGCCATCGTCCCTGGCGACCCGGATCGTGTGGAAAAGATCGCCGCGCTGATGGATAAGCCGG
TTAAGCTGGCATCTCACCGCGAATTCACTACCTGGCGTGCAGAGCTGGATGGTAAACCTGTT
ATCGTCTGCTCTACCGGTATCGGCGGCCCGTCTACCTCTATTGCTGTTGAAGAGCTGGCACA
GCTGGGCATTCGCACCTTCCTGCGTATCGGTACAACGGGCGCTATTCAGCCGCATATTAATG
TGGGTGATGTCCTGGTTACCACGGCGTCTGTCCGTCTGGATGGCGCGAGCCTGCACTTCGCA
CCGCTGGAATTCCCGGCTGTCGCTGATTTCGAATGTACGACTGCGCTGGTTGAAGCTGCGAA
ATCCATTGGCGCGACAACTCACGTTGGCGTGACAGCTTCTTCTGATACCTTCTACCCAGGTC
AGGAACGTTACGATACTTACTCTGGTCGCGTAGTTCGTCACTTTAAAGGTTCTATGGAAGAG
TGGCAGGCGATGGGCGTAATGAACTATGAAATGGAATCTGCAACCCTGCTGACCATGTGTGC
AAGTCAGGGCCTGCGTGCCGGTATGGTAGCGGGTGTTATCGTTAACCGCACCCAGCAAGAGA
TCCCGAATGCTGAGACGATGAAACAAACCGAAAGCCATGCGGTGAAAATCGTGGTGGAAGCG
GCGCGTCGTCTGCTGTAA 
 
Sequence ID No. 6 : BH1533 nucleotide sequence 
 
ATGCGCATGGTTGACTTAATCGAAAAAAAGCGTGACGGTCTCGCATTAACGAAAGAAGAGAT
TGATTTTATCATTTCAGGCTATACGAACGGTGATATTCCCGACTATCAAATGTCGGCGTTTG
 Patent 264 
CGATGGCGATTTTCTTTCAAGATATGACAGCAGATGAACGAGCGTATTTGACGATGGCAATG
GCTGAATCAGGCGATCAAATCGACCTCTCTGGCATTGAAGGTGTTAAGGTTGATAAACATTC
CACAGGAGGCGTTGGCGATAAGACGACGATTGCCCTTGCTCCCCTCGTGGCATCGGTTGGTG
TTCCTGTTGCCAAAATGTCTGGAAGGGGGCTCGGGCATACAGGTGGAACGATTGACAAGCTA
GAGTCGATCGCAGGTTTTAACGTGGAAATTCCGACGGAGCGCTTTCTTGAGCTTGTGAACAA
AAATAAGCTTGCCGTCGTTGGGCAAACAGCGAATTTAACCCCTGCCGATAAAAAGTTGTACG
GCCTTCGCGATGTGACCGCAACGGTGAATTCGATTCCGCTCATTGCCAGCTCGATCATGAGC
AAAAAAATAGCTTCAGGCGCTAACGCCATCGTTCTCGATGTAAAAACAGGGTCAGGGGCGTT
TATGAAAGAGCTTGAGCAATCAAAAGAGCTTGCCGAAGCGATGGTGGAAATCGGCAACAACC
TTGGAAGGCAAACAATGGCGGTTATTTCTGATATGAATCAGCCGCTTGGATGGGCTGTTGGA
AATGCCCTTGAAGTGAAGGAAGCAATTGATATGCTTCGGGGCGAGGGACCAGATGATTTGCG
CGAGCTTTGTTTAACCCTTGGTAGCCATATGGTCTTTTTAGCGAAACAAGCTACTTCCGTGG
CAGACGCCCGTCAAAAGCTAGAGGAAGCGATTTCCTCTGGTAAAGCACTGGACACACTAAAA
ACGTTCATTAGTGCGCAAAACGGTGATCCATCTGTAGTAGACAATCCGCAGCTTCTTCCAAC
TGCCCAATTCCAAATAGAAGTAAAGGCAGAGGAAAATGGACATGTAGCGTCGATTGTTGCTG
ACCGTATTGGTACTGCAGCGATGGTTCTCGGAGCTGGACGAGCAACGAAGGAATCGGACATT
GATTTGTCTGTTGGAATCGTTCTGAAGAAGAAAATGGGTGAGTCGGTGCAAGCAGGTGAAAC
GCTTGCGATTCTTCATGCAAACAAAGAGGATGTCCAAGAAGTGATCGATAGGGTGATTAAAG
CCTATCACATCTCTCCTGATCCTGTCGCAAAGCCAACGCTCATTTACGAGGAGATTCATTAA 
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